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Abbreviations 
 Acronym Full Title 
AATOM(-C; -R) Australian Alcohol Treatment Outcome Measure (Clinicians; Researchers) 
ADHDQ Attention Deficit Hyperactivity Disorder Questionnaire 
ADS Alcohol Dependence Scale  
ASI  Addiction Severity Index 
ASSIST The Alcohol, Smoking and Substance Involvement Screening Test 
AUDIT Alcohol Use Disorders Identification Test 
AVON Avon Mental Health Measure 
BAI Beck Anxiety Inventory 
BASIS-32 Behaviour and Symptom Identification Scale 
BDDQ Body Dysmorphic Disorder Questionnaire 
BDEPQ  Benzodiazepine Dependence Questionnaire 
BDI  Beck Depression Inventory 
BHS Beck Hopelessness Scale 
BIDQ Body Image Disturbance Questionnaire 
BPRS Brief Psychiatric Rating Scale 
BSI Brief Symptom Inventory 
BSSI Beck Scale for Suicidal Ideation 
BTOM  Brief Treatment Outcome Measure 
CABA Child and Adolescent Burden Assessment 
CAGE / CAGEAID Cutdown, Annoyed, Guilty, Eye-Opener (Adapted to Include Drugs) 
CAN Camberwell Assessment of Need 
CAPE-BRS Clifton Assessment Procedures for the Elderly  
CAPS Clinician-Administered PTSD Scale  
CBLC Child Behavior Check List 
CCQ Cocaine Craving Questionnaire  
CDI  Children’s Depression Inventory 
(C)GAS (Children’s) Global Assessment Scale 
CIBIC+ Clinician’s Interview Based Impression of Change Scale  
CIDI Composite International Diagnostic Interview 
ComQoL Comprehensive Quality of Life Scale  
CPQ Cannabis Problems Questionnaire 
CUDIT Cannabis Use Disorders Identification Test 
D&A Drug and Alcohol  
DALI Dartmouth Assessment of Lifestyle Instrument 
DAS Disability Assessment Schedule 
DASS Depression Anxiety Stress Scales 
DAST(-A) Drug Abuse Screening Test (Adolescent) 
DHS Dispositional Hope Scale 
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DSM(-III; -IV) Diagnostic and Statistical Manual of Mental Disorders (3rd; 4th Edition) 
DUDIT Drug Use Disorders Identification Test 
(CH)EAT (Children’s) Eating Attitudes Test 
EDI Eating Disorder Inventory 
GAF Global Assessment of Functioning Scale 
GAIN Global Appraisal of Individual Needs 
GHQ General Health Questionnaire 
GWB General Wellbeing Scale  
HoNOS  Health of a Nation Outcome Scale 
ICD(-9; -10) International Classification of Diseases (9th; 10th Revision) 
ICQ Impaired Control Scale 
IES Impact of Events Scale 
IRIS Indigenous Risk Impact Screen 
K10 Kessler Psychological Distress Scale 
LDQ Leeds Dependence Questionnaire  
LES  Life Experience Survey 
LOCSS Location of Community Support Scale 
LRI Life Regard Index 
LSP Life Skills Profile 
MAP Maudsley Addiction Profile 
MAT Manchester Audit Tool 
(b; S)MAST(-G) (Brief; Short) Michigan Alcoholism Screening Test (Geriatric) 
MCQ Marijuana Craving Questionnaire  
MCS  Mental Component Summary 
MHI  Mental Health Inventory 
MMSE  Mini-Mental State Examination 
MOS-SSS Medical Outcome Study Social Support Survey 
NPV Negative Predictive Value 
OAP Outcome Assessment Program 
OMP Opioid maintenance pharmacotherapy 
OPUS Outcome of Problems of Users of Services 
OTI Opiate Treatment Index 
PACS Penn Alcohol-Craving Scale  
PANAS Positive and Negative Affect Schedule 
PANSS  Positive and Negative Syndrome Scale 
PC-PTSD Primary Care PTSD Screen 
PCL-C PTSD Checklist 
PCS  Physical Component Summary 
PDS Posttraumatic Stress Diagnostic Scale 
PIL Purpose in Life Test  
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POSIT Problem Oriented Screening Instrument for Teenagers substance use/abuse 
scale 
PPV Positive Predictive Power Value 
PSAS Psychiatric Symptom Assessment Scale 
PSH Psychosocial History   
(M)PSS-SR (Modified) PTSD Symptom Scale Self-Report 
PTSD Posttraumatic Stress Disorder 
QoL Quality of Life assessment 
RAS Recovery Assessment Scale 
RAFLS  Resource Associated Functional Level Scale 
RCMAS Revised Children’s Manifest Anxiety Scale 
RFS Role Functioning Scale 
SA-45 Symptom Assessment 
SADD  Short Alcohol Dependence Data Questionnaire 
SADQ(-C) Severity of Alcohol Dependence Questionnaire 
SANS Scale for Assessment of Negative Symptoms 
SAS Social Adjustment Scale 
SBS Social Behaviour Scale 
SCAN Schedules for Clinical Assessment in Neuropsychiatry 
SCID Structured Clinical Interview for DSM-IV 
SCL-90-R Symptom Checklist-90-Revised 
SDQ  Strengths & Difficulties Questionnaire 
SDS Severity of Dependence Scale 
SDSS Substance Dependence Severity Scale 
SF-36; SF-12 Short-Form Health Survey 
SOC Sense of Coherence Scale 
SODQ  Severity of Opiate Dependence Scale 
SPWB Scales of Psychological Well-being 
SRQ Self Reporting Questionnaire 
STAI (STAI-S; STAI-T) Spielberger State Trait Anxiety Inventory  
STORI Stages of Recovery Instrument 
T-ACE  Tolerance; Annoyed; Cut down; Eye Opener  
TLEQ Traumatic Life Events Questionnaire 
TLFB Timeline Followback Method 
TOP Treatment Outcomes Profile 
TSQ Trauma Screening Questionnaire 
TWEAK Tolerance; Worried; Eye Opener; Amnesia; (K) Cut down 
WHODAS World Health Organisation Disability Assessment Schedule 
WHOQoL World Health Organisation Quality of Life 
YSR  Youth Self Report 
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Scope of this Review (Aims and Limitations) 
Standardised tools cover a range of areas which may be relevant to Drug and Alcohol (D&A) services. 
This review provides an overview of some useful standardised tools that can be used to measure 
treatment outcomes and to screen and assess for mental health symptoms and conditions, drug and 
alcohol use and disorders and general functioning. Focus has been given to tools that require limited 
training to use and are freely available. It should be noted that some of these tools require specialist 
training, or else mislabelling, misinterpretation, or inappropriate use may occur (Groth-Marnat, 2003; 
Roche & Pollard, 2006). Some tools are copyright protected and need to be purchased, and/or require 
the user to have specific qualifications. It is important that workers are aware of what they are, and are 
not, trained to use, and seek training where required.  
Screening is designed only to highlight the existence of symptoms, not to diagnose clients. Most of the 
measures described are completed as a self-report (i.e., they are completed by the client). Others, 
however, need to be administered by a worker. It should be noted that, unfortunately, there are no 
brief measures with established reliability and validity for the identification of possible personality 
disorders. The possible presence of these disorders needs to be assessed by a health professional that is 
qualified and trained to do so (e.g., a registered or clinical psychologist, or psychiatrist). 
There is a general lack of a standardised approach to screening, assessment and outcome measurement 
in the D&A sector. A variety of different tools are used, some of which are empirically established 
instruments whilst others are purpose-built, internally designed tools with increased practicality and 
utility but unknown validity and reliability (Roche & Pollard, 2006). This review focuses solely on the 
former. Similarly, it is important to note that this review, in and of itself is not exhaustive, as the number 
of available instruments is vast. Nevertheless, all attempts have been made to include the most relevant 
and useful measures. 
Methodology  
This review will focus on both domestic and international tools with particular consideration given to 
those tools widely used in NSW. The review includes tools and measures related to substance misuse, 
mental health symptomology and wider general health and social functioning issues. Information on the 
psychometric properties, availability, applicability and accessibility of each measure/tool will be 
presented. To obtain such information, a thorough search of the literature was conducted, using a range 
of databases (including: Medline, PsychInfo, Cochrane Database of Systemic Reviews, Pubmed, the 
National Clearinghouse for Alcohol and Drug Information, Evidence Based Medicine Reviews, industry 
magazines such as ‘Of Substance’, the Alcohol and Other Drug Council of Australia’s (ADCA) Drug 
database, and associated reference lists), in conjunction with both other published literature and a grey 
literature search. 
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Introduction 
Given the high rates of co-occurring mental health conditions among clients of D&A treatment services, 
it is essential that routine screening and assessment be undertaken for these conditions as part of case 
formulation. Case formulation involves the gathering of information regarding factors that may be 
relevant to treatment planning, and formulating a hypothesis as to how these factors fit together to 
form the current presentation of the client’s symptoms (Sim, Gwee, & Bateman, 2005). This information 
is the first step to devising (and later revising) the client’s treatment plan. There is no standardised 
approach to case formulation (Roche & Pollard, 2006), but it is crucial that a range of different 
dimensions be considered, including history of present illness, D&A use history (amount and frequency, 
abuse or dependency syndrome), physical/medical conditions, mental state, psychiatric history, trauma 
history, suicidal or violent ideation, readiness to change, family history, criminal history, social and 
cultural issues. Consideration also needs to be given to the client’s age, sex, sexual orientation, ethnicity, 
spirituality, socio-economic status, and cognitive abilities. Screening is the initial step in the process of 
identifying possible conditions (Croton, 2007). This process is not diagnostic (i.e., it cannot establish 
whether a disorder actually exists); but rather, it identifies the presence of symptoms which may 
indicate the presence of a disorder. Thus, screening helps to identify individuals with symptoms that 
may require further investigation and treatment. 
Identifying the needs of clients is fundamental to the case formulation process. It is important that 
whatever needs the client might have are recognised as they will undoubtedly impact upon treatment. 
Early diagnosis and treatment of conditions can improve client treatment outcomes (Myrick & Brady, 
2003). Identification does not necessarily mean that the worker has to personally treat the difficulty the 
client is experiencing; however, it allows workers to consider the impact of these needs, manage them 
accordingly, and engage other services where necessary.  
Early identification of all conditions present allows for early intervention, which may lead to better 
prognosis, more comprehensive treatment, and the prevention of secondary disorders (Chan, Dennis, & 
Funk, 2008). Diagnostic assessment should ideally occur subsequent to a period of abstinence (Hasin, 
Trautman, & Endicott, 1998; Quello, Brady, & Sonne, 2005), or at least when the person is not 
intoxicated or in withdrawal. While the length of this period is not well established, a stabilisation period 
of between two to four weeks is recommended (Strain, 2002). If symptoms persist after this period, they 
can be viewed as independent rather than substance-induced. Realistically, such a period of abstinence 
is a luxury rarely afforded in D&A treatment settings and, therefore, to avoid possible misdiagnosis, it 
has been recommended that multiple assessments be conducted over time. This process allows the D&A 
worker to formalise a diagnosis and develop a tailored case plan that is reviewed and modified, allowing 
for greater accuracy and flexibility in assessment and treatment. 
Screening forms one of the first parts of the assessment process. Unlike screening, assessment is a 
process rather than a one-off event, which involves the ongoing monitoring of clients’ mental health and 
substance use disorder symptoms along with their psychosocial functioning and wellbeing. Ongoing 
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assessment is important because clients’ symptoms and functioning may change throughout treatment. 
For example, a person may present with symptoms of anxiety and/or depression upon treatment entry; 
however, these symptoms may subside with abstinence. Alternatively, a person may enter treatment 
with no mental health symptoms, but symptoms may develop after a period of reduced use or 
abstinence, particularly if the person has been using substances to self-medicate these symptoms.  
Groth-Marnat (2003) suggests that a combination of both informal and standardised assessment 
techniques is the best way to develop a case formulation. In addition to these assessments, with the 
client’s consent, it may be useful to talk with family members or carers; they can provide invaluable 
information regarding the client’s condition which the client may not recognise or may not want to 
divulge (Australian Government Department of Health and Ageing, 2006).   
An equally important component of a treatment program is regular review and assessment of the 
client’s progress in relation to their treatment goals, that is, outcome assessment (Treatment Protocol 
Project (TPP), 2000). Again, both informal (non-standardised) and formal procedures are necessary. For 
instance, the measurement of quantity/frequency of substance use, mental health symptoms, and any 
other relevant outcomes as required by the initial assessment, and/or the service environment within 
which the individual worker is operating (APA, 2006; NSW Health, 2008).   
For the purpose of this paper, only standardised tools for the screening, assessment and outcome 
process are to be considered, however, it is important for workers to be aware of informal procedures 
(e.g., the semi-structured interview, available from the NSW Department of Health (2007)), as these 
procedures may capture individual client factors specifically relevant to their situation. 
Standardised tools can be a useful means of gathering data by providing an objective (reliable and valid) 
view of the client’s difficulties and current life situation (Ries, 1995; Winters, 1999). Furthermore, when 
conducted appropriately the process of standardised assessment can be a source of rapport building. 
Groth-Marnat (2003) suggests that when conducting standardised assessment, it is important to: 
• Provide the client with the reasons for assessment and the purpose of each instrument. 
• Explain that it is a standard procedure. 
• Explain how standardised assessment can be useful in helping clients achieve their goals (e.g., by 
providing an objective measure). 
• Provide appropriate and timely feedback of the results of the assessment. 
Standardised assessment should be completed upon entry into and exit from treatment, as well as at 
follow-up (Mattick & Hall, 1993; Winters, 1999). Specific instruments are also often useful and 
recommended for periodic completion to monitor client condition (e.g., it is recommended that the 
BTOM be completed every 3 months). Test results can provide useful clinical information (for both the 
client and D&A worker) on the client’s case and an evaluation of how effective treatment has been. A 
variety of different tools are used, some of which are empirically established instruments, whilst others 
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are purpose-built, internally designed tools with increased practicality and utility but unknown validity 
and reliability (Roche & Pollard, 2006). There are no definite rules guiding the frequency with which 
outcome measurement and monitoring should occur, and therefore is often a matter of judgement by 
the individual worker (Treatment Protocol Project (TPP), 2000). Several authors have suggested that 
most interventions are likely to show results within one month (if the client is going to respond at all), 
depending on the frequency of sessions (Kay-Lambkin, Baker, & Lewin, 2004; Scogin, 2003; Scogin, 
Hanson, & Welsh, 2003). However, in some service settings (specifically opioid maintenance 
pharmacotherapy (OMP)), 3-monthly assessment/review sessions are recommended (NSW Health, 
2008).   
Psychometric Properties 
In assessing screening instruments and assessment tools in general, particular attention should be paid 
to the sensitivity and specificity of the instrument as well as its reliability and validity. The term 
sensitivity describes the proportion of individuals with the condition who test positive on that test, 
while the specificity of a test is the proportion of those without the condition who test negative. These 
have values between 0 and 1 and research in this area is devoted to ascertaining the best cut-off for a 
test or screen that produces the highest combination of these two variables.  
A test needs to be valid in that it is measuring what it is intended to measure. There are a range of 
different forms of validity. Content validity refers to the instrument’s comprehensiveness (i.e., how 
adequately the sampling of items reflects its aims). It is often assessed by feedback from consumers and 
clinicians. Construct validity involves conceptually defining the construct to be measured by the 
instrument, and assessing the internal structure of its components and the theoretical relationship of its 
item and subscale scores. Convergent validity is the degree to which an instrument is similar to 
(converges on) other measures that it theoretically should also be similar to, while discriminant validity 
describes the degree to which the instrument is not similar to (diverges from) other measures that it 
theoretically should not be similar to. Criterion validity assesses the extent to which the instrument 
correlates with other established measures (benchmark standard or “gold standard” measures). 
Concurrent validity measures an instrument’s similarity to comparative measures, at the same point in 
time, while predictive validity assesses its ability to predict a future outcome. 
 A test also needs to be reliable in that it will give high positively-correlated results when re-
administered by the same rater at two different points in time, given nothing else has changed (test-
retest reliability). A good scale also has good inter-rater reliability which relates to the degree of 
agreement when the same instrument is applied to the same client by different raters at the same point 
in time. Clearly a scale or test cannot be valid if it is not reliable. A good scale will also be internally 
consistent in that all items make a significant contribution to the final score or rating. The level of 
reliability of an instrument is traditionally measured by a kappa value. Kappas of ≤ 0.20 are regarded as 
poor, 0.21-0.40 as fair, 0.41-0.60 as moderate, 0.61-0.80 as good, and ≥0.81 as very good. 
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Layout of Current Review 
Many tools used in the case formulation process do not fit cleanly into one particular category (i.e., a 
depression measure) but rather contain items that measure a range of factors (e.g., social functioning 
and general psychological distress). Similarly, they do not necessarily function only as an –outcome tool 
or a screening tool but can be used as both. This is discussed on an individual basis for each measure. 
Therefore this review is broken down into several categories: 
1. Global measures – tools that measure a range of client factors (e.g., substance use, 
psychological and physical health, social functioning). 
2. General health and functioning measures – tools that rate an individual’s functioning abilities 
and limitations. 
3. General mental health measures – tools that measure a range of psychological symptoms (e.g. 
distress). 
4. Specific mental health measures – tools that measure the symptoms of one disorder class only. 
5. Positive mental health measures – an emerging area for outcome measurement in mental 
health has come from the philosophies of recovery, wellbeing, empowerment and 
rehabilitation. 
6. General substance misuse measures – brief tools to ascertain the existence/nature of the 
substance problem  
7. Severity of substance misuse measures – more specific tools to measure the severity of the 
substance use problem 
8. Craving measures – this section provides an outline of some potentially useful drug craving 
measures 
For each tool, information has been included on its psychometric properties (according to available 
research), its suitability for particular client groups, availability/cost and scoring administration and 
expertise required.
A Review of Screening, Assessment and Outcome Measures for Drug and Alcohol Settings 
13 
 
Summary Table 
Instrument Utility/Measures Administration Strengths  Limitations Cost 
GLOBAL INSTRUMENTS 
Addiction Severity 
Index (ASI) 
Assessment and outcome measurement. 
30 day & lifetime alcohol use, drug use, medical 
problems, psychiatric problems, family/social 
problems, employment, legal problems. 
Interview or self-
report  
Widely used across a range of 
population groups.  
Psychometric and 
interpretation concerns. 
Less extensive Australian 
use. Lengthy 
No 
Brief Treatment 
Outcome Measure 
(BTOM) / Australian 
Alcohol Treatment 
Outcome Measure 
(AATOM) 
Outcome measurement. 
Bloodborne virus risk, drug use, social and 
psychological functioning, health. 
Interview  Adequate reliability and validity. 
Australian. No training required. 
Previous use within D&A sector in 
NSW. Public domain. 
Limited testing across 
populations  
No  
Global Appraisal of 
Individual Needs (GAIN) 
Assessment and outcome measure. 
Background information, substance use, physical 
health, risk behaviors, mental health, 
environment, legal, and vocational information. 
Interview (can also 
be self-administered)  
DSM-IV diagnosis. Includes 
satisfaction index. Range of short 
versions. Comprehensive. Good 
psychometrics. 
Copyrighted/cost. 
Lengthy.  American 
terminology. Not widely 
used outside USA. 
Yes  
Health of the Nation 
Outcome Scale (HoNOS) 
Assessment and outcome measurement. 
Severity of aggression, self harm, D&A use, 
memory/orientation, physical problems, mood 
disturbance, hallucination and delusions, other 
mental, social relationships/environment. 
Interview  Generally adequate validity and 
reliability. Thoroughly evaluated 
and extensively used across a range 
of populations (incl. Indigenous 
Australians). Public domain.  
Inter-rater reliability 
concerns. Training 
required. 
No  
Indigenous Risk Impact 
Screen (IRIS) 
Screening. 
D&A problems and mental health risks. 
Interview Aboriginal and Torres Strait 
Islander specific. Adequate 
reliability and validity. Brief. Public 
domain. 
Aboriginal and Torres 
Strait Islander specific. 
Limited empirical 
validation 
No  
Maudsley Addiction 
Profile (MAP) 
Outcome measurement.  
Substance use, health risk behaviour, physical 
and psychological health, social functioning. 
Self-report or 
interview 
Adequate reliability and validity. 
Used widely across different 
cultural groups. Public domain 
Limited validation in 
specific population groups 
and outside of Europe. 
No  
Opiate Treatment Index 
(OTI) 
Assessment and outcome measurement. 
D&A use, risk taking, social functioning, 
criminality, health status, psychological 
adjustment. 
Interview  Good reliability and validity. 
Australian. Public domain. 
Training required. Only 
moderate validation in 
different populations. 
Lengthy. Predominantly a 
research instrument.  
No  
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Instrument Utility/Measures Administration Strengths  Limitations Cost 
GENERAL HEALTH & FUNCTIONING INSTRUMENTS 
Camberwell Assessment 
of Need (CAN) 
Assessment and outcome measurement. 
Comprehensive needs in 22 areas. 
Interview (or self-
report) 
Widely used. Validated in Australia. 
Specific versions for different client 
groups. No formal training 
required. 
Descrepancies between 
client and clinician ratings 
of need. 
Yes  
Children’s Global 
Assessment Scale 
(CGAS)  
Assessment and outcome measurement.  
Functioning and psychiatric dysfunction for 
children and adolescents 
Interview Specifically children and 
adolescents but adult version also 
exists. Good validity. Use in variety 
of populations. Freely available. 
Concerns over inter-rater 
reliability. Clinical 
expertise required. 
No 
Global Assessment of 
Functioning Scale (GAF)  
Assessment and outcome measurement. Overall 
level of psychological, social and occupational 
client functioning. 
Self-report Used in both psychiatric and D&A 
populations. Freely available. Based 
on DSM criteria. 
Training essential to 
interpretation. Some 
validity and reliability 
concerns. 
No  
Life Skills Profile (LSP) Outcome measurement and assessment. 
Range of functioning areas (Self-care, anti-social, 
withdrawal, compliance). 
Interview Positive mental health philosophy. 
Generally good psychometrics. 
Validated in a range of populations 
(incl. D&A, psychiatric and 
Indigenous). Brief and easy to use. 
Some inter-rater issues. No  
Short-Form 36 Health 
Survey (SF-36; SF-12) 
Screening, assessment and outcome 
measurement. 
Physical/emotional role limitation and 
functioning, bodily pain, mental health, social 
functioning, vitality/ general health perceptions.  
Self-report Brief. Very good psychometrics. 
Widely validated in an Australian 
context and across a range of 
populations (incl. D&A users and 
mentally ill).  
Licence fees apply. Yes  
Strengths and 
Difficulties 
Questionnaire (SDQ) 
Screening, assessment and outcome 
measurement.  
Conduct problems, emotional symptoms, 
hyperactivity, peer relationships and prosocial 
behaviour.  
Variety of collection 
methods  
Moderate-good psychometrics. 
Widely used in psychiatric and D&A 
populations and cross culturally. 
Although copyrighted it is available 
without cost. Australian norms. 
Brief. 
Limited to 
children/adolescents 
Not for 
non-
profit 
organi-
sations 
World Health 
Organisation Disability 
Assessment Schedule II 
(WHODAS II) 
Assessment and outcome measurement 
Assess the activity limitations and participation 
restrictions experienced by an individual 
(understanding and communicating, getting 
around, self-care, getting along with people, life 
activities, participation in society). 
Variety of collection 
methods  
Brief. Public domain. Adequate 
psychometrics. Cross cultural and 
Australian validation. 
Limited use in D&A 
populations. 
No  
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Instrument Utility/Measures Administration Strengths  Limitations Cost  
World Health 
Organisation Quality of 
Life-BREF (WHOQoL-
BREF)  
Outcome measurement and assessment. 
Physical health, psychological health, social 
relationships, and environment.  
 
Self-report Brief. Cross cultural and Australian 
validation. Used widely across a 
range of populations (incl. D&A 
users and mentally ill). Adequate 
psychometrics. Public domain.  
Requires competent 
reading ability. 
No  
GENERAL MENTAL HEALTH INSTRUMENTS 
The Behaviour and 
Symptom Identification 
Scale 32 BASIS-32® 
Screening and Outcome measure. 
Impulsive and addictive behaviour, Psychosis, 
Relation to self and others, Depression and 
anxiety and Daily living and role functioning 
Variety of collection 
methods  
Good psychometrics. Australian 
version available. Used in D&A 
samples 
Copyrighted/cost. High 
reading level required for 
self-report version. 
Yes  
Brief Psychiatric Rating 
Scale (BPRS) 
Screening. 
Thought disorder, withdrawal, 
anxiety/depression, hostility and activity. 
Interview  Successfully used in D&A 
populations and across age groups. 
Adequate validity 
Inter-rater reliability 
concerns. Training and 
qualifications required and 
intensive ongoing 
supervision. 
No  
Depression Anxiety 
Stress Scale (DASS) 
Screening and outcome measurement.  
Depression, anxiety and stress (general 
psychological distress). 
Self-report Good reliability and validity. Fairly 
widely used across cultures and 
age groups. 
Interpretation requires 
expertise. 
No  
General Health 
Questionnaire (GHQ) 
Screening. 
Somatic symptoms, anxiety/insomnia, social 
dysfunction, severe depression. 
Self-report Good reliability and validity. Widely 
used across a range of populations 
(incl. D&A users).  
Lower reliability in general 
population. 
Yes but 
GHQ-
28 is 
part of 
the OTI  
Kessler psychological 
distress scale (K10) 
Screening. 
Psychological distress. 
Self-report (or 
interview if required) 
Good reliability and validity. Widely 
used across a range of populations 
(incl. D&A users). Australian norms. 
Public domain. Brief. 
Only screens for distress 
broadly. 
No  
Mental Health 
Inventory (MHI) 
Screening and outcome measurement. 
General psychological distress and wellbeing. 
Self-report or 
interview 
Adequate psychometrics. Easy to 
use.  
Only limited use across 
population groups. 
No  
PsyCheck Screening. 
General mental health, suicidality/self-harm, 
depression and anxiety symptoms. 
Mixed administration Adequate reliability and validity. 
Australian. Designed for use in D&A 
treatment settings. 
Few empirical studies. No  
 
A Review of Screening, Assessment and Outcome Measures for Drug and Alcohol Settings 
16 
 
Instrument Utility/Measures Administration Strengths  Limitations Cost  
Symptom Checklist-90-
Revised (SCL-90-R) 
Screening and outcome measurement. 
Somatisation, obsessive compulsive, 
interpersonal sensitivity, depression, anxiety, 
hostility, phobic anxiety, paranoid ideation, 
psychoticism. 
Self-report Good reliability and validity. Used 
in D&A populations. Long and 
shorter versions available. 
Costs involved and 
qualifications required. 
Yes  
SPECIFIC MENTAL HEALTH INSTRUMENTS 
Beck Inventories Screening, assessment and outcome 
measurement.  
Symptoms of depression and anxiety, 
hopelessness and suicidal ideation. 
Self-report or 
interview 
Generally well researched, with 
good psychometrics. Brief. 
Cost involved in use and 
only available to those 
with psychiatric or 
psychological 
qualifications. 
Yes  
Body Dysmorphic 
Disorder Questionnaire 
(BDDQ) 
Screening. 
Disturbed body image 
Self-report Good sensitivity/specificity. Brief.  Lack of reliability/validition 
studies.  
Yes  
Eating Attitudes Test 
(EAT) 
Screening and outcome measurement. 
Disturbed eating patterns. 
Self-report Brief. No special training required. 
Freely available online. Good 
psychometrics. 
Does not assess more 
general dysfunctional 
attitudes and related 
psychopathology. Limited 
validation in men and D&A 
users 
No  
Impact of Event Scale 
(IES) 
Screening and outcome measurement. 
Current degree of subjective stress (PTSD 
symptoms) experienced as a result of a specific 
event. 
Self-report Extensive testing. Good 
psychometrics. Freely available 
online. No special training 
required. Brief. 
Requires competent 
reading ability. 
No  
Primary Care PTSD 
Screen (PC-PTSD) 
Screening. 
PTSD symptoms. 
Self-report Very brief. Public domain. Used in 
D&A settings, adolescents and 
veterans.  
Limited empirical testing.  No  
Psychosis Screener (PS) Screening. 
Psychotic symptoms. 
Interview  Adequate reliability and validity. 
Used in homeless and D&A using 
populations. 
Mixed success in prison 
populations. 
Sensitivity/specificity 
varies. 
No  
PTSD Checklist (PCL) Screening. 
PTSD symptoms. 
Self-report Excellent psychometrics. Different 
versions available. Public domain. 
Used in a variety of populations 
(incl. D&A users). 
Cut-off points and scoring 
methods may vary. 
No  
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Instrument Utility/Measures Administration Strengths  Limitations Cost  
PTSD Symptom Scale 
Self-Report (PSS-SR) / 
Posttraumatic Stress 
Diagnostic Scale (PDS) 
Screening and outcome measurement.  
PTSD symptoms. 
Self-report Good psychometrics. Used in wide 
range of populations (incl. D&A 
users). 
Copyrighted/cost. Yes  
Spielberger State Trait 
Anxiety Inventory 
(STAI) 
Screening and outcome measurement. 
Transitory and enduring anxiety. 
Self-report Widely used (incl. D&A users). 
Moderate-good psychometrics. 
Cost involved in use and 
qualifications required. 
Yes  
Traumatic Life Events 
Questionnaire (TLEQ) 
Screening. 
Intense fear, helplessness and horror symptoms 
of trauma and frequency trauma. 
Self-report or 
interview 
Adequate reliability and validity. 
Used in adolescents, D&A user and 
prison populations. 
Copyrighted/cost involved. 
Limited empirical testing. 
Yes  
Trauma Screening 
Questionnaire (TSQ) 
Screening. 
Re-experiencing and arousal PTSD symptoms. 
Self-report Simple. Adequate psychometrics in 
preliminary studies. Freely 
available. 
Limited empirical studies. No  
POSITIVE MENTAL HEALTH INSTRUMENTS 
Dispositional Hope 
Scale (DHS) 
Outcome measurement. 
Hope. 
Self-report Used across cultures. No training 
required. Freely available. Brief.  
Limited empirical 
evidence. 
No  
Recovery Assessment 
Scale (RAS) 
Outcome measurement. 
Empowerment, coping ability, and quality of life. 
Self-report Simple and effective. Freely 
available online. 
Not widely used. No  
Social & Emotional 
Wellbeing &  
Empowerment Tool 
Outcome measurement  
Empowerment. 
Self-report Aboriginal and Torres Strait 
Islander specific. 
Still being finalised - 
Scales of Psychological 
Well-being (SPWB) 
Outcome measurement. 
Psychological well-being: autonomy, positive 
relationships, environmental mastery, personal 
growth, purpose in life, and self-acceptance. 
Self-report Used across cultures. No training 
required. Long and shorter versions 
are available. 
Small cost in obtaining the 
tool. Moderate and mixed 
reliability and validity. 
Minimal  
Stages of Recovery 
Instrument (STORI) 
Outcome measurement. 
Recovery as the concept is described by mental 
health consumers. 
Self-report Freely available. Brief. Good 
preliminary findings. 
Limited empirical 
evidence. 
No  
GENERAL D&A INSTRUMENTS 
Alcohol, Smoking and 
Substance Involvement 
Screening Test (ASSIST) 
Screening. 
D&A use and risk (lifetime/recent substance use, 
specific substance involvement, frequency, 
dependence, abuse, intravenous drug use). 
Interview  Good psychometrics across a range 
of cultures. Brief and simple to 
administer. Includes brief 
intervention strategies. Public 
domain. 
Limited empirical evidence 
for sub-populations. 
No  
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Instrument Utility/Measures Administration Strengths  Limitations Cost 
Alcohol Use Disorders 
Identification Test 
(AUDIT) 
Screening and outcome measurement. 
Alcohol use: consumption, dependence, and 
related-problems. 
Self-report or 
interview 
Freely available. Brief. Good 
psychometrics across a vast range 
of populations (incl. mentally ill). 
No training required. Australian 
version. 
Concerns about utility in 
females, Indigenous and 
older populations. 
Intended for general 
population. 
No  
CAGE/CAGEAID Screening. 
Identify problem alcohol use. 
Self-report or 
interview 
Very brief. Moderate-good 
psychometrics. Used in a variety of 
populations (adapted for 
Indigenous Australians). Freely 
available. 
Test-retest concerns. 
Concerns about utility in 
females and mentally ill 
populations. 
No  
Dartmouth Assessment 
of Lifestyle Instrument 
(DALI) 
Screening. 
Substance use disorders use with people with 
severe mental illness. 
Interview  Brief and simple. No special 
training required. Adequate 
psychometrics 
Limited studies in different 
populations. 
No  
Drug Abuse Screening 
Test (DAST) 
Screening and assessment. 
Identify problem drug use. 
Self-report or 
interview 
Brief. Freely available. Good 
psychometrics in range of 
populations (incl. mentally ill). 
Concerns over applicability 
to women and across 
cultures. Does not 
discriminate between past 
and present use. 
No  
Michigan Alcoholism 
Screening Test (MAST) 
Screening and assessment. 
Identify problem alcohol use. 
Self-report or 
interview 
Brief. Public domain. Good 
psychometrics across a range of 
populations (incl. mentally ill). No 
training required for use. 
Does not discriminate 
between past and present 
drinking. Concerns over 
applicability to women 
and across cultures. 
No  
T-ACE/TWEAK Screening. 
Specifically designed to identify at-risk drinking 
pregnant women (but has some utility in other 
groups). 
Interview  Available online without cost. Very 
brief. Moderate psychometrics. No 
training required. 
Does not provide a picture 
of pattern of use. Debate 
over suitable cut-off 
scores. 
No  
Timeline Followback 
Method (TLFB) 
Assessment and outcome measurement. 
Information on the amount/duration of D&A use 
over a specified period of time. 
Variety of collection 
methods 
Widely used (incl. in mentally ill 
populations). Simple. Adequate 
psychometrics. 
Training required.  Minimal  
D&A SEVERITY INSTRUMENTS 
Alcohol Dependence 
Scale (ADS)  
Assessment and outcome measurement. Identify 
and assess alcohol abuse and dependence. 
Self-report 
 
Adequate psychometrics. Brief. 
Fairly widely used in a variety of 
populations  
Copyrighted/cost. Yes  
 
A Review of Screening, Assessment and Outcome Measures for Drug and Alcohol Settings 
19 
 
Instrument Utility/Measures Administration Strengths  Limitations Cost 
Cannabis Problems 
Questionnaire (CPQ) 
Screening. 
Problematic cannabis use. 
Self-report Australian developed. Brief. Good 
psychometrics. Public domain. 
Limited empirical studies 
across different 
population groups. 
No  
Leeds Dependence 
Questionnaire (LDQ)  
Assessment and outcome measurement. 
Severity of D&A dependence 
Self-report Can be used across D&A 
dependence. Good psychometrics. 
Brief. Freely available. Incorporates 
psychological dependence rather 
than just consumption and physical 
dependence. 
Limited use in all types of 
substance dependence. 
Limited use across 
cultures.  
No  
Short Alcohol 
Dependence Data 
Questionnaire (SADD) 
Assessment and outcome measurement.  
Less severe alcohol dependence, behavioural and 
subjective changes.  
Self-report 
 
Freely available. Adequate 
psychometrics. Brief. 
Limited empirical studies. 
Lack of use across 
cultures. 
No  
Severity of Alcohol 
Dependence 
Questionnaire (SADQ) 
Assessment and outcome measurement.  
Severity of dependence on alcohol, withdrawal 
symptoms etc.  
Interview  Freely available. No special training 
required. Brief. Good 
psychometrics.  
Not widely used across all 
groups (e.g. psychiatric). 
Concerns about use in 
older people and women. 
No  
Severity of Dependence 
Scale (SDS) 
Screening and outcome measurement. 
Psychological dependence on a given substance. 
Self-report Very brief. Public domain. Good 
psychometrics. Widely validated in 
an Australian context and across 
drug types.  
Very brief. No  
Substance Dependence 
Severity Scale (SDSS)  
Assessment and outcome measurement. 
Severity of dependence on a variety of 
substances. 
Interview Generally adequate psychometrics. 
Range of substances. Based on 
DSM-IV validation.  
Lengthy. Some concern 
about the cannabis and 
sedative subscales. 
Minimal  
CRAVING MEASURES 
Cocaine Craving 
Questionnaire (CCQ)  
Screening. 
Cocaine craving 
Self-report  Brief. Easy to use. Adequate 
psychometrics. Used in psychiatric 
populations. 
Limited Australian 
empirical validation. 
Minimal  
Cocaine Craving 
Questionnaire (Weiss et 
al) 
Screening. 
Cocaine craving 
Self-report  Brief. Easy to use. Adequate 
psychometrics. 
Limited empirical studies 
across different groups. 
No  
Marijuana Craving 
Questionnaire (MCQ) 
Screening. 
Marijuana craving 
Self-report  Brief. Easy to use. Adequate 
psychometrics. 
Limited empirical studies 
across different groups. 
Minimal  
Penn Alcohol-Craving 
Scale (PACS)  
 Screening. 
Alcohol craving 
Self-report  Brief. Easy to use. Adequate 
psychometrics. Used in different 
settings in an Australian context. 
Limited empirical studies. Minimal  
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Global Screening, Assessment and Outcome Measures 
Opiate Treatment Index (OTI) 
The Opiate Treatment Index (OTI) (Darke, Ward, Hall, Heather, & Wodak, 1991) is a structured interview 
primarily developed to allow comparability between research findings. It is an appropriate measure for 
users of all different drugs, including alcohol (Darke, Hall, Wodak, Heather, & Ward, 1992). However, 
there is some dispute the utility of the OTI for alcohol as it does not assess patterns of use (Copeland, 
2009; personal communication). Mattick and Hall (1993) recommend the use of the OTI as a general 
initial assessment and outcome measure for clients using both licit and illicit drugs. The OTI measures six 
independent outcome domains: drug use, HIV risk-taking behaviour, social functioning, criminality, 
health status and psychological adjustment as measured by the GHQ-28. While it was not intended to be 
an alternative to a clinical assessment, it is a useful clinical tool providing information from which to 
evaluate a treatment program. 
The OTI was originally validated in an Australian opiate treatment setting in 1992 and demonstrated 
high levels of test-retest reliability (.77-.99) on all scales regardless of whether the same or a different 
interviewer administered the test (Darke et al., 1992). These findings were supported by a later UK study 
(Adelekan, Green et al., 1996). It also demonstrated generally high levels of internal consistency ranging 
from Cronbach’s alpha = .38-.83 in the Australian study and Cronbach’s alpha = .34-.93 in the UK study 
(Adelekan, Green et al., 1996; Adelekan, Metrebian, Tallack, Stimson, & Shanahan, 1996; Darke et al., 
1992). 
The OTI was found to have two main factors – ‘drug using lifestyle’ and ‘health and well being’  – which 
accounted for 60% and 55.4% of the total variance in the Australian and London studies respectively 
(Adelekan, Green et al., 1996; Darke et al., 1992). The instrument was also shown to have good 
convergent validity with the relevant ASI subscales (Darke et al., 1992). Scores on individual scales of the 
OTI were also compared with other relevant measures and found to significantly correlate with scores 
on the Health Status scale with independent medical examinations, between drug use scores and 
urinalysis results and between reported recent behaviours and partner collateral reports (Darke et al., 
1992). These findings were again replicated in the UK study, providing support for the convergent 
validity and cross-cultural validity of the measure (Adelekan, Green et al., 1996). 
Despite some concern over standardisation across interviewers, studies have found good levels of inter-
rater reliability, with few or no significant differences between information given to clinicians compared 
with research assistants (Adelekan, Metrebian et al., 1996; Deering & Sellman, 1996). The OTI has also 
been found to be sensitive to changes in D&A behaviour over time (Baker, Boggs, & Lewin, 2001; Baker 
et al., 2002a; Padaiga, Subata, & Vanagas, 2007; Shearer et al., 2001; Verthein et al., 2008). 
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Client groups 
Although initially developed for opioid use (Darke et al., 1992) the OTI is effective when used across licit 
(including alcohol; although concern has been raised regards its applicability to alcohol) and illicit drugs 
(Barrowcliff, Champney-Smith, & McBride, 1999; Mattick & Hall, 1993).It has been translated into a 
range of languages (e.g., Liu et al., 2000; Ruz, Gonzalez, & Ruiz, 1998; Swift, Maher, & Sunjic, 1999) and 
has been used effectively with people with serious mental illness and substance use problems in inner 
city Sydney (Teesson & Gallagher, 1999) and more widely across Australia (Baker et al., 2002b). 
The OTI is also an effective instrument when used in adolescent populations (Mills, Teesson, Darke, 
Ross, & Lynskey, 2004; Spooner, Mattick, & Noffs, 2001) 
Availability/cost 
The OTI is in the public domain and may be used without cost but with due acknowledgment of the 
source. It can be found at: 
• http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_29/$file/TR.011.pdf  
Scoring, administration and expertise required 
The manual clearly describes the administration procedure and scoring system for each of the scales, 
although scoring does require the calculation of formulas. The OTI can be administered without any 
specific training and takes approximately 20-40 minutes to complete.  
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Brief Treatment Outcome Measure (BTOM); Australian Alcohol Treatment Outcome 
Measure (AATOM) 
The Brief Treatment Outcome Measure (BTOM) (Lawrinson, Copeland, & Indig, 2003) is a tool developed 
specifically to routinely assess outcomes of treatment for clients receiving OMP services and for use in 
treatment evaluation research. Treatment outcome is measured by scales developed or adapted from 
other instruments across the domains of drug dependence (measured by SDS), blood borne virus 
exposure risk, drug use, health, psychological functioning and social functioning (Lawrinson et al., 2003). 
It was adopted for routine D&A treatment outcome monitoring in NSW.  It includes the National 
Minimum Data Set data items nested within it so does not duplicate existing data collection 
requirements. 
The evaluation of the BTOM took place in 37 metropolitan, rural and prison OMP services in NSW, 
among 160 OMP clients. The internal reliability of the BTOM was found to be satisfactory. Test-retest 
reliabilities for the scales and drug use scores are good to excellent indicating their consistency with 
multiple measurements across time and different interviewers and concurrent validation of BTOM 
scales with analogous scales from similar instruments (i.e., the OTI) yielded acceptable agreement 
(Lawrinson, Copeland, & Indig, 2005, 2006). 
Preliminary reviews were conducted on the predictors of outcome monitoring and existing outcome 
measures (Copeland, Rush, Reid, Clement, & Conroy, 2000; Teesson, Clement, Copeland, Conroy, & 
Reid, 2000). Similarly, an advisory group and on-going appraisal by clinicians and program administrators 
informed the development of the BTOM content. In this way, the BTOM has good content validity. 
A shorter version of the BTOM, the Brief Treatment Outcome Measure – Concise (BTOM-C) is also 
available. In this version the SDS, the Psychological Functioning Scale, days client spent in hospital and 
psychiatric medication questions have been dropped (NSW Department of Health, 2004). 
The recently designed Australian Alcohol Treatment Outcome Measure (AATOM) was developed as an 
equivalent alcohol tool. Two versions of the AATOM exist, one intended for use amongst clinicians for 
the purpose of routine treatment outcome monitoring (AATOM-C) and one for use amongst researchers 
(AATOM-R). In the initial sample of clients from D&A treatment agencies, the inter-rater and test-retest 
reliability of the AATOM-C was good to excellent for most scales. Internal consistency was considered 
acceptable (Cronbach’s alpha ≥ .73), as was concurrent validity (correlation coefficients between .55-
.93). Content validity was achieved in the same way as the BTOM. The results of the study demonstrate 
that the AATOM-C is, overall, a valid and reliable instrument, taking on average 10-15 minutes to 
administer (Simpson, Lawrinson, Copeland, & Gates, 2007). In line with its purpose, the instrument 
demonstrated the ability to measure change in client functioning over time (Simpson, Lawrinson, 
Copeland, & Gates, 2009).  
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Client groups 
Both the BTOM and the AATOM were designed to be administered to all new treatment clients and are 
suitable for all clients who can understand spoken English. Simpson and colleagues (2007) emphasise 
the importance of comprehensive and consistent training of those who are to administer the AATOM-C, 
as it was found one interviewer repeatedly produced poorer test-retest reliability. This is fundamental to 
each of these measures.  
Availability/cost 
The BTOM is in the public domain and is freely available from: 
• http://www.health.nsw.gov.au/pubs/2004/pdf/btomclinicansguide.pdf  
• http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_11/$file/TR.156.PDF  
The AATOM is published in Simpson and colleagues (2007), NDARC technical report 288. It is available 
for a minimal fee at: 
• http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/page/NDARC%20Technical%20Reports 
Scoring, administration and expertise required 
Both the BTOM and the AATOM are brief, easy to administer and can be easily scored, requiring no 
special training. Each take approximately 10-20 minutes to complete and it is recommended that they 
be completed once every three months. Concise versions are shorter and therefore take less time to 
complete. 
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Health of the Nation Outcome Scale (HoNOS)  
Health of the Nation Outcome Scale (HoNOS) (Wing et al., 1998) is a measurement tool designed to 
assess general health and social functioning of mentally ill people. It is a 12-item questionnaire that 
measures the severity of aggression, self harm, alcohol and drug use, memory/orientation, physical 
problems, mood disturbance, hallucination and delusions, other mental, social relationships, social 
environment. It has been found to be a useful measure of treatment effectiveness/client change over 
time if conducted at set intervals (Gallagher & Teesson, 2000b; Sharma, Wilkinson, & Fear, 1999; 
Teesson et al., 2000). However, some concerns have been raised by other authors who have 
recommended that it not be implemented as a major outcome tool, due to concerns regarding its 
reliability and validity  (Brooks, 2000).  
Generally studies looking at the inter-rater reliability of the HoNOS have found that the overall 
agreement between raters is only moderate at best (Amin et al., 1999; Bebbington, Brugha, Hill, 
Marsden, & Window, 1999; Brooks, 2000; Hope, Trauer, & Keks, 1998; Orrell, Yard, Handysides, & 
Schapira, 1999; Shergill, Shankar, Seneviratna, & Orrell, 1999; Wing et al., 1998) and that agreement is 
even poorer on particular items. Factors associated with improved inter-rater reliability include training, 
familiarity with consumers and setting (Audin, Margison, Clark, & Barkham, 2001; Brooks, 2000). 
Relatively few studies have examined the test-retest reliability of the HoNOS, but those that have, 
generally report fair to moderate overall reliability scores (r = .4-.8) (Brooks, 2000; Orrell et al., 1999; 
Shergill et al., 1999; Teesson et al., 2000). 
Several studies have suggested that the HoNOS has moderately high level of internal consistency 
(Cronbach’s alpha ranging from .59 to .76) and low levels of item redundancy, supporting its use as a 
meaningful summary of severity of symptoms (McClelland, Trimble, Fox, Stevenson, & Bell, 2000; Orrell 
et al., 1999; Page, Hooke, & Rutherford, 2001; Shergill et al., 1999; Trauer, 1999; Wing et al., 1998). It 
has been suggested, however, that the HoNOS should not be regarded as unidimensional, measuring a 
single, underlying construct of mental health status, but rather a tool to assess a broad range of 
problems typically experienced by consumers of mental health services and some factorial studies have 
supported this assertion (McClelland et al., 2000; Preston, 2000a; Trauer, 1999). 
The content validity of the HoNOS  has generally been found to be good (Teesson et al., 2000). A 
number of studies have reported that consumer/carer advocacy groups and mental health professionals 
felt the HoNOS was appropriate, well-designed and thorough, and highlights consumers’ problems 
quickly, indicating changes in their mental health status over time. However, not all items were 
regarded equally. A number of items and terminology was seen to be problematic and this raised 
concerns about misinterpretation of the scoring (McClelland et al., 2000; Orrell et al., 1999; Shergill et 
al., 1999). 
Preliminary studies found the scores on the HoNOS correlated well with clinician-rated instruments such 
as the Social Behaviour Scale (SBS), Schedules for Clinical Assessment in Neuropsychiatry (SCAN) (Amin 
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et al., 1999; Bebbington et al., 1999). Similarly, it has been found to perform well against the Role 
Functioning Scale (RFS), the BPRS, the GAS (Amin et al., 1999; Browne, Doran, & McGauran, 2000; 
McClelland et al., 2000; Orrell et al., 1999; Shergill et al., 1999; Wing et al., 1998), the LSP (Parker, 
O'Donnell, Hadzi-Pavlovic, & Proberts, 2002), the Manchester Audit Tool (MAT) (Rees, Richards, & 
Shapiro, 2004), the Disability Assessment Schedule (DAS) (Amin et al., 1999), Location of Community 
Support Scale (LOCSS) (Amin et al., 1999; Orrell et al., 1999). Shergill and colleagues (1999) found the 
HoNOS to correlate well with a range a measures including the Clifton Assessment Procedures for the 
Elderly (CAPE-BRS), the Clinical Dementia Rating,  the Mini-Mental State Examination (MMSE) and the 
Scale for Assessment of Negative Symptoms (SANS). 
By contrast, the HoNOS has shown poor or mixed performance against consumer-rated instruments 
such as the Social Adjustment Scale (SAS), SCL-90-R, the SF-36 (Hope et al., 1998; Parker et al., 2002), 
the Quality of Life assessment (QoL) (Hunter et al., 2004), the Avon Mental Health Measure (AVON), the 
Outcome of Problems of Users of Services (OPUS) (Audin et al., 2001; McClelland et al., 2000) and even a 
self-rating version of the HoNOS with a similar question structure (Rees et al., 2004). Brooks (2000), for 
instance, in a series of studies found the  HoNOS to have poor validity in relation to the SF-36 and the 
SCL-90-R. Other studies have reported correlations between the HoNOS and consumer-rated measures 
– e.g., the SF-36, the GHQ, the SCL-90-R, SF-36 and the Comprehensive Quality of Life scale (ComQoL) 
(McClelland et al., 2000; Orrell et al., 1999). However, they tend to vary across domains and be lower 
than those between the HoNOS and clinician-rated measures. This kind of difference in scores between 
measures which use self-report compared with informant-rated is not uncommon. 
The HoNOS has also been shown to discriminate between individuals with and without mental health 
diagnoses and symptoms (e.g., high scores on relative scales to be associated with drug and alcohol, 
psychotic and bipolar disorders, aggressive behaviour, anxiety, depression) (Bech et al., 2003; Browne et 
al., 2000; McClelland et al., 2000; Rees et al., 2004). However, a recent Italian study was less positive, 
suggesting the instrument lacks sufficient discriminatory ability in a sample of patients with psychotic 
disorders (Gigantesco, Picardi, de Girolamo, & Morosini, 2007). High scores on the HoNOS have also 
been found to predict a significant proportion of variance in treatment outcome and resource use 
(Ashaye, Seneviratna, Shergill, & Orrell, 1999; Broadbent, 2001; Schneider, Wooff, Carpenter, Brandon, 
& McNiven, 2002) despite these findings, however,  other authors have found little association between 
the HoNOS and resource use (Boot, Hall, & Andrews, 1997; Goldney, Fisher, & Walmsley, 1998).  
The ability of the HoNOS to detect genuine improvement, deterioration or stability in symptoms has 
been found to generally be greater in inpatient settings compared with community settings (Audin et al., 
2001; Goldney et al., 1998; Teesson et al., 2000). Although others have suggested this relationship may 
be more complex as aspects like severity and diagnosis may be pertinent (Andrews, 2003a). HoNOS 
scores have also been found to correlate with changes in consumers’ and clinical judgements about 
whether they had improved, remained stable or deteriorated (Gallagher & Teesson, 2000b; Hunter et 
al., 2004; Taylor & Wilkinson, 1997). Scores on the HoNOS have also been found to correlate with 
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existing established measures of outcome, the GAS and the BPRS (Ashaye et al., 1999; Hope et al., 1998; 
Page et al., 2001). Finally, Bech and colleagues (2003) found that HoNOS scores for consumers who 
received evidence-based therapies (e.g., lithium and/or electro-convulsive therapy) showed greater 
improvement on the HoNOS than consumers who did not, most notably on the Behaviour and 
Symptoms subscales. 
Overall, psychometric reports are mixed regarding the HoNOS, with some recent concerns raised about 
the reliability, specificity and the overall clinical utility of the tool as an outcome measure (Audin et al., 
2001; Bebbington et al., 1999; Preston, 2000a; Sharma et al., 1999; Trauer et al., 1999). Nevertheless, 
others believe it is a promising contender for routine use (Gallagher & Teesson, 2000b; McClelland et al., 
2000). 
Client groups 
Since its original development, the HoNOS has been translated into a number of languages (Bech et al., 
2003; Bonsack, Borgeat, & Lesage, 2002; Lauzon et al., 2001; Lora et al., 2001; Morosini, Gigantesco, 
Mazzarda, & Gibaldi, 2003). Different versions of the HoNOS have been established for different age 
groups (HoNOS for adults, HoNOSCA for children & adolescents (15 items), and HoNOS65+ for older 
people). Each has been widely used in Australia. 
The construct validity for the HoNOSCA was found to be adequate but that subscale/section scores 
should be treated with caution (Gowers, Bailey-Rogers, Shore, & Levine, 2000; Gowers et al., 1999). 
Gowers and colleagues (2000) also found the measure to have adequate concurrent validity and 
reasonably good inter-rater reliability (although some items performed poorly). These findings were 
supported in subsequent studies (Bilenberg, 2003; Brann, Coleman, & Luk, 2001; Yates, Garralda, & 
Higginson, 1999). Garralda and colleagues (2000) reported good correlations between scores overtime 
(test-retest reliability; between 0.69-0.80 over various time spans). A number of studies have reported 
significant associations between change (or lack of change) recorded on the HoNOSCA and clinician’s 
global judgements of outcome (Bilenberg, 2003; Brann et al., 2001; Garralda et al., 2000; Gowers et al., 
2000; Gowers et al., 1999)  
A number of authors have found the concurrent validity of the older person’s version of the HoNOS 
(HoNOS65+) to be adequate (Bagley et al., 2000; Burns et al., 1999; Mozley et al., 1999; Spear, Chawla, 
O'Reilly, & Rock, 2002)and the limited research available on the construct and content validity of the 
tool suggest this version has adequate validity in this sense (Burns et al., 1999). The reliability studies 
that exist using the HoNOS65+ offer mixed findings with Burns and colleagues(1999) and Spear and 
colleagues (2002)  both concluding the inter-rater reliability to be good to very good for most items, 
while others have shown less positive results (Allen et al., 1999). Spear and colleagues (2002) also found 
the HoNOS65+ to be moderately sensitive to change as measured by assessment and discharge from 
inpatient and community services and scores on the Clinician’s Interview Based Impression of Change 
Scale (CIBIC+). 
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In a recent unpublished report the HoNOS was found to show similar levels of internal consistency of the 
subscales when applied with Indigenous consumers as that observed in non-Indigenous populations 
(Haswell-Elkins, 2006). As well as good correlations with scores and indicators of wellness and illness 
identified by Indigenous consumers and carers in in-depth interviews, indicating content validity of the 
measure. The author recommends the continued use of HoNOS with Indigenous consumers, together 
with a set of guiding principles, as a tool that has the capacity to capture important information for the 
consumer, carer and clinician, but that the development and validation of consumer-rated tools that 
capture the more fundamental and culturally determined aspects of Indigenous mental health needs to 
occur (Haswell-Elkins, 2006). 
Availability/cost 
The HoNOS is in the public domain, and available free of charge, however, training costs may apply. It is 
available at: 
• http://www.crufad.com/phc/honos.htm  
• http://www.ergpa.com.au/cms/resources/HoNOS_Score.pdf 
Scoring, administration and expertise required 
The HoNOS is a clinician-rated tool whereby the clinician rates the consumer on each of the items over a 
recent period of time (previous 2 weeks and symptoms are scored on a scale of one to five. The tool 
takes approximately 15-30 minutes to complete and must be administered by a trained clinician. HoNOS 
is recommended for use by qualified mental health care practitioners, called Raters. However, any 
experienced mental health worker who has been trained in the use of HoNOS and achieves similar 
scores to other qualified health practitioners can use the HoNOS. One day training is recommended 
initially, with a half day retraining every two years. Various training packages and resources have been 
developed (Morris-Yates, Barber, Harris, & Zapart, 1999; Wing, Lelliott, & Beevor, 2000). 
It has been suggested that although no instrument will fulfil all needs, the HoNOS is a comprehensive, 
easy to use tool that is likely to be effective in routine outcome measurement (Ashaye, Mathew, & 
Dhadphale, 1997; Gallagher & Teesson, 2000b; McClelland et al., 2000; Miles et al., 2003). Others claim 
that while it is useful as a routinely administered outcome measure, its major use is in research (Gilbody, 
House, & Sheldon, 2002; Stafrace, 2002; Stein, 1999).  
In the United Kingdom, several studies have reported that clinicians were relatively positive about the 
HoNOS, viewing it as potentially useful, but insisting that its ongoing use would depend on appropriate 
resourcing, adequate infrastructure, regular feedback and ongoing training (Broadbent, 2001; James & 
Kehoe, 1999; Milne, Reichelt, & Wood, 2001). In field trials conducted at five sites in Victoria, Trauer 
(1998) found that clinicians at one site were extremely positive about the HoNOS, whereas those at the 
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other four were more ambivalent, believing that it contributed only minimally to their treatment 
practices.  
Overall it appears likely that the HoNOS alone would not be expected to guide day-to-day clinical 
practice, but it may complement other pieces of evidence that normally form the basis for clinical 
judgements (Wing et al., 2000). 
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The Maudsley Addiction Profile (MAP) 
The Maudsley Addiction Profile (MAP) (Marsden et al., 1998) was developed as a brief, multi-
dimensional instrument for assessing treatment outcome in people with drug and/or alcohol problems. 
It is an easily administered at intake, during and after an index treatment episode. It covers four 
domains of substance use, health risk behaviour, physical and psychological health and personal social 
functioning. The MAP, however, does not include the collection of demographic data so it needs to be 
linked to other client data collection systems. 
In the initial sample of 60 drug users and 80 alcohol users, internal reliability and concurrent validity 
assessments of the scales (compared with the Life Stressors and Social Resources Inventory, the ASI, and 
self-reported behaviours) and items were found to be in the range of moderate to good. Test-retest 
reliability was found to be good after three days. However, this is an inadequate timeframe for 
measuring such reliability (Copeland, 2009; personal communication). MAP subscores have also been 
found to correlate well with the relevant ASSIST scores (Marsden et al., 1998; Sharma et al., 1999). 
More recently, a new tool, based partially on the MAP, has been devised and is being rolled out in some 
substance misuse treatment centres in the UK. This instrument, the Treatment Outcomes Profile (TOP), 
was developed as a brief alternative to the MAP and has a total of 20 items across four sections 
(offending, health and social functioning, substance use and health risk behaviour). The preliminary 
report on the TOP has found the measure to have good reliability and validity and to show adequate 
sensitivity to client change (Marsden et al., 2008).   
Client groups 
The MAP has been translated and validated in a number of different European countries (Bacskai, Rozsa, 
& Gerevich, 2005; Hernández & Gómez, 2004; József, Erika, & Sándo, 2004; Mandersen et al., 2001; 
Marsden, Nizzoli et al., 2000). In a sample of 124 subjects in Italy, Spain and Portugal, the internal and 
test-retest reliabilities of the MAP were satisfactory (Marsden, Nizzoli et al., 2000).  
The tool has also been used successfully in psychiatric/comorbid populations (Marsden, Gossop, 
Stewart, Rolfe, & Farrell, 2000; Miles et al., 2003). One study has used the MAP on a population of 
adolescents aged between 14 and 16 years (Best, Manning, Gossop, Gross, & Strang, 2006). 
However, further studies are required to evaluate the instrument for other population groups and larger 
samples. 
Availability/cost 
The MAP is in the public domain and therefore can be used without cost but with due acknowledgement 
of its source. The tool itself, along with scoring information can be found at:  
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• http://www.iop.kcl.ac.uk/iopweb/blob/downloads/locator/l_346_MAP.pdf 
• http://eib.emcdda.europa.eu/html.cfm/index3667EN.html 
 
The TOP is available at: 
• http://www.nta.nhs.uk/areas/outcomes_monitoring/rollout_products.aspx 
Scoring, administration and expertise required 
The MAP consists of 60 questions and preliminary studies found the interviewer version to take 
approximately 12-25 minutes to complete. Scoring procedures are specified in the User's Manual and 
scoring time is approximately 5 minutes.  
Recently a self-report version of the MAP has been developed, assessing and monitoring the functioning 
of opioid-dependent patients. Correlation coefficients between interview and self-completion version 
for alcohol, drug, psychiatric, family and legal problems were in excess of 0.7 for the majority of the 20 
items that were compared. The authors concluded that this version was a practical alternative to the 
interview (Luty, Perry, Umoh, & Gormer, 2006). 
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The Addiction Severity Index (ASI) 
The Addiction Severity Index (ASI) (McLellan, Luborsky, Woody, & O'Brien, 1980; McLellan et al., 1992)  
is one of the most commonly used standardized assessment (rather than basic screening) instruments in 
the field of substance use disorders. The ASI is a 155-item multidimensional structured interview for 
assessing alcohol and drug dependence. It assesses frequency of drug and alcohol use as well as other 
psychosocial areas affected by substance use (e.g., a psychiatric subscale is included). The ASI consists of 
7 sub-scales assessing past 30 day and lifetime alcohol use, drug use, medical problems, psychiatric 
problems, family/social problems, employment and legal problems. The scoring of the ASI takes into 
account both subjective ratings of problems by clients, and objective tests of use (such as laboratory 
tests) across each scale to provide an overall severity rating. Various changes have been made since the 
tool’s development and it is currently in its fifth-revised edition. A modified short version the ASI has 
also been developed and has shown promising results (Cacciola, Alterman, McLellan, Lin, & Lynch, 
2007). 
The ASI was initially developed as an outcome measure to evaluate treatment across a 6-program 
treatment network and in follow-up studies to assess treatment-related change (McLellan et al., 1980). 
The ASI assesses frequency of use, without addressing quantity of use, a marked difference to other 
instruments. This is because, firstly, quantity correlates with frequency, and furthermore, frequency is 
easier to recall than quantity, secondly, because drug use has a lack of standardisation (i.e., there is no 
“standard drink” equivalent) and similarly there is likely to be a disparity between what respondents 
believe they have consumed, and what they actually consumed (McLellan et al., 1992). It has been 
widely used as a tool to measure outcome of treatment (Ahmadi, Kampman, & Dackis, 2006; Craig & 
Olson, 2004; Ghitza, Epstein, & Preston, 2008). 
While there have been mixed findings across populations, the ASI has been generally found to have 
good test-retest and inter-rater reliability as well as good content, construct and criterion validity for a 
range of substance abusing populations in dozens of studies (e.g., Alterman, Brown, Zaballero, & McKay, 
1994; Alterman et al., 1998; Appleby, Dyson, Altman, & Luchins, 1997; Argeriou, McCarty, Mulvey, & 
Daley, 1994; De Jong, Willems, Schippers, & Hendricks, 1995; Drake, McHugo, & Biesanz, 1995; 
Hendricks, Kaplan, Van Limbeek, & Geerlings, 1989; Hodgins & el-Guebaly, 1992; Joyner, Wright, & 
Devine, 1996; McCusker, Bigelow, Servignon, & Zorn, 1994; McLellan et al., 1985; Rogalski, 1987; Wertz, 
Cleaveland, & Stephens, 1995; Zanis, McLellan, Cnaan, & Randall, 1994). Drake and colleagues (1995) 
found scale scores to have test-retest reliability coefficients of ≥.60 in a sample of homeless people, with 
higher coefficients for younger, female, less mentally ill respondents. Similarly, Stoffelmayr, Mavis and 
Kasim (1994) found the ASI to have high inter-rater reliability, as measured by intra-class correlation 
coefficients for composite scores (ranging from .83 to 1.00 across domains), but considerably lower 
reliability for severity scores (ranging from .40 to .87 across domains), which remained stable over a two 
year period. Internal consistency has been shown to vary across scales, ranging from .65 for the 
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employment problems scale to .89 for medical problems (Leonhard, Mulvey, Gastfriend, & Shwartz, 
2000). 
Calsyn and colleagues (2004) found the ASI composite scores provided effective initial screening for 
patients with impaired functional status as measured by the corresponding SF-36 component summary 
scores, indicating both good concurrent and discriminant validity. 
Svikis and colleagues (1996) found the measure to be highly sensitive (.96) and specific (.94) to DSM-III-R 
diagnoses of alcohol abuse or dependence, among a sample of drug-abusing women when using a 
definition of heavy drinking as ≥3 drinks per occasion on ≥3 days/week over at least the previous 12 
months on the ASI as the predictor. In a more recent study, the ASI was found to have 85% sensitivity 
and 80% specificity (Rikoon, Cacciola, Carise, Alterman, & McLellan, 2006). Cut-off scores for men 
ranged from 0.17-0.19 for alcohol dependence and 0.11-0.16 for drug dependence, and 0.13 and 0.12-
0.18 respectively for women.   
However, a recent review of thirty-seven studies, cast significant doubt on the psychometric 
performance of the ASI. Claiming inter-rater and test-retest reliabilities of the severity ratings and 
composites scores vary from excellent to unsatisfactory and high internal consistencies were reported 
regularly for only three of the seven composite scores (medical status, alcohol use, psychiatric status). 
The remaining four composite scores (employment status, drug use, legal status, family/social relations) 
were found to have low consistencies in at least four different studies. Coefficients of criterion validity 
were also found to be consistently low (Mäkelä, 2004). However, the omission of a number of studies 
may have lead to drastic – and somewhat biased – conclusions (McLellan, Cacciola, & Alterman, 2004). 
Nonetheless, other authors have raised similar concerns with both the psychometric properties of the 
measure and its interpretation (Melberg, 2004).  
Client groups 
The items of the ASI appear to assess relevant aspects of alcohol and drug use and associated problems, 
indicating good content validity across populations, although several researchers have noted that some 
items may be less relevant to some populations (e.g., Carey, Cocco, & Correia, 1997; Corse, Hirschinger, 
& Zanis, 1995; Wertz et al., 1995; Zanis et al., 1994; Zanis, McLellan, & Corse, 1997). Nevertheless, the 
tool has been validated and is frequently used across a variety of substance abusing populations, 
including psychiatric patients, homeless people, pregnant women and incarcerated prisoners, and has 
been used to assess treatment outcome across a range of substances, including opiates, cocaine and 
alcohol (Joyner et al., 1996; McLellan et al., 1992). 
The ASI has been translated into a range of languages and evaluated across a range of countries 
(Gerevich, Bácskai, Kó, & Rózsa, 2005; Krenz et al., 2004; Schmidt et al., 2007). However, there have 
been no validation studies in Australia, nor have there been any reports of its use with Indigenous 
Australians. Nevertheless, Teesson and colleagues (2000) claim that the ASI does meet requirements for 
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use in routine assessment and outcome measurement in Australia. It should be noted, however, that a 
number of items on the ASI use American terminology and such items would need to be altered to take 
into account Australian-specific terminology and culture. 
Although the ASI has been shown to be a reliable and valid measure in female drug abusing populations, 
some authors have suggested it fails to assess some important female-specific aspects of substance 
dependence (e.g., pregnancy-related issues, care-giving, violence) (Comfort, Zanis, Whiteley, Kelly Tyler, 
& Kaltenbach, 1999). As a result, the Psychosocial History (PSH; female-specific 2-hour, 300-item 
version) was developed by Comfort and Kaltenbach (1996). Preliminary validation research suggests the 
PSH has adequate validity and reliability in adult women and appears to outperform the ASI, particularly 
in those specifically targeted areas (Comfort & Kaltenbach, 1996). The measure, however, is 
considerably lengthier and more time consuming than the ASI. 
Similarly, an adolescent version (the Teen-ASI) of the ASI is available, as the standard version neglects 
adolescent-related issues. Preliminary studies show it to be a promising measure of adolescent drug 
abuse within teenagers (Kaminer, 2008; Kaminer, Bukstein, & Tarter, 1991; Kaminer, Wagner, Plummer, 
& Seifer, 1993). 
In psychiatric populations the general conclusion drawn from most individual studies and research 
summaries, is that many of the sub-scales perform poorly with people who have severe mental illness 
(Carey et al., 1997). Studies validating the ASI with drug dependent clients with severe and persistent 
psychiatric disorders have consistently found weak reliability and validity (Carey et al., 1997; Corse et al., 
1995; Zanis et al., 1994; Zanis et al., 1997). Accordingly, the use of the ASI in this population is not 
recommended.  
Availability/cost 
The ASI interview is in the public domain and can be used without cost but with due acknowledgement 
of the authors. A copy of the ASI can be found at:  
• http://www.tresearch.org/resources/instruments.htm    
• http://www.densonline.org/DENSASI.pdf  
• http://faculty.ugf.edu/jgretch/syllabi/adc_asi_form.pdf      
The computerised version is available from: 
• Biomedical Computer Research Institute, 9743 Redd Rambler Place, Philadelphia, PA 19115, 
USA, Tel: 1-215-676-9743. 
Copies of the self-administered questionnaire are available from: 
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• Craig S. Rosen, Center for Health Care Evaluation, VA Palo Alto Health Care System (152-MPD), 
795 Willow Road, Menlo Park, CA, 94025, USA. Tel: 1-650-493-5000 ext 22846, fax: 1-650-617-
2736, or at crosen@stanford.edu.  
The Teen-ASI is not under copyright but may not be reproduced without permission from the author:  
• Yifrah Kaminer, Director, Bradley Substance Abuse Intervention Center (BASIC), Bradley 
Hospital, 1011 Veterans Memorial Parkway, East Providence, RI, 02915. 
Scoring, administration and expertise required 
The ASI is an interviewer-administered assessment tool. Administration of the interview form is 
somewhat lengthy and takes between 30-60 minutes. Administration of the ASI does not required any 
specialist educational pre-requisites and may be administered by physicians, drug treatment personnel, 
research technicians and other interested persons who have been trained in its use. Scoring takes 
approximately 10-20 minutes and instructions for the original interviewer-administered format are 
included in the manual.  
The ASI’s authors warn against its use as a self-administered instrument due to the high level of literacy 
required. However, a recently developed self-administered pen and paper version was found to have 
good internal consistency (Cronbach’s alpha >.70) for the alcohol, drug, psychiatric and medical 
problems scales, with somewhat lower consistency in the remaining scales in a predominately male 
inpatient sample  (Rosen, Henson, Finney, & Moos, 2000). Composite scores on the alcohol and drug use 
scales were similar across the two formats (r = .87 and .73, respectively). However, further validation of 
this questionnaire is required in other populations. 
A computer program was also developed to assist with administration and scoring (McLellan et al., 
1992) and recently a computerised multimedia CD-ROM has been developed (ASI-MV) and has shown 
promising psychometric characteristics, leading the authors to suggest that this form may be a viable 
alternative to potentially unreliable interviewer format (Butler et al., 2001). Furthermore, an internet 
and automated phone administration method has also been developed (Brodey et al., 2004). 
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Global Appraisal of Individual Needs (GAIN) 
The Global Appraisal of Individual Needs (GAIN) (Dennis, White, Titus, & Unsicker, 2006) was developed 
as a comprehensive biopsychosocial assessment tool in 1993. It is a progressive and integrated series of 
measures and computer applications designed to support a number of treatment practices, including 
initial screenings; brief interventions; referrals; standardised clinical assessments for diagnosis and 
treatment planning; monitoring of changes in clinical status, service utilisation, and costs to society; and 
specific needs assessment and evaluation (Dennis, White et al., 2006). A number of different versions of 
the GAIN exist and are outlined below. 
The GAIN includes over 100 scales and indices. It can be summarised into eight broad sections 
background information, substance use, physical health, risk behaviors, mental health, environment, 
legal, and vocational information (Dennis, Chan, & Funk, 2006; Titus, Dennis, Lennox, & Scott, 2008). The 
GAIN’s main scales have good internal consistency (alpha over 0.90 on main scales, 0.70 on subscales) 
and test-retest reliability (kappa ≥ 0.60 on categorical measures). The scales are also highly correlated 
with measures of use from timeline follow-back measures, urine tests, collateral reports, treatment 
records, and blind psychiatric diagnosis (kappa ≥ 0.60)  (Dennis, Godley et al., 2004; Dennis et al., 2002; 
Dennis, Funk, Godley, Godley, & Waldron, 2004; Dennis, Scott, & Funk, 2003; Dennis, White et al., 2006; 
Lennox, Dennis, Ives, & White, 2006; Lennox, Dennis, Scott, & Funk, 2006). 
Confirmatory factor analyses suggest that the GAIN’s collection of psychiatric and behavioural problems 
items vary largely along four dimensions: (1) substance use problems (e.g., abuse, dependence, 
induced), (2) internalising problems (e.g., depression, anxiety, trauma, suicide), (3) externalising 
problems (e.g., attention deficit, hyperactivity/impulsivity, conduct disorders), and (4) crime and 
violence (e.g., interpersonal, verbal, and physical violence, property crime, drug related crime, violent 
crime) (Dennis, Chan et al., 2006) 
Using discriminant analysis, the GAIN scales could also reliably predict independent and blind staff 
psychiatric diagnoses of co-occurring psychiatric disorders including attention deficit hyperactivity 
disorder (kappa = 1.00), mood disorders (kappa = .85), conduct disorder/oppositional defiant disorder 
(kappa = .82), adjustment disorder (kappa = .69), or the lack of a non-substance use diagnosis (kappa = 
.91) (Shane, Jasiukaitis, & Green, 2003). 
Interpretive cut-off scores for the full GAIN comorbidity scales have been found to vary by scale. To 
simplify interpretation, a low severity level is assigned when 0-24% of the items are endorsed, moderate 
is assigned when 25-74% of the items are endorsed, and a high severity is designated by endorsement of 
75-100% of the items on each scale. Using an interpretive range of moderate or above, Titus and 
colleagues (2008) found the GAIN to have 98% sensitivity for any internalising and any externalising 
problems for both adults and adolescents, with sensitivity for many common specific problems in the 95 
to 99% range. Using this same cut-off point to determine specificity resulted in correctly ruling out 42 to 
73% of non-cases. Thus, the moderate/high cut-off point errs on the side of inclusion, with over 
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identification of potential cases. Using the high severity cut-off point improved specificity to 97% or 
better, but reduced sensitivity to 49 to 74% (erring on the side of exclusion) (Titus et al., 2008).  
Client groups 
The psychometrics of the GAIN and the scale norms have been established for both adults and 
adolescents and is used widely in substance disorder treatment settings and across a range of substance 
use disorders (Chan, Godley, Godley, & Dennis, 2009; Harris, Griffin, McCaffrey, & Morral, 2008; Liddle, 
Rowe, Dakof, Henderson, & Greenbaum, 2009; Martin & Copeland, 2008). It has also been used 
successfully in prison populations (Friedmann, Melnick, Jiang, & Hamilton, 2008) 
However, there are a number of cultural limitations (e.g., American phrases and words) which may not 
be understood or applicable in an Australian context. Empirical findings relating to the GAIN are limited 
outside of the United States. 
Availability/cost 
The GAIN is copyrighted by Chestnut Health Systems. Licensing to use any of the GAIN family of 
instruments is $100 per agency for 5 years of use. Information can be found at: 
• http://www.chestnut.org/LI/GAIN  
Scoring, administration and expertise required 
Training in the use of the GAIN is required.  The GAIN can be orally administered to a client by a clinician 
or self-administered by the client. While self-administration can be efficient and reliable, it typically 
leads to more missing data and may have less validity (e.g., because questions may be incorrectly 
interpreted). Therefore, careful monitoring is recommended (Dennis, White et al., 2006). 
The GAIN-Initial takes 60-120 minutes to complete and is designed to provide a standardised 
biopsychosocial assessment for people presenting to a substance abuse treatment using DSM-IV for 
diagnosis, it also is useful in treatment planning, performance/outcome monitoring, economic analysis 
and to support referral/communications with other systems. GAIN-Monitoring 90-Day is a quarterly 
follow-up version of this instrument for evaluating change over time. The GAIN-Quick is a briefer version 
of the initial GAIN and takes 15-20 minutes to complete and is useful in basic assessment and need for 
referral to specialty health, mental health, and/or substance use systems, and/or to support 
motivational interviewing related to substance use. The GAIN Shorter Screener is a 5 minute version 
used for screening in a general population to quickly identify who is likely to have an internal, external, 
or substance use diagnosis. Finally, the GAIN Treatment Satisfaction Index is a 3-minute measure of 
working alliance and engagement.  
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The Indigenous Risk Impact Screen (IRIS) 
The Indigenous Risk Impact Screen (IRIS) (Ober & Schlesinger, 2005) was developed by an expert group 
of Indigenous and non-Indigenous researchers in Queensland to assist with the early identification of 
D&A problems and mental health risks. The tool consists of two sections, screening for both mental 
health problems and D&A misuse. In a validation study of 175 Aboriginal and Torres Strait Islander 
people from urban, rural, regional and remote locations in Queensland, the IRIS was found to have two 
factors corresponding to these two sections (Schlesinger, Ober, McCarthy, Watson, & Seinen, 2007).  
Preliminary findings found the IRIS alcohol and drug and mental health subscales to demonstrate good 
convergent validity (correlation coefficients between .55 and .74) with other well-established screening 
instruments (DASS, LDQ, SDS, AUDIT) and self-reports of mental health symptoms and D&A use. Both of 
the subscales showed high internal consistency for each factor (alcohol and drug factor: Cronbach’s 
alpha = .84; mental health factor: Cronbach’s alpha = .81). Similarly, the IRIS was found to show good 
temporal stability, as the test-retest reliability of both the alcohol and drug subscale (r = .79) and the 
mental health subscale (r = 0.81) was excellent. Finally, using a cut-off score of 10 the alcohol and drug 
subscale had optimal sensitivity (65%) and specificity (86%). While a score of 11 was found to be the 
best balance of sensitivity (83%) and specificity (84%) for the mental health subscale (Schlesinger et al., 
2007). 
Client groups 
IRIS is suitable for people who have self-identified as being from an Aboriginal or Torres Strait Islander 
background and are 18 years of age or older. The client must have a basic understanding English and the 
measure must not be used when the client is in acute withdrawal or the acute phase of physical/mental 
illness or is intoxicated (Australian Government Department of Health and Ageing, 2007).  
Availability/cost 
The IRIS is freely available online in the Australian Alcohol Treatment Guidelines for Indigenous 
Australians (Schlesinger et al., 2007): 
• http://www.alcohol.gov.au/internet/alcohol/publishing.nsf/Content/AGI02  
Scoring, administration and expertise required 
The IRIS is made up of two sets of questions, with items 1 through 7 forming the ‘D&A risk’ component 
and items 8 through 13 forming the ‘mental health and emotional well-being risk’ component. The items 
assessing mental health and emotional well-being focus on symptoms of anxiety and depression. The 
client chooses the answer from a list of response options which best describes his/her current situation. 
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After tallying up the corresponding numbers, a score of 10 or greater on the D&A component indicates 
problematic use of D&A is likely, while a score of 11 or greater indicates the need for further assessment 
or brief intervention regarding mental health and emotional well-being (Australian Government 
Department of Health and Ageing, 2007). Any worker is able to administer/score the screening tool.
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General Health and Functioning Measures 
The Short-Form Health Survey (SF-36; SF-12)  
The Short-Form 36 Health Survey (SF-36) (Ware, Kosinski, & Keller, 1996; Ware & Sherbourne, 1992) is a 
self-administered, 36-item questionnaire assessing the client’s functioning status, symptoms/well-being 
and overall health. The SF-36 has 8 separate scales including physical functioning, physical role 
limitation, emotional role limitation, bodily pain, mental health, social functioning, vitality and general 
health perceptions. The SF-12 includes 12 questions from the SF-36. These include: 2 questions 
concerning physical functioning; 2 questions on role limitations because of physical health problems; 1 
question on bodily pain; 1 question on general health perceptions; 1 question on vitality 
(energy/fatigue); 1 question on social functioning; 2 questions on role limitations because of emotional 
problems; and 2 questions on general mental health (psychological distress and psychological well-
being). The SF-36 has been found to a particularly useful as an outcome tool (Gandek et al., 1998; 
Havard, Teesson, Darke, & Ross, 2006; McCallum, 1995; McHorney, Ware, Lu, & Sherbourne, 1994; 
Oslin, Slaymaker, Blow, Owen, & Colleran, 2005; Sannibale, Fucito, O'Connor, & Curry, 2005; Sanson-
Fisher & Perkins, 1998); however, the SF-12 has not been used extensively in this sense, although 
preliminary findings suggest it too may be useful when used in this sense. Lenert and colleagues (2000), 
for instance, found SF-12 scores to be associated with a clinical change (remission) in depression, 
indicating the measure is sensitive to health outcomes. The main limitation in using these measures as 
outcome tools is that neither version registers quantity or frequency data on D&A use. 
Across a range of different population groups the internal reliability of the SF-36 is acceptable to good 
(consistently ≥ 0.70)  (Hopman et al., 2004; Kagee, 2001; Sanson-Fisher & Perkins, 1998). Gandek and 
colleagues (2004) for instance, found internal consistency was 0.83 to 0.93 for the eight scales and 0.94 
(Physical Component Summary; PCS) and 0.89 (Mental Component Summary; MCS) for component 
summary measures. The test-retest reliability of the SF-36 has also been reported to be good (Beaton, 
Hogg-Johnson, & Bombardier, 1997; Calsyn et al., 2004; Essink-Bot, Krabbe, Bonsel, & Aaronson, 1997; 
Prieto, Alonson, Ferrer, & Antò, 1997; Stewart et al., 2003).  
The SF-36 has also been found to correlate adequately with other measures of functioning (Brazier et 
al., 1992; Elliott, Renier, & Palcher, 2003; Jenkinson, Wright, & Coulter, 1994) and has generally been 
found to have good criterion validity (Brazier et al., 1992; Jenkinson, 1999; Keller et al., 1998; McHorney 
et al., 1994; McHorney, Ware, & Raczek, 1993; Sanson-Fisher & Perkins, 1998; Ware et al., 1998). The 
SF-36 has also been found to have strong content and construct validity in a number of studies 
(Cuthberston, Scott, Strachan, Kilonzo, & Vale, 2005; Ferguson, Robinson, & Splaine, 2002; Jenkinson et 
al., 1997; Jenkinson, Lawrence, McWhinnie, & Gordon, 1995; Jenkinson, Peto, & Coulter, 1994; Rost, 
Smith, Burnam, & Burns, 1992; Sharples, Todd, Caine, & Tait, 2000). 
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Finally, as previously mentioned, the SF-36 has been shown to be adequately sensitive to change in 
functioning and overall health over time (Salyers, Bosworth, Swanson, Lamb-Pagone, & Osher, 2000; 
Ware et al., 1996).  
On the whole, the SF-12 has been found to have equally good psychometric properties (Ware et al., 
1996). Test-retest reliability, for instance, was found to be good for both summary measures (PCS = 
0.89, MCS = 0.76). Similarly, Resnick and Parker (2001) found the test retest reliability of the SF-12 to be 
in a similar range (r = 0.73-0.86) and the  internal consistency of the revised SF-12 to be in line with the 
original (Cronbach’s alpha coefficients of 0.72 to 0.89). This version too, was found to correlate well with 
other measures (Burdine, Felix, Abel, Wiltraut, & Musselman, 2000; Johnson & Coons, 1998; Lundberg, 
Johannesson, Isacson, & Borgquist, 1999; Macran, Weatherly, & Kind, 2003) and both construct and 
criterion validity have been shown to be strong (Gandek et al., 1998; Jenkinson & Layte, 1997). In 
Australia, the Hunter Heart and Stroke study (Lim & Fisher, 1999), the Longitudinal Study on Women’s 
Health (Schofield & Mishra, 1998) and two mental health studies (Sanderson & Andrews, 2002a; 
Sanderson, Andrews, & Jelsma, 2001)  have supported the construct validity of the SF-12.  
Although international data suggests both forms of the survey are generally comparable (Gandek et al., 
1998), one Australian study reported a much poorer degree of reproducibility, with the 12 items 
explained only 56% of the variance in the MCS and 82% in the PCS (McCallum, 1997). The author 
concluded that the standard SF-12 was not suitable for use in Australia, and that an Australian short 
form with a different subset of items may be more appropriate. However, Sanderson and Andrews 
(2002b) cross-validated the selection of the questionnaire items for the SF-12 in an Australian sample 
and found the SF-12 items predicted at least 90% of the variance in both the physical and mental 
summary scales of the SF-36, whether they were scored with Australian or United States normative 
data, concluding that the SF-12 was an appropriate substitute for the SF-36 when a briefer instrument is 
required (Sanderson & Andrews, 2002b). Consequently, population health data using the SF-12 can be 
found in the 1997 Australian National Survey of Mental Health and Well-Being (Andrews, Henderson, & 
Hall, 2001), the 2000 Mental Health Status of South Australian Population Study (Taylor et al., 2000), the 
2002 Longitudinal Investigation of Depression Outcomes Study (Herrman et al., 2002) and the 2003 
Australian Gulf War Veteran’s Health Study (Sims et al., 2003). 
In choosing between the SF-12 and the SF-36, users should consider the trade-off between test taker 
burden (i.e. number of questions, time to complete) and the precision of scores (i.e. how reliable the 
obtained score needs to be).  Ware and colleagues (1996) reports that there is a 10% loss in the SF-12’s 
ability to distinguish between different disease groups as compared to the SF-36. 
Client groups 
The SF Health Surveys have been translated into a number of languages (Bullinger et al., 1998; 
Pernegerv, Lepledge, & Etter, 1999). The validity of the SF-12 items in reproducing the SF-36 summary 
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scales was compared across nine European countries, with the 12 items explaining 89-92% of the 
variance in PCS scores and 88-94% of the variance in MCS scores (Gandek et al., 1998). 
In other cross cultural studies, authors have found translations to be culturally appropriate and 
comparable in their content, but may prove problematic in those instances where respondents 
complete the questionnaire via an untrained translator, such as a friend or family member, translating 
the English version (Jenkinson, Chandola, Coulter, & Bruster, 2001; Wagner et al., 1998). In Australia, the 
SF-36 has been utilised for people from a non-English speaking background in Western Sydney (Cardona, 
Jorm, Williamson, & Chey, 1995). Watkins and colleagues (2000) translated the SF-36 and surveyed 
1,610 Vietnamese migrants to Australia. The authors found all but two SF-36 items had good 
discriminant validity, and all eight scales of the Vietnamese version of the SF-36 had good discriminant 
validity, which supports the use of SF-36 constructs to assess self-reported health status among 
Vietnamese migrants. However, the mental health, vitality and bodily pain scales demonstrated low 
internal consistency. In Australia, little research has been reported on the use of SF-12 with people from 
a non-English speaking background. Neither version has been extensively applied to the Australian 
Indigenous population. Scott and colleagues (2000), however, reported some difficulties in applying the 
SF Health Surveys to the Maori and Pacific ethnic groups in New Zealand.  
In a longitudinal study of women in 3,500 households across Australia the validity of both forms of the 
SF Health Survey were examined. The SF-12 PCS discriminated between women with poor versus good 
physical health, and MCS discriminated between groups who were or were not psychologically 
distressed on GHQ-12. The SF-36, relative to the SF-12, however, was found to be a more reliable 
measure for examining changes in health status over time and between groups (Schofield & Mishra, 
1998).  
The SF Health Surveys have been used successfully in countless subpopulations, for instance, in 
substance misusing populations (McGregor, Machin, & White, 2003; Morgan, Morgenstern, Blanchard, 
Labouvie, & Bux, 2003; Ryan & White, 1996; Stein, Herman, & Anderson, 2009), including older (Rosen, 
Smith, & Reynolds III, 2008) and adolescent users (Goldstein, Asarnow, Jaycox, Shoptaw, & Murray, 
2007). 
Both versions have also been used extensively in psychiatric samples (Feld, Colantonio, Yoshida, & 
Odette, 2003; Goldney, Fisher, Wilson, & Cheok, 2001; Sciolla, Patterson, Wetherell, McAdams, & Jeste, 
2003; Sherbourne, Wells, & Ludd, 1996). Sanderson and Andrews (Andrews, 2002; Sanderson & 
Andrews, 2002a; Sanderson & Andrews, 2002b; Sanderson et al., 2001) have consistently found the SF-
12 to be a good measure of disability in individuals suffering mild mental disorders (anxiety and 
depression). Whilst Salyers and colleagues (2000) have found the SF-12 to be a useful tool in a severe 
mental illness population. 
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The measures have also been used in studies of elderly populations (Resnick & Nahm, 2001; Sciolla et 
al., 2003) and homeless persons (Larson, 2002; Mares, Greenberg, & Rosenheck, 2008; Wong, Nath, & 
Solomon, 2007). 
Availability/cost 
Both forms of the SF are copyrighted and an annual license fee applies for the use of the instruments. 
Survey users are required to register and obtain a quote for the annual license fee that applies to their 
project. The license charge will depend upon whether users require a commercial or research license. 
Further information is available at: 
• www.qualitymetric.com.  
• http://www.sf-36.com/ 
 
An online version is also available on the CRUfAD website: 
• http://www.crufad.com/phc/sf-12.htm 
Scoring, administration and expertise required 
The SF-36 takes approximately 5- 15 minutes to complete (SF-12 takes approximately two minutes). The 
scores are summed for each item, but an overall score is not calculated. Rather a profile for scores on 
the different dimensions is used. No training is required for those professionals with qualifications and 
experience in psychometrics and statistics. For those professionals without these qualifications, basic 
training is required in survey administration and the characteristics of the SF Health Surveys.  
The traditional scoring method for the SF-12 is somewhat difficult when scored by hand, however, in a 
recent community and clinical-based sample, scores generated by the standard scoring method were 
found to correlate with a simplified scoring method. Means and standard deviations were similar and no 
individual scores deviated by more than 2.89 in the community sample or by 3.06 in the clinical sample. 
Thus scoring can be simplified where hand scoring is an advantage (Andrews, 2002). 
The SF Health Survey elicited mostly positive responses when compared to other measures in a sample 
of consumers (Stedman et al., 2000). Furthermore, an electronic version of the SF-36 has been found to 
be slightly quicker to complete, equivalent in performance and more effective than the paper version 
(Ryan, Corry, Attewell, & Smithson, 2002). 
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The Children’s Global Assessment Scale (CGAS)  
The Global Assessment Scale (GAS) (Endicott, Spitzer, Fliess, & Cohen, 1976) is a rating scale for 
evaluating the overall functioning of a subject during a specified time period on a continuum from 
psychological/psychiatric sickness to health. This was adapted to form a version for children and 
adolescents aged 4 to 16, known as the Children’s Global Assessment Scale (CGAS) (Schaffer et al., 
1983). The original GAS is used only on occasion but the CGAS is currently in routine use in Australia and 
therefore this review will focus on the latter version.  
The CGAS offers a means of establishing levels of dysfunction for children and adolescents. It is designed 
to be used in conjunction with diagnostic measures, and aims to provide more detailed information 
upon which to develop management plans and to evaluate improvement or deterioration in functioning 
following treatment or over time (Dyrborg et al., 2000; Steinhausen, 1987). 
Overall the CGAS has performed well on various tests of its psychometric properties. However, the tool 
has been criticised for its vulnerability to rater manipulation (and therefore accuracy) and the global 
nature of the scoring has been criticised for failing to consider different domains of functioning in any 
organised manner (Hodges & Gust, 1995). Others have found the CGAS inter-rater reliability to be 
moderate (Hanssen-Bauer, Aalen, Ruud, & Heyerdahl, 2007). Nonetheless, Shaffer and colleagues (1983) 
found both inter-rater and test-retest reliability of the CGAS to be excellent and subsequent studies 
have supported these findings (Bird, Canino, Rubio-Stipec, & Ribera, 1987; Dyrborg et al., 2000; Green, 
Shirk, Hanze, & Wanstrath, 1994; Weissman, Warner, & Fendrich, 1990). Weissman and colleagues 
(1990) also assessed the sensitivity of the CGAS as an outcome measure and observed higher scores in 
the subgroup of children who developed disorders with those who remained disorder-free. Other 
studies have supported the use of this tool as an outcome measure (Ginieri-Coccossis, Liappas, Tzavellas, 
Triantafillou, & Soldatos, 2007; Hintikka et al., 2006; McShane, Bazzano, Walter, & Barton, 2007; 
Remschmidt et al., 2007). 
The development process of the CGAS demonstrated the content validity of the tool (Schaffer et al., 
1983) and the concurrent validity has been generally found to be strong with the CGAS demonstrating 
high correlations with independent measures of competence, intellectual and social functioning, and 
problem solving, and only moderate correlations with measures of symptomatology (Bird et al., 1987; 
Green et al., 1994; Schaffer et al., 1983; Sourander & Piha, 1997; Steinhausen & Metzke, 2001; 
Weissman et al., 1990). Lower average scores have also been demonstrated for inpatients when 
compared with outpatients (Schaffer et al., 1983), psychiatric services users when compared with non-
users (Steinhausen, 1987), referred clients when compared with non-referred clients, and cases meeting 
diagnostic criteria  when compared with those that do not (Bird et al., 1987). These findings give further 
support to the validity of the measure. 
Finally, Sourander and colleagues (1996; 1996) have found that CGAS ratings at admission to inpatient 
care were predictive of functioning and residential status at follow-up.  
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Overall, a recent review found the CGAS to have adequate psychometric properties for routine use 
(Schorre & Vandvik, 2004). 
Client groups 
The CGAS is specifically designed for young people aged between 4 and 16 but the standard version is 
available for adults and elderly individuals (Fisher & Copenhaver, 2006). It has been validated as an 
appropriate tool for cross-cultural comparison and has been translated into a range of languages 
(Canino et al., 2004; Hanssen-Bauer, Gowers et al., 2007; Petersen, Bilenberg, Hoerder, & Gillberg, 2006; 
Roberts, Roberts, & Xing, 2006; Szobot, Ketzer, Parente, Biederman, & Rohde, 2004).  
The measure has also been used in prison populations (Abram, Paskar, Washburn, & Teplin, 2008) and 
routinely within various psychiatric populations (Green et al., 2007; McShane et al., 2007). 
Availability/cost 
The CGAS is freely available at: 
• http://depts.washington.edu/washinst/Training/CGAS/CGAS%20Index.htm  
Scoring, administration and expertise required 
The CGAS is a clinician-administered tool and provides a single global rating of a child or adolescent’s 
lowest level of functioning over the previous two weeks. Ratings range from 1 (severe dysfunction) to 
100 (superior functioning), and the threshold of psychopathology is suggested to sit between 61 and 71  
(Bird et al., 1990; Weissman et al., 1990). No formal training materials are provided with the CGAS, 
although the Australian Mental Health Outcomes and Classification Network have developed training 
materials as part of its standard package. However, in making their rating, clinicians rely heavily on 
clinical judgement and are therefore, presumed to have clinical expertise and training in the use of 
psychometric measures. Clinicians are guided by anchor points at every 10th degree on the scale; these 
offer an indication of the type of behavioural functioning displayed by consumers at that level. 
The CGAS is generally regarded as a useful measure of child and adolescent functioning, providing more 
detailed information for guiding treatment decisions than diagnosis- or symptom-based measures alone 
(Bird et al., 1990; Dyrborg et al., 2000; Weissman et al., 1990).  
The instructions accompanying CGAS are brief and easy to understand. When the information required 
is available and the raters are experienced in using the scales, scoring is said to take only a minute or 
two (Schorre & Vandvik, 2004). 
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Global Assessment of Functioning Scale (GAF) 
The Global Assessment of Functioning Scale (GAF) (Endicott et al., 1976) is a slightly modified form of 
the Global Assessment Scale and it is a tool used to measure overall level of psychological, social and 
occupational client functioning on a scale ranging from 1 to 100. The GAF can be completed with 
reference to varying time periods (e.g., currently, highest level of past year) and it constitutes the 
operationalisation of Axis V of the DSM-IV mutiaxial assessment (American Psychiatric Association, 
1994).  It has been used as an assessment and an outcome tool in various populations (Fridell & Hesse, 
2006; Goldman, Skodol, & Lave, 1992). 
An early study by Shanks (1994) reported that the potential utility of GAF in clinical practice was limited. 
Using a sample of 103 severely mentally ill patients, Jones and colleagues (1995) found the measure to 
be a reliable and valid measure of psychiatric disturbance. The different subscales showed good internal 
consistency (coefficients between 0.71 and 0.76). However, rater effects were found to be a significant 
source of variation in assessments. Having said this, raters had only one brief training session on the 
instrument. All GAF scores were associated with current support needs of patients. Symptom and 
disability scores were associated with changes in antipsychotic medication in the previous month 
indicating good validity. Similar findings were reported in a subsequent study (Coffey, Jones, & 
Thornicroft, 1996) which concluded that although the GAF in itself appears to be unsuitable for making 
individual treatment decisions it could be used as a preliminary step prior to more sophisticated scales. 
A recent study by Schwartz (2007) investigated the construct validity of the GAF in clients with 
schizophrenia. This study compared point-specific GAF scores with concurrent ratings of 
symptomatology and social and occupational impairments using the Functional Assessment Rating Scale, 
and found work and school-related problems, danger to others, and psychotic symptoms predicted 
lower GAF scores, indicating good validity. This study showed similar findings to an earlier study 
(Patterson & Lee, 1995).  Similarly, in a sample of 398 individuals with schizophrenia or schizoaffective 
disorder, a modified GAF exhibited very high levels of reliability, while the occupational and symptom 
subscales showed good convergent and discriminant validity (compared to the PANAS and the QoL 
interview). Further support for the validity of the GAF comes from a recent study, in a sample of 
individuals suffering from schizophrenia, GAF ratings were highly correlated with ratings of symptoms 
(as measured by the PANAS) and social behaviour (as measured by the Social Behaviour Schedule) at 
both follow-ups, but not at initial assessment (Startup, Jackson, & Bendix, 2002). 
Roy-Byrne and colleagues (1996) found the GAF to correlate strongly  with ratings of clinical symptoms, 
not functioning and concluded that reliance on the GAF as the only tool to assess patients' functioning 
may be problematic. Similarly, although Dufton and Siddique (1992) found the GAF to be of use in 
detecting change from admission to discharge, they suggest changes in GAF scores may lack clinical 
significance, and concurrent validity. However, this study used a very early version which has undergone 
revisions to correct for these early shortcomings. The original GAF confounded two areas of functioning: 
symptomatology and social functioning. Goldman and colleagues (1992) suggested that the GAF be 
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administered as both an overall scale and as two separate measures assessing symptoms and disability. 
The modified GAF scale has more detailed criteria and a more structured scoring system than the 
original GAF. This modified version was found to have improved inter-rater reliability (correlation 
coefficients of 0.81, compared with 0.62 for the original). Validity studies showed a high correlation 
(0.80) between the two sets of scores. The authors suggest this modified GAF may be particularly useful 
when persons with varying skills and employment background – and with little GAF training – must rate 
patients (Hall, 1995). 
Client groups 
The tool was developed for use in both children and adults and a recent review has generally confirmed 
this utility (Schorre & Vandvik, 2004), however, Piersma and Boes (1997) conducted a study on three 
psychiatric populations and found a significant difference between mean GAF for adult and adolescent 
inpatients both at admission and at discharge. They concluded that validity and reliability established for 
adults cannot easily be transferred to children and adolescents. It has also been recommended that a 
modified GAF scale specifically reflecting an older adult's activities during this period of life be created 
(Mossbarger, 2005; Whitney, Kunik, Molinari, Lopez, & Karner, 2004).  
As indicated above the GAF has been successfully used in a range of psychiatric populations (Jones et al., 
1995; Patterson & Lee, 1995; Startup et al., 2002), along with a variety of substance using (often 
comorbid) populations (Batki, Leontieva, Dimmock, & Ploutz-Snyder, 2008; Maremmani et al., 2008; 
Mátyássy, Kelemen, Sárközi, Janka, & Kéri, 2006; McCarty et al., 2008; Schwartz, Hilscher, & Hayhow, 
2007; Wobrock et al., 2007).  
Availability/cost 
The GAF is freely available online: 
• http://psyweb.com/Mdisord/DSM_IV/jsp/Axis_V.jsp  
Scoring, administration and expertise required 
Training in the use of the scale is fundamentally important to the reliability of the instrument (Bates, 
Lyons, & Shaw, 2002; Rey, Starling, Wever, Dossetor, & Plapp, 1995; Yamauchi, Ono, Baba, & Ikegami, 
2001). A self-report version of the GAF was found to be a valid and reliable unidimensional instrument 
measuring psychological, social and occupational functioning (Bodlund, Kullgren, Ekselius, Lindström, & 
von Knorring, 1994).  
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Life Skills Profile (LSP)  
The Life Skills Profile (LSP) (Rosen, Hadzi-Pavlovic, & Parker, 1989) was originally developed as a measure 
of aspects of functioning which affected how successfully people with schizophrenia lived in the 
community and has since been applied to other major psychiatric disorders and to a broad range of 
other diagnoses (Rosen, Hadzi-Pavlovic, Parker, & Trauer, 2006). The LSP has a positive mental health 
philosophy whereby it aims to emphasize a person’s “life skills” rather than their “lack of life skills” 
(Rosen et al., 2006). 
There are three versions of the LSP (the LSP-39 and two abbreviated versions: the LSP-20 and the LSP-
16). The subscales of each version are displayed in Table 1 below: 
Table 1. LSP versions and respective subscales 
Subscale LSP-39 LSP-20 LSP-16 
1 Self-care Self-care Self-care 
2 Non-turbulence Anti-social Anti-social 
3 Social contact Withdrawal Withdrawal 
4 Communication Bizarre — 
5 Responsibility Compliance Compliance 
Early studies of the LSP-39 reported good psychometric properties, principally when completed by case 
workers, residential carers and parents. The internal consistency of the LSP has been reported as 
moderately high with subscale correlations ranging from 0.64 to 0.88 and total score correlations 
ranging from 0.93 to 0.94 (Dickinson & Coursey, 2002; Stedman, Yellowlees, Mellsop, Clarke, & Drake, 
1997; Trauer, Duckmanton, & Chiu, 1995). The Communication subscale has been shown to have the 
poorest internal consistency (and was later dropped in the LSP-16) (Parker, Rosen, Emdur, & Hadzi-
Pavlov, 1991; Trauer et al., 1995). 
Rosen and colleagues (1989) found the measure to have good predictive validity, with worse LSP 
predicting more changes in accommodation. While the mean total measure inter-rater reliability was 
moderately high (correlation coefficient was 0.68). In a subsequent study, test-retest reliability was also 
found to be high (overall correlation coefficients of 0.89 for total scores and 0.78-0.90 for the 5 scales), 
although interrater reliability was found to differ between the different types of scorers (e.g., carers 
compared to parents). The authors suggest this may be due to differing rater relationships with the 
subjects (Parker et al., 1991). Concurrent validity of the LSP was also good. LSP scores were compared 
with those generated by the Katz Adjustment Scales (Katz & Lyerly, 1963) scales. The total scores on 
both scales were moderately correlated (r = 0.65). Further support has been found for the concurrent 
validity of the LSP  in that it has been shown to perform well against the HoNOS, the GAF, the RFS, the 
QoL, the SBS, the Resource Associated Functional Level Scale (RAFLS) and the GAS (Dickinson & Coursey, 
2002; Norman et al., 2000; Parker et al., 2002; Stedman et al., 1997; Trauer et al., 1995; Trauer, Eagar, 
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Gaines, & Bower, 2004; Wooff, Schneider, Carpenter, & Brandon, 2003). However, the LSP has 
performed less well and more inconsistently against the BASIS-32, the MHI and the SF-36 (Stedman et 
al., 1997), the General Well-Being Scale (GWB) (Norman et al., 2000; Trauer, Duckmanton, & Chiu, 
1998), and the BPRS (Wooff et al., 2003).  Although it has been suggested that this may be a result of the 
self-report style of many of these measures, and that a number assess symptomatology rather than 
functioning (Pirkis, Burgess, Kirk, Dodson, & Coombs, 2005). 
Trauer and colleagues (1995) suggested modifications to the original version based on confirmatory 
factor analyses among 200 severely mentally ill patients. Again internal consistencies were generally 
good, but inter-rater reliabilities were only marginally acceptable (some scores were found to vary with 
how well and how long the rater had known the patient). The Communication subscale had the poorest 
psychometric properties. The LSP was compared to locus of care (i.e. community or hospital), BPRS 
ratings and RAFLS ratings in order to attain concurrent validity, which was found to be good.  
The LSP-20 was found to have good internal consistency (Cronbach’s alpha ranging from .71-.90) while 
the subscales of the LSP-20 and total score correlated at 0.92 or higher with the original. Test-retest and 
inter-rater reliabilities are also comparable with the original, and validity was demonstrated with 
expected correlations with items of the Positive and Negative Syndrome Scale (PANSS). Compared with 
the LSP-39, scores on the LSP-20 tend to reflect lower functioning, meaning these levels or thresholds 
pertaining to one instrument cannot be directly compared with those of the other (Rosen, Trauer, Hadzi-
Pavlovic, & Parker, 2001). 
The LSP-16, has also been found to correlate well with the original measure. Buckingham and colleagues 
(1998) found an 85% to 90% concordance between the top four items of each subscale with the full 
subscale of the LSP-39. Likewise, Rosen and colleagues (2001) found the LSP-16 performed well against 
its parent instrument. Trauer (2003) also found the LSP-16 correlated well with the HoNOS, but that – 
like the LSP-39 – it showed poor or mixed performance against the BASIS-32. 
Parker and colleagues (2002) suggest that the LSP-39 performs less well in predicting client outcomes 
when compared to other outcome measures. However, other studies have suggested the LSP does show 
good validity in predicting outcomes relating to retention in the community (Preston, 2000b), hospital 
readmission  (Andrews, Teesson, Stewart, & Hoult, 1990; Parker & Hadzi-Pavlovic, 1995), change in locus 
of care (Trauer, Duckmanton, & Chiu, 1997), length of inpatient stay (Ballesteros, Martinez, Martin, 
Ibarra, & Bulbena, 2002; Kisely, Preston, & Rooney, 2000) and overall costs of care (Kisely et al., 2000; 
Trauer et al., 1998). Similarly, the LSP has been found to demonstrate greater levels of improvement in 
those who participate in more intensive treatment and care than in those who undergo routine case 
management (Hambridge & Rosen, 1994; Hamernik & Pakenham, 1999; Johnston et al., 1998; Rosen & 
Teesson, 2001).  
Overall, the LSP has been found to be a useful measure of client treatment outcome (Eagar, Trauer, & 
Mellsop, 2005; Horner & Asher, 2005). 
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Stedman and colleagues (1997) found further support for the predictive potential of the LSP when 
scores were compared with client self-reported improvement or deterioration over time. LSP scores 
were worse in the group who reported a decline in their levels of functioning. However, this finding 
requires further study as there was no association between LSP score and self-reported change for any 
other group. 
The LSP-16 is completely contained within the LSP-20, with the major difference between the two, being 
the presence of a “Bizarre” subscale in the LSP-20. Therefore, the LSP-16 would be a suitable instrument 
to use with populations in which psychosis was absent or uncommon, but the LSP-20 when psychosis is 
more prevalent. The LSP-20 may be more suited to routine service disability and aggregated outcome 
assessments, but less suited than the LSP-39 to detailed research, or to interactive use as part of service 
user’s individual care planning and review. 
Client groups 
Studies have generally elicited a positive responses from public sector mental health service providers 
regarding the LSP-39 as a measure of disability (Andrews, Peters, & Teesson, 1994; Stedman et al., 
1997). However, the LSP has been criticised for lacking relevance in community setting and long-term 
inpatient settings because of the restrictiveness of the response options or a lack of opportunity to 
exhibit some of the skills (Eu, Lee, Parker, & Loh, 2001; Hadzi-Pavlovic, Rosen, & Parker, 1992; Stedman 
et al., 1997).  
In a recent unpublished report the LSP-16 was found to show similar levels of internal consistency for 
the subscales when applied with Australian Indigenous consumers as that observed in non-Indigenous 
populations (Haswell-Elkins, 2006). Good correlations with scores and indicators of wellness and illness 
identified by Indigenous consumers and carers in in-depth interviews, indicating content validity of the 
measure. The author recommended the continued use of LSP-16 with Indigenous consumers, together 
with a set of guiding principles, as a tool that has the capacity to capture important information for the 
consumer, carer and clinician. They further suggested  that the development and validation of 
consumer-rated tools that capture the more fundamental and culturally determined aspects of 
Indigenous mental health, needs to occur (Haswell-Elkins, 2006). 
The LSP has been translated and validated in a wide range of different countries, languages and ethnic 
groups (Afuwape et al., 2006; Bulbena Vilarrasa, Fernández de Larrinoa Palacios, & Domínguez Panchón, 
1992; Burgés, Fernández, Autonell, Melloni, & Bulbena, 2007; Fernández de Larrinoa Palacios, Bulbena 
Vilarrasa, & Domínguez Panchón, 1992; Hasegawa et al., 1997; Huang, Sousa, Tsai, & Hwang, 2008; 
Mohr, Simon, Favrod, Fokianos, & Ferrero, 2004; Uys & Zulu, 1996; Zizolfi, 1997). The tool has also been 
used as an outcome measure in substance misusing populations (Bradley, Baker, & Lewin, 2007; Moller 
& Linaker, 2006) and homeless populations (Goldfinger, Schutt, Seidman, Turner, & et al., 1996). 
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The LSP has been used in a range of settings amongst various populations with generally high levels of 
success. It has been suggested, however, that different groups may show particular patterns of scores 
on the LSP. For instance, Rosen and colleagues (1989) found that younger people more frequently 
showed low scores on the Responsibility and Non-turbulence subscales of the original LSP-39. As 
mentioned above, the tool has been used with homeless populations and those in long-term residential 
care settings as well as those in more stable accommodation and total scores on the LSP have also been 
found to distinguish between consumers (i.e., more preferable scores for more stable accommodation) 
(Andrews et al., 1990; Browne & Courtney, 2004; Keller & Hayes, 1998; Kirkby, Daniels, Jones, & 
McInnes, 1997; Trauer et al., 1997; Trauer et al., 1998).   
Availability/cost 
The LSP is in the public domain and may be used without cost, but with due acknowledgment of the 
source. It is available at: 
• http://www.blackdoginstitute.org.au/search/index.cfm 
• http://www.sswahs.nsw.gov.au/MHealth/mhoat/LSP16forCSAHS16Mar04.pdf 
Scoring, administration and expertise required 
The original LSP-36 is scored in line with its positive mental health philosophy so that high scores 
indicate high levels of life skills. The LSP-16, however, was scored in the direction of impairments (high 
ratings indicate poorer functioning). Since the LSP-20 represents an abbreviation of the LSP-39 as well as 
an extension of the LSP-16, either a ‘strengths’ or ‘impairments’ oriented scoring template could be 
used (Rosen et al., 2001). No training is required to use the scale. 
Stedman and colleagues(1997) surveyed service providers about their experience with using the LSP, 
and found the majority of service providers felt the measure was easily understood and viewed the 
questions as relevant, useful and effective in measuring outcomes for consumers. Respondents in public 
sector psychiatric settings, in particular, rated the LSP more highly than other observer-rated measures 
(Stedman et al., 2000; Stedman et al., 1997).  
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Camberwell Assessment of Need (CAN) 
The Camberwell Assessment of Need (CAN) (Phelan et al., 1993) is a comprehensive needs assessment  
and treatment outcome tool. The CAN is one of the most widely used instruments for this purpose. It 
assesses need in 22 areas: accommodation, food, self-care, looking after the home, daytime activities, 
physical health, psychotic symptoms, information about condition and treatment, psychological distress, 
safety to self and others, alcohol, (abuse of) drugs, company, intimate relationships, sexual expression, 
child care, access to a telephone, education, transport, budgeting and benefits (Phelan et al., 1995). 
Both research and clinical versions of the tool exist, while a shorter version, the CANSAS (Camberwell 
Assessment of Need Short Appraisal Schedule) also exists and uses one item from the 22 areas in the 
original CAN. 
Correlations of the inter-rater and test-retest reliability of the total number of needs identified by staff 
were 0.99 and 0.78 respectively in the preliminary study of the instrument. The percentage of complete 
agreement on individual items ranged from 100-81.6% (inter-rater) and 100-58.1% (test-retest) (Phelan 
et al., 1995). Generally though, concerns have been raised about the relationship between staff-rated 
needs and client-rated needs and the inter-rater reliability generally. For instance, Slade and colleagues 
(Slade, Phelan, Thornicroft, & Parkman, 1996) reported staff and clients rated a similar number of 
needs, but not in the same areas. There was better agreement between staff and clients regarding 
needs that have a specific service intervention. The authors concluded that needs are very often 
assessed differently by staff and clients, which has implications for how needs are assessed in clinical 
practice (Slade et al., 1996).  
In an Australian context, the CAN has been validated (Gallagher & Teesson, 2000a; Issakidis & Teesson, 
1999). However, although Issakidis and Teesson (1999) found the tool to be applicable to an Australian 
setting there was poor agreement between clinicians and clients in identification of the 22 need areas. 
These findings highlight the fact that staff and clients differ in their assessment of need. Similar findings 
have been made in relation to the CANSAS in an Australian context (Andresen, Caputi, & Oades, 2000). 
This has been reported, particularly concerning unmet needs, in a range of studies (Hansson et al., 2001; 
Macpherson, Collins-Atkins, Gregory, Slade, & Lerescu, 2008; Trauer & Tobias, 2004). Test-retest 
reliability is generally strong (Arvidsson, 2003; Trauer & Tobias, 2004). However, Wennström and Wiesel 
(2006) found that summary scores conceal changes in need on the underlying items and thus is 
recommended not to be used as dependent measures when comparisons among populations or 
between points in time are of interest.  
In the initial development process a draft version of the instrument was sent for comments to 50 
experienced professionals in the fields of social work, psychiatry, psychology, psychiatric nursing and 
occupational therapy. The consensus was that there was a requirement for a needs assessment 
instrument, and that the CAN would be useful and relevant (Phelan et al., 1995). Further evidence of 
content validity was found through a parallel survey that was conducted of 59 people with severe 
mental illness who were either current inpatients or attending a psychiatric day-hospital. All topics were 
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rated as being at least moderately important, indicating that the instrument is free from item bias 
(Phelan et al., 1995).   
The total scores of the CANSAS were found to moderately correlate with the GAF and the HoNOS (Salvi, 
Leese, & Slade, 2005). Some have suggested, however, that although the CANSAS was found to be useful 
in assessing when treatment should be commenced or continued, it may be insufficiently sensitive to be 
used as an outcome measure (Slade, Beck, Bindman, Thornicroft, & Wright, 1999). 
In response to the reliability concerns a newly developed patient-rated, short form (CANSAS-P) has been 
evaluated. The CANSAS-P exhibited comparable detection of needs with its predecessor, better 
identification of domains that are problematic for patients to respond to, good test-retest reliability, 
especially for unmet needs, and generally positive evaluations by patients. The CANSAS-P has been 
recommended as the needs assessment measure of choice for completion by patients (Trauer, Tobias, & 
Slade, 2008). 
Client groups 
The CAN has been translated and validated in a range of countries, particularly across Europe (Ericson, 
Hansson, & Teike, 1997; Heinze, Taylor, Priebe, & Thornicroft, 1997; Knudsen et al., 2000; McCrone et 
al., 2005; McCrone et al., 2000; Nielsen et al., 1999; Ruggeri, Lasalvia, Nicolaou, & Tansella, 1999; 
Wiersma, Nienhuis, Giel, & Slooff, 1998; Yeh, Luh, Liu, Lee, & Slade, 2006). The tool is also widely used in 
Australia (Gallagher & Teesson, 2000a; Issakidis & Teesson, 1999), but has not been specifically used in 
Indigenous populations. 
The tool is also used among D&A populations (Nielsen, Petersen, Werdelin, Hou, & Lindhardt, 2000). 
Furthermore, there are a number of specialised versions of the CAN that have been developed and 
validated including a version for adults with developmental and intellectual disabilities (CANDID) 
(Xenitidis et al., 2000) and the elderly (CANE) (Reynolds et al., 2000) as well as a version for pregnant 
mothers (CAN-M) (Howard et al., 2007) and the CANFOR for forensic populations (Thomas et al., 2008). 
Availability/cost 
To attain the full versions of the CAN instruments, the manual must be purchased: 
• http://www.rcpsych.ac.uk/publications/howtoorder.aspx  
Scoring, administration and expertise required 
Generally the CAN is administered in an interview format, although a newly developed self-report also 
exists (see above). It was developed to be easily learned and used, without formal training and usable by 
a wide range of professionals (Phelan et al., 1995). For each topic examples are given in the CAN for 
what constitutes a need, and the presence of a need is rated on a 3-point scale: 0 = "no problem", 1 = 
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"no/moderate problem because of continuing intervention" and 2 = "current serious problem". If there 
is a need (need rating = 1 or 2) then further questions on the topic are asked. A 4-point scale (from 0 = 
"no help" to 3 = "high help") assesses the level of help received from informal sources (friends and 
relatives) and services (e.g. paid staff) and the level of help the interviewee (patient or staff member) 
thinks is needed from services. A 2-point scale (0 = "no" and 1 = "yes") is used to rate whether the 
interviewee thinks the patient is getting the right type of help. For each question a rating of 9 is used for 
"not known" (Phelan et al., 1995). 
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Strengths & Difficulties Questionnaire (SDQ)  
The Strengths and Difficulties Questionnaire (SDQ) (Goodman, 1997) was developed as a brief screening 
tool that describes children and adolescents’ behaviours, emotions and relationships. It aims to assess 
both negative and positive attributes of behaviour and to equally cover five dimensions (namely conduct 
problems, emotional symptoms, hyperactivity, peer relationships and prosocial behaviour). The author 
suggests that the SDQ can be used for screening, as part of a clinical assessment, as a treatment-
outcome measure, and as a research tool (Goodman, 2001). 
Various studies have considered the psychometric properties of the SDQ (Pirkis et al., 2005). Although 
there have been limited studies examining the measure’s content validity, confirmatory factor analysis 
studies have generally found five-factor solutions that corresponded with the original scales proposed 
by Goodman (Goodman, 2001; Hawes & Dadds, 2004; Koskelainen, Sourander, & Vauras, 2001; Muris, 
Meesters, & van den Berg, 2003; Roy, Veenstra, & Clench-Aas, 2008; Smedje, Broman, Hetta, & von 
Knorring, 1999; Thabet, Stretch, & Vostanis, 2000), suggesting good construct validity. However, some 
recent findings have raised concern about the factors structure (Mellor & Stokes, 2007; Percy, 
McCrystal, & Higgins, 2008) 
The internal consistency of the SDQ has also been found to be strong (Cronbach’s alpha ≥ 0.70 for total 
difficulties) (Goodman, 2001; Goodman, Meltzer, & Bailey, 2003; Koskelainen et al., 2001; Malmberg, 
Rydell, & Smedje, 2003; Mellor, 2004; Muris et al., 2003; Ronning, Handegaard, Sourander, & Morch, 
2004; Smedje et al., 1999; van Widenfelt, Goedhart, Treffers, & Goodman, 2003). However, the parent-
rated and teacher-rated scales tend to have better internal consistency than the self-report scales and 
the Conduct Problems and Peer Problems subscales have been found to have comparatively poorer 
internal consistency (relative to the good consistency reported in other scales) (Goodman, 2001; Muris 
et al., 2003). For instance, Bourbon and colleagues (2005) found a Cronbach’s alpha coefficient of only 
0.46 for the Peer Problems subscale which was in contrast to the coefficients of between 0.63-0.77 for 
the other subscales and 0.83 for Total Difficulties scale. 
A recent study found father and mother ratings to correlate well overall, however fathers reported 
higher mean scores than mothers for externalising behaviours. Higher reporting by fathers was related 
to alcohol misuse, the couple relationship, parenting strategies, and father employment. The authors 
suggest using combined parental reports in clinical settings for improved sensitivity when identifying 
problem behaviours (Davé, Nazareth, Senior, & Sherr, 2008). 
The concurrent validity of the SDQ has also been supported by findings that scores on the tool correlate 
well with those on the Rutter questionnaires, the Child Behavior Check List (CBLC), the Children’s 
Depression Inventory (CDI), the Revised Children’s Manifest Anxiety Scale (RCMAS), the Attention Deficit 
Hyperactivity Disorder Questionnaire (ADHDQ), an abbreviated version of the Child and Adolescent 
Burden Assessment (CABA) and the Youth Self Report (YSR) (Goodman, 1997; Goodman & Scott, 1999; 
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Klasen et al., 2000; Koskelainen, Sourander, & Kalijonen, 2000; Muris et al., 2003; van Widenfelt et al., 
2003). 
Similarly, the SDQ has been found to distinguish between those children/adolescents receiving 
treatment and those who are not, and could do so at least as well as other, more established 
instruments like the Rutter questionnaires, the CBCL, and the YSR (Goodman, 1997, 1999; Goodman, 
Meltzer, & Bailey, 1998; Goodman et al., 2003; Hawes & Dadds, 2004; Malmberg et al., 2003; Mellor, 
2004; Mullick & Goodman, 2001). 
Furthermore, within clinic-based samples, the SDQ has been shown to be able to discriminate between 
particular diagnoses or problematic behaviour as well or better than other instruments like the CBCL and 
the YSR (Goodman, Ford, Simmons, Gatward, & Meltzer, 2000; Goodman, Renfrew, & Mullick, 2000; 
Goodman & Scott, 1999; Hawes & Dadds, 2004; Klasen et al., 2000; Koskelainen et al., 2000; Mathai, 
Anderson, & Bourne, 2004; Mullick & Goodman, 2001). Others have claimed that although the measure 
has good convergent validity, its discriminant validity is less strong (Hill & Hughes, 2007). 
The measure has shown to be adequately sensitive and specific and the Australian normative data for 
appropriate cut-off scores is presented in Table 2 below. 
Table 2. Abnormal/of concern SDQ Cut-off scores for subscales and total difficulties (boys and girls) 
Subscale  
 7- 10 years 11-13 years 14-17 years 
 Self 
report 
Parent 
report  
Teacher 
report  
Self 
report 
Parent 
report  
Teacher 
report  
Self 
report 
Parent 
report  
Teacher 
report  
Boys          
          
Emotional symptoms ≥6 ≥5 ≥4 ≥5 ≥5 ≥3 ≥5 ≥5 ≥3 
Conduct problems ≥5 ≥4 ≥4 ≥5 ≥4 ≥3 ≥5 ≥4 ≥3 
Hyper-activity ≥7 ≥8 ≥9 ≥6 ≥7 ≥7 ≥7 ≥7 ≥6 
Peer problems ≥5 ≥5 ≥4 ≥4 ≥4 ≥4 ≥3 ≥6 ≥4 
Prosocial ≤5 ≤6 ≤4 ≤5 ≤5 ≤4 ≤5 ≤5 ≤4 
Total difficulties score ≥20 ≥19 ≥17 ≥16 ≥17 ≥15 ≥19 ≥18 ≥15 
          
Girls  
          
Emotional symptoms ≥6 ≥5 ≥4 ≥6 ≥5 ≥4 ≥6 ≥5 ≥3 
Conduct problems ≥4 ≥3 ≥3 ≥4 ≥4 ≥3 ≥4 ≥4 ≥3 
Hyper-activity ≥6 ≥6 ≥5 ≥6 ≥6 ≥5 ≥6 ≥6 ≥5 
Peer problems ≥4 ≥5 ≥4 ≥4 ≥4 ≥4 ≥3 ≥4 ≥4 
Prosocial ≤6 ≤6 ≤5 ≤6 ≤6 ≤6 ≤6 ≤6 ≤6 
Total difficulties score ≥17 ≥17 ≥15 ≥17 ≥17 ≥14 ≥15 ≥17 ≥14 
Adapted from Mellor (2005) 
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The stability of the SDQ (test-retest reliability) was found to be good across a range of time intervals 
(ranging from 3-4 weeks to 12 months), even for young children. However, non-self-report ratings were 
more stable than those using self-report (Goodman, 1999, 2001; Hawes & Dadds, 2004; Muris et al., 
2003). 
The majority of studies examining the inter-rater reliability of the SDQ have found positive correlations 
between different raters on the individual scale scores, the total difficulties score and the impact score 
(Goodman, 1997, 2001; Goodman et al., 1998; Koskelainen et al., 2000; Mellor, 2004; Muris et al., 2003; 
van Widenfelt et al., 2003), but there have been some exceptions (Cury & Golfeto, 2003; Thabet et al., 
2000). 
Again, in general, correlations between the parent and teacher versions of the SDQ have been found to 
be higher than correlations between either of these versions and the self-report version (Pirkis et al., 
2005). In a recent Victorian clinical sample, Mathai and colleagues (2003) found the SDQ to be sensitive 
to client outcome change over time (as measured by the HoNOSCA). 
Client groups 
The SDQ has been translated into more than 40 languages (Goodman, 2001) and used widely both 
internationally and within Australia (Capron, Thérond, & Duyme, 2007; d'Acremont & Linden, 2008; Du, 
Kou, & Coghill, 2008; Leeuwen, Meerschaert, Bosmans, De Medts, & Braet, 2006; Matsuishi et al., 2008; 
Mellor, 2005; Rothenberger, Becker, Erhart, Wille, & Ravens-Sieberer, 2008). However, the majority of 
studies come from European populations. Separate versions for different aged children have also been 
created (4-10 years and 11-17 years). The major differences are wording modifications to ensure 
relevance to the age group in question. Similarly, several different informant versions of the SDQ also 
exist (teacher, parent, self-report).  
The SDQ has also been widely used in psychiatric populations (Mathai et al., 2008), and has also been 
found to be useful within intellectually disabled children (Emerson, 2005; Kaptein, Jansen, Vogels, & 
Reijneveld, 2008). It has also been used in substance abusing youth (Christie et al., 2007; Cosden, 
Panteleakos, Gutierrez, Barazani, & Gottheil, 2004). 
Availability/cost 
The SDQ is copyrighted, however paper versions may be downloaded and subsequently photocopied 
without charge by individuals or non-profit organisations provided they do not charge clients: 
• http://www.sdqinfo.com/  
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Scoring, administration and expertise required 
In each version of the SDQ, either the parent, teacher or child/adolescent is asked to consider the 
child/adolescent’s behaviour over the past six months (or over the last one month in the case of follow-
up administrations), and rate each statement. It can be completed in 5-10 minutes and contains 25 
items. 
For the majority of items, a response of ‘not true’ is scored 0, a response of ‘somewhat true’ is scored 1 
and a response of ‘certainly true’ is scored 2. The exceptions are items 7, 11, 14, 21 and 25, where the 
reverse scoring order applies. This scoring method yields a score of 0-10 for each subscale, and a total 
difficulties score of 0-40, generated by summing the scores from all of the scales except the Prosocial 
Behaviour subscale (Goodman, 2001, 2003).  
The limited data that exists suggests it is a simple tool to use, particularly compared to other measures 
by mothers (Goodman & Scott, 1999). A recent review concluded that the SDQ is easy to complete, 
user-friendly because of its positive attributes items, allows comparisons to be made between different 
populations and is sensitive to change (Vostanis, 2006).  
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World Health Organisation Disability Assessment Schedule II (WHODAS II) 
The World Health Organisation Disability Assessment Schedule II (WHODAS II) was developed to assess 
the activity limitations and participation restrictions experienced by an individual, irrespective of 
medical diagnosis. WHODAS II provides a profile of functioning across six activity domains, as well as a 
general disability score. The domains included in the instrument are: 
• Understanding and communicating 
• Getting around 
• Self care 
• Getting along with people 
• Life activities 
• Participation in society 
The intra-class correlations within each domain on the 36-item questionnaire were good (0.71-0.92) and 
the six domains loaded on a general disability factor. A short 12-item form was derived and accounted 
for 85% of the variance of the full 36-item version (Andrews, 2008). All questions have proven 
psychometric qualities in terms of sensitivity, specificity, reliability, validity and cross-population 
comparability shown in general population surveys and in clinical sensitivity to change studies and cost-
effectiveness studies (Chisolm, Abrams, McArdle, Wilson, & Doyle, 2005; World Health Organization, 
2009). One recent study using a modified version reported good internal consistency for most scales. 
The total coefficient alpha score was reported as 0.86 (Buist-Bouwman et al., 2006). This was supported 
by a later study reporting the coefficient alpha ranged from 0.70 to 0.97 for the different subscales of 
WHODAS II (Pösl, Cieza, & Stucki, 2007). 
The tool has been reported as ideal for epidemiology and for routine outcome measurement (Andrews, 
2008). It was found to be particularly sensitive to change in anxiety symptom change (Perini, Slade, & 
Andrews, 2006). 
In a small sample of patients with long-term psychotic disorders, the WHODAS II was experienced as 
relatively complex and at times difficult to administer with full co-operation in this clinical sample. The 
test-retest reliability was low. However, it gave valuable insights into patients' experiences, which 
should be acknowledged in order to assess treatment outcomes, as patients tended to report fewer 
activity limitations and impairments in mental functions than reported by clinicians. It was also useful in 
assessing restrictions in social functioning and environmental barriers (Chopra, Couper, & Herrman, 
2004).  
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Client groups 
Currently, the WHODAS II is available in eleven versions and eighteen languages. The instrument was 
cross-culturally developed and is applicable across the spectrum of cultural and educational 
backgrounds. The interviewer-administered version can be used where literacy is low. 
The WHODAS II has been widely used with a range of different psychiatric populations (Chopra et al., 
2004; Morrow-Howell et al., 2008; Mubarak & Barber, 2003; Norton, de Roquefeuil, Benjamins, 
Boulenger, & Mann, 2004; Perini et al., 2006; Pösl et al., 2007). Similarly, it has been used in a range of 
substance abusing populations (e.g. alcohol, opiate, cannabis users; both inpatient and outpatient 
services) (McEvoy & Shand, 2008; Philip, Greg, & Khelifa, 2007). However, some limitations exist in 
severely mentally ill clients (Chopra et al., 2004). The tool has also been found to be satisfactory for use 
in older populations (McKibbin, Patterson, & Jeste, 2004).  
Availability/cost 
It is necessary to register as a user to access the training manual, but the tool itself is on the WHO 
website at:  
• http://www.who.int/icidh/whodas/index.html 
• http://www.who.int/classifications/icf/whodasii/en/index.html  
Scoring, administration and expertise required 
The 36-item version is available in self-administered, interviewer-administered (recommended) and 
proxy (i.e. to relatives) versions. It is probably best utilised for the determination of status and outcome 
in an individual. The 12-item version can be self-administered or interviewer-administered. 
Administration time for the 12-item version is approximately 5 minutes and 15 minutes for the 36-item 
version (but will vary depending upon administration method). 
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World Health Organisation Quality of Life-BREF (WHOQoL-BREF) 
The World Health Organisation Quality of Life-BREF (WHOQoL-BREF) instrument comprises 26 
items, which measure the following broad domains: physical health, psychological health, social 
relationships, and environment (Murphy, Herrman, Hawthorne, Pinzone, & Evert, 2000). The WHOQoL-
BREF is a shorter version of the original instrument that may be more convenient for use in large 
research studies or clinical trials. Domain scores produced by the WHOQoL-BREF have been shown to 
correlate at around 0.9 with the WHOQoL-100 domain scores. 
The tool was devised for a range of uses including medical practice and research as an outcome and 
assessment tool (World Health Organization, 1994, 1995, 1998). Both the original WHOQOL-100 and the 
WHOQoL-BREF have been shown to display good discriminant validity, convergent and criterion validity, 
sensitivity to change and test-retest reliability (Castro, Oliveira, Miguel, & Araujo, 2007; Nelson & Lotfy, 
1999; O'Carroll, Smith, Cousten, Cossar, & Hayes, 2000; World Health Organization, 1997). 
In a study of 533 Dutch psychiatric patients, Trompenaars and colleagues (2005) found the WHOQoL- 
BREF to load on four factors (with internal consistency ranging from 0.66 to 0.80) and correlate at 0.92 
with the original version of the WHOQoL. Content and construct validity was also strong, significant 
correlations were found between the Perceived Social Support Scale (PSSS) and subscales of the 
SCL-90-R and equivalent domain scores on the WHOQoL-BREF. 
In a recent Australian study, Hawthorne and colleagues reported that the WHOQoL-BREF had good 
validity and reliability and particular utility as an outcome measure. Population norms and psychometric 
properties which aid interpretation were provided (Hawthorne, Herrman, & Murphy, 2006). 
Client groups 
The core WHOQoL instruments can assess quality of life in a variety of situations and population groups 
and were developed collaboratively in a number of centres worldwide. Since the initial development 
process, the WHOQoL instruments have also been translated and validated in a vast range of countries 
and cultures (Carpiniello, Pinna, Carta, & Orrù, 2006; Hao, Fang, & Power, 2006; Saxena, Carlson, 
Billington, & Orley, 2001; Skevington, Sartorius, & Amir, 2004). 
The tools have been used successfully in adolescent (Chen, Wu, & Yao, 2006; Mugno, Ruta, D'Arrigo, & 
Mazzone, 2007) and older populations (Kalfoss, Low, & Molzahn, 2008; Peel, Bartlett, & Marshall, 2007). 
A specialised version for the older population has also been developed (Power, Quinn, & Schmidt, 2005) 
The WHOQoL instruments have been used extensively with psychiatric populations (Berlim, McGirr, & 
Fleck, 2008; Hsu, Hwang, Lee, & Chen, 2006; Kauer-Sant'Anna et al., 2007; Masskulpan, Riewthong, 
Dajpratham, & Kuptniratsaikul, 2008; Stengler-Wenzke, Kroll, Riedel-Heller, Matschinger, & Angermeyer, 
2007; Yen et al., 2008) and have also been used widely in substance misusing populations (Gunther, 
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Roick, Angermeyer, & Konig, 2008; Padaiga et al., 2007). In a sample of alcohol dependent males (da 
Silva Lima, Fleck, Pechansky, de Boni, & Sukop, 2005), the WHOQoL-BREF was found to have good 
internal consistency (Cronbach’s alpha ranging from .78-.89) and criterion validity. The measure 
correlated significantly with both the SF-36 domains and SCL-90-R total scores. Furthermore, the 
WHOQoL-BREF discriminated between low/moderate dependent individuals and highly dependent 
alcohol abusers (as measured by the SADD). 
Availability/cost 
The appropriate language version of the WHOQoL-BREF, permission for using it and manuals can be 
obtained from: 
• http://www.who.int/substance_abuse/research_tools/whoqolbref/en/  
Scoring, administration and expertise required 
The WHOQoL-BREF produces domain scores, but not individual facet scores, unlike the longer, original 
version. It is a self-report measure consisting of 26 items scored on a five point scale, which add  to four 
separate domain scores. 
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General Mental Health Screening, Assessment and Outcome Measures 
Kessler Psychological Distress Scale (K10; K6) 
The Kessler psychological distress scale (K10) (Kessler, 1996) is a widely used, simple self-report measure 
of psychological distress which can be used to identify those in need of further assessment for anxiety 
and depression. This measure was designed for use in the general population to detect high-prevalence 
mental health disorders; however, it may also serve as a useful clinical tool, and scores may be an 
indicator of mental health disorders with lower population prevalence (e.g. schizophrenia) (Croton, 
2007). In addition, the tool can also be used as an outcome measure. The K10 comprises 10 questions 
that are answered using a five-point scale (where 5 = all of the time, and 1 = none of the time). For all 
questions, the client circles the answer best describing them in the past four weeks. Scores are then 
summed with the maximum score of 50 indicating severe distress, and the minimum score of 10 
indicating no distress. A guide to interpreting K10 scores is provided in Table 3.  
Table 3. Severity of psychological distress according to K10 score 
K10 score Level of psychological distress 
10-15 Low 
16-21 Moderate 
22-29 High 
30-50 Very High 
Adapted from Andrews and Slade(2001) 
People who score 0-15 have one quarter the population risk of meeting criteria for an anxiety or 
depressive disorder as identified by the Composite International Diagnostic Interview (CIDI), and are 
unlikely to make a suicidal attempt in their lifetime. The moderate risk group (scores 16-30) have three 
times the population risk of having a current anxiety or depressive disorder and three times the 
population risk of ever having made a suicide attempt (Andrews, 2003b). Those who score 30 or above 
have ten times the population risk of meeting criteria for an anxiety or depressive disorder and 20 times 
the population risk of ever having made a suicide attempt (Andrews, 2003b; Andrews & Slade, 2001). 
Andrews and Slade (2001) found 68% of the 1997 National Survey of Mental Health and Well Being 
respondents  fell into the first (low risk) group, while 3% scored 30 or above. 
The brief questionnaire has been shown to have good construct and criterion validity (Kessler et al., 
2002), being significantly associated with measures of mental health symptoms and disability as well as 
the frequency on consultations for a mental health problem in the previous 12 month period. The 
process of selecting and refining the potential items on the instrument was assisted by an expert 
advisory panel of survey researchers, which rated each potential item for clarity and wording. Only 
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those items that were consistently rated as clear were included in the pool of items from which the final 
10 were chosen (Kessler et al., 2002). Scores on the K10 were also significantly associated with current 
CIDI diagnosis of anxiety and affective disorders, other mental disorder categories and the presence of 
any current mental disorder.  The tool was also found to outperform other screening scales (e.g. GHQ-
12) in discriminatory power in detecting DSM-IV anxiety and depressive disorders (Furukawa, Kessler, 
Slade, & Andrews, 2003). This finding was supported by a recent study which found the K10 and K6 to 
outperform a number  of competing instruments (Gill, Butterworth, Rodgers, & Mackinnon, 2007).   
The sensitivity and specificity scores are outlined in Table 4 and indicate a high level of both over the 
various K10 scores. Similarly strong ratios were found by Kessler and colleagues (2002; 2003), who also 
found the Cronbach's alpha for the K10 (a measure of internal consistency reliability) to be high (.93). 
Data from the Australian National Survey of Mental Health and Wellbeing (NSMHWB) yielded a 
Cronbach’s alpha of 0.92 (Andrews & Slade, 2001).  
Table 4. Sensitivity and specificity of the K10 in identifying people who met CIDI criteria for any current anxiety 
or affective disorder (prevalence 7.1%). 
K10 Score Hit Rate (Sensitivity) Correct Rejection Rate (Specificity) 
>=14 0.94 0.63 
15 0.90 0.72 
16 0.86 0.78 
17 0.81 0.83 
18 0.77 0.87 
19 0.71 0.90 
20 0.66 0.92 
21 0.60 0.94 
22 0.55 0.95 
23 0.50 0.97 
24 0.45 0.97 
25 0.41 0.98 
26 0.36 0.98 
27 0.33 0.99 
28 0.31 0.99 
29 0.27 0.99 
30 0.24 0.99 
31 0.21 1.00 
32 0.18 1.00 
Andrews and Slade (2001)  
Modified versions of the K10 exist and are useful for specific assessment circumstances. For instance, 
the K10-LM is intended for use mainly at initial assessment and contains the ten distress items plus four 
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supplementary questions, and uses a rating period of the “last four weeks”.  While the K10-L3D contains 
only the ten distress items and has a rating period of the “last three days”. It is designed for use to 
assess distress during care or prior to discharge. A six-item version of this scale (the K6) is also available 
and has been found to be psychometrically sound. 
Client groups 
The simplicity of the K10 to administer and score makes it a versatile tool for a wide range of clients, 
services types and staff. Clients can complete the scale individually in less than ten minutes. The K10 has 
also been translated into many languages, including Arabic, Bosnian, Chinese, Croatian, Farsi, Greek, 
Hindi, Italian, Korean, Macedonian, Serbian, Spanish, Tagalog, Turkish and Vietnamese (Australian 
Government Department of Health and Ageing, 2002). The K10 and K6 have been validated with a 
number of different cultural groups (Baggaley et al., 2007; Furukawa et al., 2008). Furthermore no 
clinically significant biases were found on the K10 based on gender or education (Baillie, 2005). 
In recent years the K10 has been used successfully in a range of populations. Kilkkinen and colleagues 
(2007) found the K10 to have good internal reliability (Cronbach’s alpha = .87) across three rural 
Australian communities. Recent studies have also applied the K10 to drug and alcohol populations. In 
one sample of 103 injecting drug users in Victoria the K10 was found to have high internal consistency 
(Cronbach’s alpha = .84). While a cut-off score of 27 was found to demonstrate the highest levels of 
sensitivity and specificity in detecting affective disorders in this population. The best trade-off across 
sensitivity and specificity correctly identified 78% of cases and 74% of non-cases (Hides, Lubman, Devlin 
et al., 2007). The K10 was found to significantly predict the presence of a current affective disorder (with 
individuals screening positive being 10 times more likely to have an affective disorder) and had an 
overall predictive accuracy of 76.7%. Similarly, in a sample of two public youth D&A services in Victoria, 
the K10’s internal consistency was again high (α = .89; Hides, Lubman, Elkins, Catania, & Rogers, 2007). 
In older populations it has been argued that short screening tools (such as the K10) may give more 
accurate results than the CIDI anxiety and depressive questions as older people may have difficulty 
attending to lengthy, complex questionnaires (O'Connor & Parslow, 2008).  
In a recent sample of 129 healthy pregnant women, the K10 showed agreeable sensitivity and specificity 
in detecting depression, posttraumatic stress disorder, panic disorder, and social phobia. The authors 
concluded that the K10 was a useful screening measure for mood and anxiety disorders in pregnant 
women (Spies et al., 2009). 
Availability/cost 
The K10 is in the public domain and therefore freely available with acknowledgment of the source. It can 
be found at: 
• http://www.crufad.com/K10/printk10.html 
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• http://www.beyondblue.org.au/index.aspx?link_id=89.678 
• http://www.sswahs.nsw.gov.au/MHealth/mhoat/kessler10_lm/Module_SR1_v2.pdf 
• http://www.sswahs.nsw.gov.au/MHealth/mhoat/kessler10_l3d/Module_SR2_v2.pdf  
Scoring, administration and expertise required 
As previously mentioned scoring and administration of the K10 is simple. Clients can self complete or it 
can be interviewer-administered for those with poor literacy.  Despite the tool’s strengths (e.g. easy to 
administer/score, brief, accessibility) the K10 is limited by its non-specific content (i.e., a measure of 
distress only) and clinical judgement is required for further client treatment. Therefore, although no 
expertise is required in the initial administration or scoring, workers may require the skills or resources 
to appropriately interpret scores above the low end on the scale.  
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The General Health Questionnaire (GHQ) 
The General Health Questionnaire (GHQ) (Goldberg & Williams, 1988) is a self-report screening 
instrument which detects the presence of psychological symptoms. It was originally a 60-item measure 
on which a client rates each statement on a four-point scale, however, shorter (12- and 28-item) forms 
have demonstrated adequate reliability and validity and are currently used (Goldberg & Williams, 1988; 
Politi, Piccinelli, & Wilkinson, 1994). The GHQ-28 provides four specific subscales: somatic symptoms, 
anxiety and insomnia, social dysfunction, and severe depression. In recent years the 12 item GHQ-12 has 
also been used extensively. 
The GHQ has reasonable test-retest reliability in the range of .85 to .90 in clinical populations (Goldberg 
& Williams, 1988) but tends to be substantially lower in the general population (Layton, 1986). The 
internal reliability of the GHQ-12 (the most commonly used) has been found to be strong (Cronbach’s 
alphas ranging from .82 to .86) (Politi et al., 1994; Sriram, Chandrashekar, Isaac, & Shanmugham, 1989; 
Winefield, Goldney, Winefield, & Tiggemann, 1989).  
Content and construct validity of the tool is also generally good and GHQ scores have been found to 
correlate well with standardised psychiatric assessment, the median correlation was .76 for the GHQ-28 
and .70 for the GHQ-12 in studies examining this property (Dawe, Loxton, Hides, Kavanagh, & Mattick, 
2002). The GHQ has been found to have good sensitivity and specificity, with a review finding the GHQ-
12 had an average sensitivity of 89% and specificity of 80%; the GHQ-28 had an average sensitivity of 
84% and specificity of 82% and the GHQ-60 had a sensitivity of 78% and a specificity of 85% (Goldberg & 
Williams, 1988). However, in substance misuse populations this tends to be lower (Ross & Glaser, 1989). 
Furthermore, the GHQ has been found to correlate well with other similar measures (e.g., r ≥  0.8 when 
compared to the SCL-90-R) (Vallejo, Mañanes, Comeche, & Díaz, 2008). 
In an extensive, international comparison of the validity of the GHQ-28 and GHQ-12, the GHQ-12 was 
found to have the ability to accurately detect CIDI diagnoses, with an overall sensitivity of 83.4% and 
specificity of 76.3% (a score of 1-2 was optimal cut-off for most sites) (Goldberg et al., 1997). Similarly, 
the GHQ-28 exhibited an overall high level of sensitivity (79.7%) and specificity (79.2%). However, these 
were no higher than the GHQ-12, although there tended to be less variation in optimal cut-off scores 
across centres. The use of simple versus complex scoring methods, translation of the instruments, use in 
developing countries, and gender, age and educational variables had no significant effect on the 
sensitivity or specificity of the instruments (Goldberg et al., 1997). These findings (related to mental 
health disorder detection) was supported by a study of 572 German primary care outpatients (Schmitz, 
Kruse, Heckrath, Alberti, & Trees, 1999). It has also been suggested the removal of 20 non-significant 
individual items from the GHQ-28 may slightly increase the predictive power of the tool from 81.6% to 
84.4%, but nonetheless showed good predictive validity (Willmott, Boardman, Henshaw, & Jones, 2008). 
Well-being is an important determinant of health and social outcomes. Measures of positive mental 
health states are needed for population-based research and a number have been included in this 
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review. There is also evidence to suggest that the GHQ-12 measures not only negative aspects of mental 
health (e.g., symptoms) but also positive aspects. These areas do correlate but are also said to be 
independent dimensions adding further utility to the measure (Hu, Stewart-Brown, Twigg, & Weich, 
2007). 
Client groups 
The GHQ has been translated into almost 50 languages and has been used in diverse cultural groups and 
the items appear to have cross-cultural relevance despite cultural variations in the expression of mental 
illness (Dawe et al., 2002). Indeed, a recent body of work has focused on the psychometric properties of 
the GHQ-12 and GHQ-28 across a range of cultural groups (e.g., elderly Iranians, Turkish primary care 
attendees, Mexican, Japanese, and Namibian adults, German and Chinese primary care patients, ethnic 
Indians living in the UK) (Caraveo Anduaga, Martinez, Saldivar, Lopez, & Saltijeral, 1998; Doi & Minowa, 
2003; Haidula, Shino, Plattner, & Feinstein, 2003; Jacob, Bhugra, & Mann, 1997; Kilic et al., 1997; 
Malakouti, Fatollahi, Mirabzadeh, & Zandi, 2007; Pan & Goldberg, 1990; Schmitz, Kruse, & Tress, 1999) 
and have found the structure of the GHQ to be robust. Recent reports have provided support for the 
validity of the GHQ-12 with young adolescents and suggest that adolescents interpret the GHQ-12 in a 
similar manner to adults (French & Tait, 2004; Tait, French, & Hulse, 2003). However, there have been 
some concerns raised about the tool’s use in antenatal populations (Swallow, Lindow, Masson, & Hay, 
2003), and postnatal population findings are mixed (Ip & Martin, 2006; Navarro et al., 2007). 
It has been suggested that the GHQ would be relevant to Indigenous Australians and there is some 
preliminary, related evidence to support this view (Hunter, 1993), however, further research is required.  
Availability/cost 
The GHQ are copyrighted instruments, however, the GHQ-28 has been incorporated into the OTI and 
can be used freely via this tool. Otherwise the tools are available for purchase from: 
• http://shop.acer.edu.au/acer-
shop/group/SD;jsessionid=5468B3660925CF57CFA34E70A2353C16  
Scoring, administration and expertise required 
The GHQ is easy to administer and score and can be used by a range of health professionals. It takes 5-
15 minutes to administer depending on which version is used. It was specifically developed for use by a 
broad range of clinicians working in community and non-psychiatric settings, and requires no special 
training. Recent studies have found both computerised and internet versions of this tool to have 
comparative psychometric properties to the pen and paper version (Vallejo et al., 2008; Wijndaele et al., 
2007). Generally a score of 10 or more on the GHQ is considered indicative of significant psychological 
distress and the presence of an underlying psychological disorder. However, it has been suggested that 
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approximately 75% of drug users could be expected to obtain scores of 10 or more upon entering 
treatment. This suggests that high levels of psychological distress may be typical among drug users who 
enter treatment. Therefore, clients need to be reassessed four weeks after entering treatment (Darke, 
2008; personal communication). Findings from prison populations suggest this to be true of this 
population group as well (Andersen, Sestoft, Lillebæk, Gabrielsen, & Hemmingsen, 2002). If the client 
continues to score 10 or more, a more in-depth psychological assessment should be conducted.  
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The Symptom Checklist-90-Revised (SCL-90-R)  
The Symptom Checklist-90-Revised (SCL-90-R) (Derogatis, 1994) is a 90-item self-report questionnaire 
measuring symptoms of somatisation, obsessive compulsive, interpersonal sensitivity, depression, 
anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. It has also been found to be a 
useful tool in measuring treatment outcome (Ronan, Dreer, & Dollard, 2000). 
The Global Severity Index (GSI) is a composite score obtained by summing the scores on the nine 
symptom dimensions and dividing this score by the total number of items (usually 90 if there are no 
missing responses). According to Derogatis (1994) the GSI is the best single indicator of severity of 
disorder and should be used in most instances where a single summary measure is required. The scale 
provides scores for severity, intensity and extensiveness of symptoms and has been shown to have 
superior sensitivity to competing scales (Mattick, Oliphant, Bell, & Hall, 1996). Shorter forms of the SCL-
90-R have been developed, including the Brief Symptom Inventory (BSI) with 53 items and the Symptom 
Assessment (SA-45), each of which show adequate reliability and validity. Correlations of the BSI 
dimensions with the SCL-90-R range from .92 to .99. The BSI has demonstrated adequate internal 
consistency ranging from .70 (phobic anxiety) to .89 (depression) and test-retest reliability ranging from 
.68 (somatisation) to .91 (phobic anxiety) over a two-week period (Boulet & Boss, 1991; Derogatis & 
Meilisaratos, 1983). The SA-45 (Davison et al., 1997) consists of nine 5-item scales assessing the same 
symptom domains as the SCL-90. The majority of scales display adequate internal consistency 
reliabilities (.7-.8) across different age and patient status variables. It has also demonstrated 
discriminant validity between controls and adolescent and adult patients and between patients at intake 
and follow up. 
The majority of factor analytic studies, indicate that both the SCL-90-R and the BSI tap a single 
predominant factor reflecting general psychological distress (Bonynge, 1993; Rauter, Leonard, & Swett, 
1996). The SCL-90-R has shown good test-retest reliability as well as very good internal reliability (alpha 
coefficients ranging from .79 to .90 for the different dimension scales) in clinical and non-clinical 
population (Horowitz, Rosenberg, Baer, Ureno, & Villasenor, 1988).  
The SCL-90-R has also been found to perform at least as well (if not better than) a range of other 
instruments in both assessment and in the measurement of change following treatment, suggesting 
validity and outcome utility are good (Derogatis, 1994).  
The SCL-90-R was found to have good overall accuracy (and sensitivity/specificity) at optimum GSI cut-
off points of .68 (sensitivity 72%, specificity 87%) in a diabetic sample and 1.00 (sensitivity 77%, 
specificity 91%) in a bulimic sample (Peveler & Fairburn, 1990). The SCL-90-R has been compared with 
the GHQ-12 and both performed equally well at detecting psychopathology (Schmitz, Kruse, Heckrath et 
al., 1999). Similarly, in a study of substance abusing clients the SCL-90-R was found to be a better 
predictor of CIDI diagnosed anxiety and mood disorders than the ASI-psychiatric problems scale, 
displaying a moderate degree of specificity and high sensitivity (Franken & Hendriks, 1999). 
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Client groups 
The SCL-90-R is suitable for both male and female respondents and adolescent populations (Hart, Bryer, 
& Martines, 1991) and has been translated into a number of languages and subsequently has been 
validated in a range of diverse populations (e.g., Hispanic, Finish, Dutch, Maori, German populations) 
(Arrindell et al., 2003; Barker-Collo, 2003; Holi, Marttunen, & Aalberg, 2003; Martinez, Stillerman, & 
Waldo, 2005). There is a lack of research using the tool in the Australian indigenous population but it has 
been suggested (based on related findings) that it would also be able to provide helpful diagnostic 
information (Dawe et al., 2002; Hunter, 1993). A Year 8 reading age is required.  
Some studies, however, have advised that its use in inpatient and outpatient samples has demonstrated 
a more variable factor structure, and lower specificity/sensitivity than in normative populations (Brophy, 
Norvell, & Kiluk, 1988; Cyr, McKenna Foley, & Peacock, 1985; Pariente, Lépine, Boulenger, Zarifian, & et 
al., 1989; Rauter et al., 1996; Starcevic, Bogojevic, & Marinkovic, 2000). Nevertheless, the tool has been 
used successfully in substance abusing populations (Franken & Hendriks, 2001).  
Availability/cost 
The SCL-90-R is a copyrighted instrument and therefore cannot be reproduced. It is published by NCA 
Assessments and distributed in Australia by Psychological Assessments Australia. All test purchasers 
must be Registered Psychologists with post-graduate qualifications in Psychology. 
Scoring, administration and expertise required 
The SCL-90-R is designed for adolescents over the age of 13 years and for adults. There is both a pen and 
paper and computerised version of the SCL-90-R. The former takes 15-25 minutes to complete. A recent 
study has found an internet version of this tool to have comparative psychometric properties to the pen 
and paper version (Vallejo et al., 2008). However, the measure is complex to score and requires special 
qualifications outlined above. 
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The Brief Psychiatric Rating Scale (BPRS) 
The Brief Psychiatric Rating Scale (BPRS) (Overall & Gorham, 1962) is a clinician administered scale 
measuring a broad range of psychiatric symptoms. It was initially devised as an instrument to assess the 
symptoms of schizophrenia on five subscales of thought disorder, withdrawal, anxiety/depression, 
hostility and activity (Hedlund & Vieweg, 1980; Overall & Gorham, 1962). Factor structure has been 
fairly consistent across a range of studies (Burger, Calsyn, Morse, Klinkenberg, & Trusty, 1997; 
Dingemans, Linszen, Lenior, & Smeets, 1995; Long & Brekke, 1999; Morlan & Tan, 1998; Mueser, Curran, 
& McHugo, 1997; Ownby & Seibel, 1994). 
The BPRS has been shown to be effective in various substance use populations (Steer & Schut, 1979; 
Westermeyer, Tucker, & Nugent, 1995). It has also shown adequate validity (Lykke, Hesse, Austin, & 
Oestrich, 2008; Morlan & Tan, 1998) and has been found to be an effective measure both of 
psychopathology and of treatment-related symptom changes (Burlingame et al., 2006; Hedlund & 
Vieweg, 1980; Varner, Chen, Swann, & Moeller, 2000). Inter-rater reliability for the BPRS has had mixed 
results but recent studies have tended to find it to be satisfactory (Flemenbach & Zimmerman, 1973; 
Hafkenscheid, 1991; Ligon & Thyer, 2000; Mueser et al., 1997).  
Suggested cut-off scores for the BPRS are included in Table 5 below. 
Table 5. BPRS cut-off points 
BPRS Cut-off score Level of psychological distress 
0-30 No notable illness 
31-40 Minimally ill  
41-53 Moderately ill 
53+ Markedly ill 
Adapted from Leucht and colleagues (2005)  
Client groups 
The attitudes and beliefs held by the clinician will have some bearing on the rating of particular 
diagnostic categories and although this is unlikely to be a major issue, in some ethnic or cultural 
populations it may impact upon clinical judgment. However, as this scale is clinician rated, it does not 
require the client to read or write, which may be helpful when assessing individuals who are either 
illiterate or who are unable to read English. It is also suitable for both male and female respondents. 
The BPRS has also been used in various research studies in which the relationship between major 
psychiatric illness and substance misuse has been investigated (Dawe et al., 2002; Lykke et al., 2008). 
Similarly, as mentioned above, it has been used successfully with individuals with opiate and alcohol 
disorders (Steer & Schut, 1979; Westermeyer et al., 1995). It has been successfully used on homeless 
persons as well as elderly and incarcerated populations (Burger, Yonker, Calsyn, Morse, & Klinkenberg, 
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2003; Greenwood & Burt, 2001; Ownby & Seibel, 1994; Panos, 2004). A children’s version has also been 
developed (Hughes, Rintelmann, Emslie, Lopez, & MacCabe, 2001; Lachar et al., 2001). 
The BPRS has also been found to demonstrate significant change during brief stays of 1 week or less in 
acute inpatient care. Therefore, the BPRS may be an appropriate outcome for aiding clinical decisions 
regarding suitability for discharge (Varner et al., 2000). 
Availability/cost 
The BPRS has been reproduced online at: 
• http://priory.com/psych/bprs.htm 
• www.cnsforum.com/streamfile.aspx?filename=BPRS.pdf&path=pdf  
Scoring, administration and expertise required 
The BPRS is a clinician rated instrument. Two main versions exist, the original 18-item version and the 
more recent 24-item version. Ratings are made after a brief (15-20 minutes) unstructured interview with 
the patient. Each item is rated on a 7-point scale ranging from “not present” to “extremely severe”. The 
tool is limited because it can only be used by adequately trained mental health professionals (e.g., 
clinical psychologists or psychiatrists), although specific training is available to clinicians with a 
background in psychology or psychiatric nursing. 
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PsyCheck 
The Australian PsyCheck screening tool was recently developed and has been demonstrated to be a 
scientifically valid and useful resource for clinicians (Lee et al., 2007). The screening tool has three 
sections: 
• A General Mental Health Screen, including history of treatment. 
• Suicide/Self-Harm Risk Assessment. 
• The Self Reporting Questionnaire (SRQ) (Beusenberg & Orley, 1994), that assesses current 
symptoms of depression and anxiety. 
PsyCheck screens for the presence of mental health symptoms that may be addressed within specialist 
services, suicide risk,  psychosis and mental health history are also assessed. Scores on the PsyCheck 
General Mental Health Screen were compared with scores on the diagnostic interview (CIDI-auto) and 
was found to significantly correlate with the presence of an affective or anxiety disorder in the previous 
month and was also predictive of a current affective or anxiety disorder within the last month. These 
findings suggest that this section of the PsyCheck screening tool could be used as an initial indicator of 
mental health status (Lee et al., 2007). The SRQ was compared to the commonly used the GHQ and both 
were validated against the CIDI-Auto (WHO, 1997). The SRQ showed good predictive ability, and was 
superior in terms of sensitivity (0.81) and specificity (0.84) when compared with the GHQ (Lee et al., 
2007). 
Client groups 
PsyCheck has only recently been developed and evidence is lacking on its applicability to a diverse range 
of populations. However, the SRQ (Beusenberg & Orley, 1994), was developed by the World Health 
Organisation (WHO) as a screening tool for common mental disorders in primary health care settings 
and has strong psychometric properties and has been adapted into a range of culturally specific 
versions. Cut-off points vary considerably depending on setting (community, primary care, hospital) and 
culture but with a cut off of 5-6, sensitivity and specificity have been found to be consistently between 
70-80%. In some cultures the cut-off needs to be raised, sometimes as high as 13 (Alsuwaida & 
Alwahhabi, 2006). Evidence for content validity is limited as it is merely a screening tool for mental 
distress and therefore cannot measure specific disorders. But criterion validity and reliability is generally 
good (Beusenberg & Orley, 1994).  
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Availability/cost 
PsyCheck is in the public domain and therefore can be used without cost but simply acknowledgement 
of its source. The tool itself, along with further information, training and supervision, treatment and 
implementation guidelines can be found at:  
• www.psycheck.org.auH 
Scoring, administration and expertise required 
The PsyCheck manual (Lee et al., 2007) includes training on how to administer, score and interpret the 
results of each section, and the subsequent steps to take according to the screening results. If the 
results of the screening tool indicate a high presence of symptomatology, further assessment may be 
warranted.  
The instrument was designed for use by non-mental health specialists but cannot be self-administered 
by the client. A degree of training is required for use of the tool. The PsyCheck Training and Clinical 
Supervision Guidelines consist of four modules, which are self-contained and delivered in four separate 
sessions via a PowerPoint Training Presentation (approximately one day). Trainer training is provided to 
clinicians/educators through a two day course. An advantage of the intensive training is that workers are 
also trained in management strategies for addressing mental health issues. 
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The Depression Anxiety Stress Scales (DASS) 
The Depression Anxiety Stress Scale (DASS) (Lovibond & Lovibond, 1995) has been shown to be a valid 
and reliable measure of the dimensions of depression, anxiety and stress separately but also tap into a 
more general dimension of psychological distress (Henry & Crawford, 2005). The DASS is available in two 
forms: the DASS-21 and the DASS-42. The use of either test in isolation is sufficient in screening for 
symptoms.  
Early findings reported the DASS-42 had excellent internal consistency and test-retest reliability and can 
distinguish between features of depression, physical arousal, and psychological tension and agitation 
better than other existing measures (Brown, Chorpita, Korotitsch, & Barlow, 1997; Lovibond & Lovibond, 
1995). A later study successfully confirmed these finding and extended it in order to apply to the DASS-
21 (Antony, Bieling, Cox, Enns, & Swinson, 1998). Cronbach's alphas for the DASS-42 Depression, 
Anxiety, and Stress subscales were .97, .92, and .95, respectively. Similarly, Cronbach's alphas for the 
DASS-21 subscales were .94 for Depression, .87 for Anxiety, and .91 for Stress. The relevant DASS-42 and 
DASS-21 scales both correlated highly with the BDI, BAI, and the STAI-T (Antony et al., 1998). In a more 
recent study the reliability of the DASS was excellent, and the measure was again found to possess 
adequate convergent and discriminant validity (Crawford & Henry, 2003). Furthermore, the DASS-21 has 
also been found to be a valid routine clinical outcome measure in the private in-patient setting (Ng et 
al., 2007). 
Client groups 
The DASS has been validated in a range of cultures including Turkey, Iran, Spain and South America and 
the Netherlands (Akin & Çetin, 2007; Daza, Novy, Stanley, & Averill, 2002; de Beurs, Van Dyck, 
Marquenie, Lange, & Blonk, 2001; Sahebi, Asghari, & Salari, 2004). It has also been used in D&A 
treatment settings (Morley et al., 2006; Sannibale et al., 2005) 
The DASS has also been used successfully in adolescents (Duffy, Cunningham, & Moore, 2005) and the 
structure of the DASS in older samples is consistent with younger age groups, demonstrating good 
internal consistency, excellent convergent validity, and good discriminative validity (Gloster et al., 2008). 
It has also been used among Aboriginal and Torres Strait Islanders in research studies (Schlesinger et al., 
2007) but its applicability to these populations has not been sufficiently tested. 
Availability/cost 
The DASS is in the public domain and therefore can be used without cost but with acknowledgement of 
its source. The tool itself, along with further information and the manual can be found at:  
• http://www2.psy.unsw.edu.au/groups/dass/   
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Scoring, administration and expertise required 
The DASS is a self-report instrument, and no special skills are required to administer or score it. 
However, decisions based on particular score profiles should be made only by experienced clinicians 
who have carried out an appropriate clinical examination (Lovibond & Lovibond, 1995). The two forms 
have 21 and 42 items respectively and are each rated on a four-point scale of how much each particular 
statement applies to the individual. A guide to interpreting DASS scores is provided in Table 6. 
Table 6. Interpreting DASS scale scores 
DASS scale score Level of psychological distress 
0 – 78 Normal 
78 – 87 Mild 
87 – 95 Moderate 
95 – 98 Severe 
98-100 Extremely severe 
Adapted from Lovibond and Lovibond  (1995) 
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Mental Health Inventory (MHI) 
The Mental Health Inventory (MHI) (Veit & Ware, 1983) was adapted from another mental health 
instrument, the General Wellbeing Schedule (GWB), and was designed to assess general psychological 
distress and wellbeing in a non-patient population. The MHI has been found to have some utility as an 
outcome measure, as consumers who rated themselves as having improved have been found to show 
corresponding improvements on the majority of MHI subscales, while those who rated themselves as 
stable have been found to show no change on the MHI, and those who rated themselves as having 
deteriorated have been found to show a decline on the MHI (Stedman et al., 1997). 
Generally the test-retest reliabilities reported have been adequately high for subscale, global scale and 
total scores on the MHI (correlations ranging from 0.56 to 0.97) (Downe-Wamboldt & Melanson, 1995; 
Stedman et al., 1997; Veit & Ware, 1983). While other studies have found the inter-rater reliability to be 
generally good (although mixed for some subscales), significant correlations between the self-report and 
interviewer-administered versions of the MHI also strengthen reliability (Pomeroy, Clark, & Philp, 2001). 
A number of studies have found the internal consistency of the MHI to be good (Cronbach’s alpha has 
ranged from 0.63 to 0.93 for the subscales, 0.90-0.97 for the global scales and 0.93 to 0.97 for the total 
score) (Brunier, Graydon, Rothman, Sherman, & Liadsky, 2002; Cohen, Hack, de Moor, Katz, & Goss, 
2000; Downe-Wamboldt & Melanson, 1995; Florian & Drory, 1990; Kravetz, Faust, & Shalit, 2001; 
Ostroff, Woolverton, Berry, & Lesko, 1996; Stedman et al., 1997; Veit & Ware, 1983). 
Generally the content validity of the MHI is good, however, concerns have been raised with the validity 
of specific items in certain population groups (e.g. youth) (Huebeck & Neill, 2000; Pirkis et al., 2005). 
While results from a Health Insurance Study (Ware, Manning, Duan, Wells, & Newhouse, 1984) into 
service use have shown support for the predictive validity of the instrument. This study indicated that 
persons with low total scores on the MHI (i.e., high psychological distress and low psychological 
wellbeing) were more likely to receive mental health care than those with higher scores. 
Scores on the MHI have been found to correlate well with comparable constructs on other standardised 
measures suggesting the measure is concurrently valid. For instance, Manne and Schnoll (2001) found 
the scores to correlate with those on the Positive and Negative Affect Schedule (PANAS), and the Dyadic 
Adjustment Scale. While Zika and Chamberlain (1992) found correlations between scores on the 
Purpose in Life Test (PIL), the Life Regard Index (LRI) and the Sense of Coherence Scale (SOC), and the 
MHI. Correlations with the GAS have also been observed (Wichstrom, Anderson, Holte, & Wynne, 1996).  
Stedman and colleagues (1997) found the MHI to correlate well with the SF-36 and the Behaviour and 
Symptom Identification Scale (BASIS-32), but less well with the LSP, Role Functioning Scale (RFS), and 
Health of the Nation outcome scales (HoNOS).  
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Kornblith and colleagues (2001) found the MHI correlated well with the Medical Outcome Study Social 
Support Survey (MOS-SSS), the Life Experience Survey (LES), and  the Systems of Belief Inventory (SBI),  
furthermore, the authors found the MHI could discriminate between those who have experienced 
stressful life events and those who have not, those with low level of social support and those with good 
social networks, and those with poor physical health and those with no medical problems (Kornblith et 
al., 2001). This discriminant validity was replicated in similar studies (Cohen et al., 2000; McCabe, 
Thomas, Brazier, & Coleman, 1996; Ware et al., 1984; Wyshak, 2001). Furthermore, MHI scores have 
been shown to relate to mental health service use (McCabe et al., 1996) and to discriminate between 
certain clinical and non-clinical samples (Cassileth, Lusk, & Strouse, 1984; Rosenthal, Downs, Arheart, 
Deal, & Rosenthal, 1991; Smith, Egert, Winkel, & Jacobson, 2002)  
Client groups 
The MHI has been translated into several other languages and validated in a number of different 
cultures and service settings (Florian & Drory, 1990; Hirini, Flett, Long, & Millar, 2005; Liang, Wu, Krause, 
Chiang, & Wu, 1992; Wu, Xu, & Li, 2002). The instrument has also been employed in a wide range of 
studies, particularly in the medical field. For example, it has been used to assess the mental health of 
consumers with cancer and human immunodeficiency virus (HIV) (Cohen et al., 2000; Kornblith et al., 
2001; Manne & Schnoll, 2001; Siegel, Gluhoski, & Karus, 1997; Smith et al., 2002).  
It has also been used as a screening tool for depression in older people and in rural communities 
(Dorfman et al., 1995; Kennedy & Yellowlees, 2003; Pomeroy et al., 2001) and as a general measure of 
mental illness for primary care consumers (Berwick et al., 1991; Weinstein, Berwick, Goldman, Murphy, 
& Barsky, 1989).  
Availability/cost 
The MHI is freely available at: 
• http://www.rand.org/health/surveys_tools/mos/mos_mentalhealth.html  
Scoring, administration and expertise required 
The MHI comprises of 38 items and can be completed either as a self-report measure or as part of a 
structured-interview; either way it takes approximately 10-15 minutes to complete. Each item includes a 
description of a particular state of mind which is scored on either a five- or six-point scale.  Item scores 
are summed to give six subscale scores; global scale scores and a total score. 
Stedman and colleagues (2000) found that consumers rated the MHI higher than either the BASIS-32 or 
the SF-36 in terms of perceived relevance, effectiveness and usefulness. Overall the MHI was seen as 
comprehensive, easy to understand, user-friendly, acceptable and appropriate. However, the tool was 
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criticised for certain aspects that restricted its utility (e.g., particular wording of items, response options 
and applicability to certain populations) (Stedman et al., 2000). 
The MHI elicited the most positive responses when compared to other measures in a sample of 
consumers (Stedman et al., 2000). A much shorter version (MHI-5) has also recently been developed and 
has shown adequate psychometric properties (Berwick et al., 1991). 
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Behaviour and Symptom Identification Scale 32 (BASIS-32®) 
The Behaviour and Symptom Identification Scale 32 (BASIS-32®) (Eisen, Dill, & Grob, 1994; Eisen, Grob, 
& Klein, 1986) was developed as a 32-item, consumer-oriented, self-report measure of symptoms and 
behavioural distress. The scale consists of five subscales measuring Impulsive and addictive behaviour, 
Psychosis, Relation to self and others, Depression and anxiety and Daily living and role functioning. The 
instrument was originally developed and validated among inpatients, but subsequent studies have 
supported its use in outpatient and residential settings (Eisen, Leff, & Schaefer, 1999; Eisen, Wilcox, Leff, 
Schaefer, & Culhane, 1999; Hoffmann, Capelli, & Mastrianni, 1997; Klinkenberg, Cho, & Vieweg, 1998; 
Russo et al., 1997). It is widely used as a measure of mental health outcomes (Dickey et al., 2003; 
Doerfler, Addis, & Moran, 2002; Hawthorne, Green, Lohr, Hough, & Smith, 1999; Uttaro & Gonzalez, 
2002) and has been found to be highly sensitive to change following treatment in both inpatient and 
outpatient samples (Eisen et al., 1994; Eisen, Grob, & D.L., 1989; Eisen, Leff et al., 1999; Eisen, Wilcox et 
al., 1999; Eisen, Wilcox, & Schaefer, 1997; Hoffmann et al., 1997; Jerrell, 2005; Klinkenberg et al., 1998; 
Russo et al., 1997; Sederer, 1992; Stedman et al., 1997; Trauer & Tobias, 2004). However, the Impulsive 
and addictive behaviours subscale and the Psychosis subscale showed poorer sensitivity to change than 
the other three subscales (Russo et al., 1997; Trauer & Tobias, 2004).  
The BASIS-32® has been found to show consistently good test-retest reliability (Eisen et al., 1994; Eisen 
et al., 1986; Klinkenberg et al., 1998). Similarly, when the self-report version of the instrument is 
compared with the interview version, or with reports of a close informant, good overall inter-rater 
reliability has been found (Eisen et al., 1986; Klinkenberg et al., 1998).  
There is some concern about the internal structure of the measure. The developers themselves have 
noted that there is ‘unnecessary redundancy in the instrument’, and as a result a shorter version (BASIS-
24®) has been developed (Eisen, Normand, Belanger, Spiro, & Esch, 2004). Nevertheless, the internal 
consistency of the BASIS-32®, subscales has generally been found to be high ranging from 0.6 to 0.9, 
across settings (inpatients and outpatients) and types of administration (structured-interview and self-
administration) (Chow, Snowden, & McConnell, 2001; Eisen, Leff et al., 1999; Eisen, Wilcox et al., 1999; 
Hoffmann et al., 1997; Klinkenberg et al., 1998; Russo et al., 1997; Stedman et al., 1997; Uttaro & 
Gonzalez, 2002).  
In assessing the content validity of the BASIS-32®, Eisen and colleagues (1999; 1997) reported that the 
instrument was comprehensive, however, participants in the other reports had mixed responses. 
Concerns identified in the work by other studies related to ambiguous and complex language, an 
exclusive focus on difficulties and issues with content areas. Recommendations from consumers 
included the addition of items to cover the outcome domains of greater relevance to them (Cameron et 
al., 2001; Graham et al., 2001). 
Numerous studies have considered the concurrent validity of the BASIS-32® and the tool has been found 
to correlate well with a range of comparable scales including: the Client Assessment of Strengths 
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Interests and Goals (Lecomte, Wallace, Caron, Perreault, & Lecomte, 2004; Wallace, Lecomte, Wilde, & 
Liberman, 2001) the Outcome Questionnaire (Doerfler et al., 2002), the SF-36 (Eisen, Wilcox et al., 1999; 
Eisen et al., 1997; Stedman et al., 1997),  the SCL-90 (Eisen et al., 1986; Hoffmann et al., 1997), the Child 
and Adolescent Functional Assessment Scale (CAFAS) (Hoffmann et al., 1997) the Hopkins Symptom 
Checklist and the BPRS (Klinkenberg et al., 1998), the MHI, and the HoNOS (Stedman et al., 1997), the 
CAN (Trauer & Tobias, 2004), the Psychiatric Symptom Assessment Scale (PSAS), Lehman’s Quality of Life 
Interview (Russo et al., 1997) and the Outcome Assessment Program (OAP) Questionnaire (Dornelas, 
Botticello, Goethe, & Fischer, 2001). However, scores on the  BASIS-32®, have been found to be 
unrelated to performance on the Social and Occupational Functioning Assessment Scale and the MMSE 
(Russo et al., 1997), the Levels of Recovery from Psychotic Disorders Scale (Sousa & Frazier, 2004), the 
Global Assessment of Relational Functioning Scale (Wilkins & White, 2001), the LSP and the RFS 
(Stedman et al., 1997).  
The BASIS-32® has been shown to correlate well with objective indicators of functioning, effectively 
discriminating between consumers who were rehospitalised (Eisen et al., 1994; Eisen et al., 1986; 
Hoffmann et al., 1997) and those who were currently employed or undertaking studies (Eisen et al., 
1994; Eisen et al., 1986) and between inpatients and outpatients (Eisen, Wilcox et al., 1999). 
Furthermore, consumers with depression, psychotic disorders and substance abuse problems have been 
shown to score highly on the Depression and anxiety, Psychosis and Impulsive and addictive behaviours 
subscales, respectively (Doerfler et al., 2002; Eisen, 1992; Eisen, Leff et al., 1999; Eisen, Wilcox et al., 
1999; Hoffmann et al., 1997; Klinkenberg et al., 1998; Russo et al., 1997). Likewise, consumers with 
comorbid mental health and substance abuse problems have been shown to score significantly higher 
on all five subscales than those with fewer disorders of less complexity (Johnson, Brems, & Burke, 2002; 
Pollack & Cramer, 2000; Pollack, Cramer, & Varner, 2000). Other studies, however, have found no link 
between BASIS-32® score and diagnosis (Doerfler et al., 2002; Klinkenberg et al., 1998). 
Finally, predictive studies have observed that, when assessed at discharge, consumers who 
subsequently require rehospitalisation score higher than those who do not relapse (Eisen et al., 1986; 
Eisen et al., 1997; Hoffmann et al., 1997). 
Client groups 
An Australian version of the BASIS-32® exists (Eisen et al., 2004) and the tool has also been translated 
into many languages including Spanish, French, Japanese, Chinese, Korean, Cambodian, Vietnamese and 
Tagalog (Eisen & Culhane, 1999). Some authors have criticised the BASIS-32®, claiming the reading level 
required is too high for individuals with limited literacy skills, and that it is difficult to complete for 
individuals who are acutely psychotic or intoxicated, or have dementia (Eisen et al., 2004; Hawthorne et 
al., 1999; Hoffmann et al., 1997; Russo et al., 1997). However, few tools are consistently effective for use 
in such populations. Nevertheless, overcoming these concerns was one of the reasons for the  
development of the BASIS-24® (Eisen et al., 2004). 
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The BASIS-32® has also been widely used in both younger and older populations, along with 
D&A/comorbid samples and homeless people (Gamst et al., 2006; Johnson, Brems, Mills, & Freemon, 
2005; Oslin et al., 2005; Smelson et al., 2007).  
Availability/cost 
The BASIS-32® is a commercial instrument and is not available in the public domain. Copyright is held by 
the McLean Hospital, and there is an annual fee and licence requirement. 
• http://basissurvey.org/basis32/  
Scoring, administration and expertise required 
The BASIS-32® (BASIS-24®) is a consumer-rated instrument comprising 32 (24) items. Each item is rated 
using a five-point scale (0 = no difficulty; 1 = a little difficulty; 2 = moderate difficulty; 3 = quite a bit of 
difficulty; 4; extreme difficulty) which are used to calculate subscales and total scores by adding the 
ratings for each item and dividing by the number of non-omitted items. The exception to this rule is the 
computation of the Daily living and role functioning subscale, which is determined by an averaging 
procedure (Victorian Department of Human Services, 2003). 
Ratings are based on the difficulty experienced during the preceding period (one-two weeks), 
ascertained by structured interview (either with a rater present or by telephone) or self-report format 
(either on-site or through mail-out). The structured interview is generally administered if the consumer 
is not capable of self-report (e.g. due to illiteracy or an excess of symptoms) in which the rating scale 
choices are presented to the consumer on large index cards. The interviewer reads each item to the 
consumer who is then required to indicate their response on the cards (Eisen, 1995). In its interviewer-
administered form, the BASIS-32® may be used by both professional and nonprofessional staff due to 
the absence of training requirements. An instruction manual is available which contains a survey form, a 
scoring algorithm, a reference list and articles relating to methodology, reliability and validity. 
The BASIS-32® takes on average 5-10 minutes to administer in the self-report format, while the 
structured interview takes approximately 15-10 minutes to complete. Stedman and colleagues (1997), 
found that the BASIS-32® was rated favourably by consumers in terms of its utility (defined in terms of 
its perceived relevance, effectiveness and usefulness), although it was not ranked as highly as the MHI. 
Others have found it to be applicable to a wide range of people receiving mental health treatment, not 
limited by diagnoses, symptom patterns or treatment setting, user-friendly and adaptable due to its 
alternative administration modes. It has also been found to place minimal burden on staff due to its 
brevity, the simplicity of its design and its absence of training requirements (Doerfler et al., 2002; Eisen, 
Leff et al., 1999; Eisen et al., 1997; Klinkenberg et al., 1998). 
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Specific Mental Health Screening, Assessment and Outcome Measures 
The following tools have been included not as part of general screening/assessment given routinely to 
all clients but rather, on the basis of high scores on general measures or identifiable symptoms of 
specific mental health conditions in order to assess symptoms (and occasionally diagnose) specific 
mental health conditions. 
The Psychosis Screener 
The Psychosis Screener (PS) (Degenhardt, Hall, Korten, & Jablensky, 2005) is an interview-style 
questionnaire and was designed specifically for use in epidemiological studies. The PS uses elements of 
the CIDI to assess the presence of characteristic psychotic symptoms and is comprised of 7 items, three 
of which (1a, 2a, 3a) were asked only if the respondent endorsed a previous question (1, 2, 3 
respectively). The items cover features of psychotic disorders: delusions of control, thought 
interference and passivity, delusions of reference or persecution, and grandiose delusions. The final 
item (Question 4) assessed whether a respondent had ever received a diagnosis of schizophrenia.  
It was validated against the CIDI, the DSM-III-R and the International Classification of Diseases, 9th and 
10th editions (ICD-9; ICD-10). Internal consistency was good in two preliminary studies (Cronbach’s alpha 
≥ .74), although the items assessing grandiose delusions performed less well (Degenhardt et al., 
2005). When using a broad definition of psychosis (schizophrenia, schizoaffective disorder, and 
affective psychosis as psychotic disorders), the screener performed best at a cut-off score of ≥1. Using 
a narrow definition of psychosis (a diagnosis of schizophrenia or schizoaffective disorder only) a cut-off 
score of 3 was found to most accurately include cases and exclude non-cases (Degenhardt et al., 2005). 
The screener demonstrated moderate-good Positive Predictive Power Value and Negative Predictive 
Value (PPV; NPV; proportion of patients who are correctly diagnosed with and without the disorder at 
both definition cut-off points in two separate samples (prison and general population), moderate 
sensitivity and specificity levels at the cut-off scores were also obtained, however, these were more 
or less strong depending upon which “gold standard” measure the scores were compared to  
(Degenhardt et al., 2005). All cut-off points on the screener, using the narrow definition of psychosis, 
from both samples are given below in Table 7. 
Table 7: Sensitivity and specificity of the Psychosis Screener in two samples for narrow definition of psychosis 
Cut-off Sample 1 Sample 2
1
 
 Sensitivity  Specificity Sensitivity Specificity 
1 92.8  54.8  99.3  20.6  
2  64.3  72.6  91.4  36.4  
3  57.1  84.9  81.6  58.9  
4  35.7  87.7  52.6  75.7  
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Cut-off Sample 1 Sample 2
1
 
5  7.1  97.3  36.2  86.9  
6  0  100  23.0  92.5  
1
Persons categorised as having psychosis if they met either ICD-10 or DSM-III-R criteria for schizophrenia or schizoaffective 
disorder (as opposed to ICD-9 in sample 1) 
Adapted from Degenhardt and colleagues (2005) 
The PS has been shown to have a moderate ability to discriminate between those who meet diagnostic 
criteria for psychotic disorders and those who do not in community and prison samples, however, there 
is no findings surrounding its applicability to clinical samples (Degenhardt et al., 2005; White & Chant, 
2006).  
Client groups 
The PS has been used successfully to measure psychosis in those suffering D&A disorders (Degenhardt & 
Hall, 2001; Degenhardt, Hall, & Lynskey, 2001) and the wider population (Scott, Chant, Andrews, & 
McGrath, 2006). It has been successfully used in a sample of 210 homeless men and women (Teesson, 
Hodder, & Buhrich, 2004) and has been used with mixed success in prison populations (Allnutt, 
Wedgwood, Wilhelm, & Butler, 2008; Butler et al., 2006; Nielssen & Misrachi, 2005). 
Availability/cost 
The PS is freely available in Degenhardt and colleagues (Degenhardt & Hall, 2001; Degenhardt et al., 
2005): 
• http://ndarc.med.unsw.edu.au/ndarcweb.nsf/resources/TR_37/$file/TR.093.pdf  
• http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_2/$file/TR.210.pdf  
Scoring, administration and expertise required 
The PS consists of seven items; the first six items cover the following features of psychotic disorders: 
delusions of control, thought interference and passivity, delusions of reference or persecution and 
grandiose delusions. The final item records whether a respondent reports ever receiving a diagnosis of 
schizophrenia. Since cut-off points vary depending upon the definition of psychosis, consideration must 
be given to the nature of the population with which a screening test is to be used before a cut-off point 
is selected (Degenhardt et al., 2005). Therefore, its current utility for clinicians is limited. 
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The Traumatic Life Events Questionnaire (TLEQ) 
The Traumatic Life Events Questionnaire (TLEQ) (Kubany et al., 2000) has been shown to adequately 
evaluate both the re-experiencing of symptoms associated with trauma as well as symptoms of intense 
fear, helplessness and horror following a traumatic episode. It also assesses the frequency of event 
occurrence.  
The development of the TLEQ was based on expert review, indicating good construct validity (Kubany et 
al., 2000). In the developmental study of the TLEQ, the tool was found to show adequate sensitivity and 
specificity, and the average test-retest reliability was .83 but was low for particular items (Kubany et al., 
2000). The tool was also found to have good convergent validity when compared with the Traumatic Life 
Events Interview (correlation coefficients averaging .80) Recent studies have suggested that the 
psychometric properties of this measure are adequate (Read, Bollinger, & Sharkansky, 2003).  
Client groups 
The TLEQ has been used in substance abusing populations, adolescents and prison populations (Adams, 
2004; Conrad, 2004; Gearon, Kaltman, Brown, & Bellack, 2003; Huang, Zhang, Momartin, Cao, & Zhao, 
2006; Kubany et al., 2000; Oyefeso, Brown, Chiang, & Clancy, 2008). Similarly, developmental studies 
were conducted using a range of ethnic groups (Kubany et al., 2000).  
Availability/cost 
The TLEQ is copyrighted and must be purchased. It is available at: 
• http://portal.wpspublish.com/portal/page?_pageid=53,70508&_dad=portal&_schema=PORTAL  
Scoring, administration and expertise required 
The TLEQ consists of 21 items (an early version had only 16 items) asking about traumatic events and 
the fear/helplessness associated with the event. Both self-report and interview-style forms exist. For 
each event, respondents are asked to provide the number of times it occurred (ranging from “never” to 
“more than 5 times”) and whether fear, helplessness or horror was present. Some events include a 
question about presence of injury, and for victimisation questions, characteristics of the perpetrator. 
The last question asks respondents to identify the one event that “causes you the most distress” among 
those endorsed. Respondents are also asked about their age upon first occurrence, date of last 
occurrence, and amount of distress the event causes (“no distress” to “extreme distress”). It takes 
approximately 10-15 minutes to complete. 
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The Primary Care PTSD Screen (PC-PTSD) 
The Primary Care PTSD Screen (PC-PTSD) (Prins et al., 2003) is a very brief, four-item screen that was 
designed for use in primary care and other medical settings to screen for Posttraumatic Stress Disorder 
(PTSD) (Prins et al., 2003).  
The preliminary study of the PC-PTSD concluded that the tool was a psychometrically sound screen for 
PTSD with comparable operating characteristics to other screens for mental disorders. The PC-PTSD 
outperformed the PCL in terms of overall quality, sensitivity, specificity, efficiency, and quality of 
efficiency. The authors suggest a PC-PTSD cut-off score of 3 for male and female patients was optimal, 
but recommend a cut-off score of 2 when high sensitivity is required, but this comes at a cost to 
specificity (Prins et al., 2003).  
A recent comparison of the PC-PTSD and the GHQ-12 found the PC-PTSD had a higher positive predictive 
value than the GHQ for detecting PTSD, indicating that disorder specific screens are important to use in 
primary care settings. But a combination of results on the two measures captured more cases than 
either individually (Ouimette, Wade, Prins, & Schohn, 2008).  
Client groups 
The PC-PTSD has been used successfully in substance use populations (Ford, Hawke, Alessi, Ledgerwood, 
& Petry, 2007; Goldstein et al., 2007). Among patients with D&A use disorders the screen has been 
shown to identify 91% of PTSD cases and has demonstrated good test-retest reliability (r = .80) and 
yielded a sensitivity of .91 and specificity of .80 using a cut-off score of 3 (Kimerling et al., 2006). 
It has also been used in adolescent populations (Asarnow et al., 2008), and regularly used among 
military and veteran populations (Friedman, 2006; Hoge, Auchterlonie, & Milliken, 2006). 
Availability/cost 
The PC-PTSD screen is in the public domain and therefore can be used without cost but simply 
acknowledgement of its source. It is available at: 
• http://www.ncptsd.va.gov/ncmain/ncdocs/assmnts/the_primary_care_ptsd_screen_pcptsd.ht
ml  
Scoring, administration and expertise required 
The PC-PTSD is very brief (4-items – one concerning each PTSD symptom cluster) and includes an 
introductory sentence to cue respondents to traumatic events; however, it does not include a list of 
potentially traumatic events. It can be used by any worker in need of a general screen for PTSD. 
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Impact of Events Scale (IES) 
The Impact of Event Scale (IES) is a 15-20 item self-report inventory of the current degree of subjective 
stress experienced as a result of a specific event (Horowitz, Wilner, & Alvarez, 1979). A number of 
revisions have been made since its development. The most recent version is the IES-R (Weiss & Marmar, 
1997). In its final form, the IES-R contains eight intrusion and eight avoidance items, derived from the 
original IES, and adds to this six items assessing hyperarousal (22 items total). The authors of the IES-R 
intended for the scale to be comparable with the original scale and made only minor changes to the 
intrusion and avoidance subscales. 
Early psychometric findings using the original IES were strong, reporting high internal consistency 
(Cronbach’s alpha = 0.79 – 0.92) and demonstrating sensitivity in significantly discriminating between 
patient and non-patient samples across time and detecting change over time, thereby supporting its 
suitability as a measure of treatment outcome (Zilberg, Weiss, & Horowitz, 1982).  
The IES has demonstrated concurrent validity with the GHQ-28 in measuring emotional distress 
(Hodgkinson & Joseph, 1995). In a recent study sensitivity was found to range between 0.93 and 1.00 
and specificity between 0.78 and 0.84 with optimal cut-offs depending upon which diagnostic tool was 
used (Wohlfarth, van den Brink, Winkel, & ter Smitten, 2003). Although others have reported much 
lower findings (Witteveen, Bramsen, Hovens, & van der Ploeg, 2005). 
Although there have been some concerns raised about the factor structure of the IES, recent reviews 
have found factor structure to be stable over different types of events, that it can discriminate between 
stress reactions at different times after the event, and that it has convergent validity with observer-
diagnosed PTSD; concluding that the IES was a useful screening and treatment outcome tool (Joseph, 
2000; Sundin & Horowitz, 2002). 
Although the IES-R was developed in 1997 it has generated surprisingly little psychometric evaluation. 
Those studies, however, t indicate that it too has good psychometric properties (Creamer, Bell, & Failla, 
2003; Ljubotina & Muslic, 2003). For instance, Creamer (2003) reported internal consistency to be 
excellent (Cronbach’s alpha = 0.96) and significant correlation with the PCL (0.84). This study found a 
cut-off score of 33 to provide the best diagnostic accuracy.  
In a recent study, Beck and colleagues (2008) found the IES-R seems to be a solid measure of post-
trauma phenomena. Internal consistency was high for both the total score (0.95) and subscales (re-
experiencing/intrusion = .90, avoidance = .86 and hyperarousal = .85). Concurrent validity was also 
supported with the measure scoring well against both the earlier version of the IES and a range of 
comparative tools (Clinician-Administered PTSD Scale (CAPS), STAI, PSS-SR, BDI-II). Furthermore, 
although the IES-R was not developed as a diagnostic tool, examination of its discriminative validity 
found that the measure could differentiate between individuals with and without PTSD.  
A Review of Screening, Assessment and Outcome Measures for Drug and Alcohol Settings 
 
Specific Mental Health Screening, Assessment and Outcome Measures 88 
 
An earlier review found the IES-R to be among the most favoured tools for trauma exposure and 
posttraumatic assessment (Elhai, Gray, Kashdan, & Franklin, 2005). Furthermore, in a review by Brewin 
(2005) the IES consistently performed well and was one (of only two) instruments, that both had been 
validated on independent samples and had been tested within one year of a traumatic event.  
Client groups 
Both versions have been used successfully with a range of trauma (Cassiday, McNally, VandeCreek, 
Knapp, & Jackson, 1992; Joseph, 2000; Robbins & Hunt, 1996; Schwarzwald, Solomon, Weisenberg, & 
Mikulincer, 1987). 
Similarly, both versions of the IES have also been translated and validated in dozens of languages and 
are widely used in a range of cultural groups (Asukai et al., 2002; Báguena et al., 2001; Brunet, St-Hilaire, 
Jehel, & King, 2003; Chengzhi, Xiangdong, & Lianxi, 2003; Çorapçioglu, Yargiç, Geyran, & Kocabasoglu, 
2006; Ferring & Filipp, 1994; Guo-Ping, Ya-Lin, & Hui, 2006; Guo, Xin, & Geng, 2007; Kazlauskas, Gailiene, 
Domanskaite-Gota, & Trofimova, 2006; Maercker & Schützwohl, 1998; Mystakidou, Tsilika, Parpa, 
Galanos, & Vlahos, 2007; Olde, Kleber, van der Hart, & Pop, 2006; Perera-Diltz, 2007; Pietrantonio, 
Gennaro, Di Paolo, & Solano, 2003; van der Ploeg, Mooren, Kleber, van der Velden, & Brom, 2004; Wu & 
Chan, 2003; Wu & Chan, 2004).  
Acceptable internal consistency and convergent validity of the IES-R have been established among 
substance dependent samples (Rash, Coffey, Baschnagel, Drobes, & Saladin, 2008). The authors of this 
study suggest a cut-off value of 22 as optimal for a substance using population, for adequate 
classification accuracy, sensitivity, and specificity. 
The IES has been successfully used among adolescents (Sack, Seeley, Him, & Clarke, 1998; Yule, Ten 
Bruggencate, & Joseph, 1994) and a version (CRIES) has also been established for children 
(Giannopoulou et al., 2006; Perrin, Meiser-Stedman, & Smith, 2005) 
Availability/cost 
The IES instruments are freely available online and can be used without cost but with due 
acknowledgement of the source by people in non-profit research or clinical work. They are available at: 
• http://www.mardihorowitz.com/impact_of_events_scale   
• www.tracsa.org.au/file.php?f=48Xeky.LjTmqy.1050  
• http://members.iinet.net.au/~gmt/IES-R-Scales.pdf  
• http://www.atft.org/research/Impact%20of%20Event%20Scale%20-%20Revised.htm  
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Scoring, administration and expertise required 
The IES is a self-report measure and takes between 10-20 minutes to complete. Information is only 
collected on one specific life event. The respondent indicates whether or not each a range of symptoms 
had been experienced within the past 7 days on a 4-point (not at all, rarely, sometimes, often) frequency 
scale. The subscale scoring for the 22-item IES is as follows: Intrusion (1, 4, 5, 6, 10, 11, 14) and 
Avoidance (2, 3, 7, 8, 9, 12, 13, 15). While the scoring for the IES-R differs: Avoidance (5, 7, 8, 11, 12, 13, 
17, 22), Intrusion (1, 2, 3, 6, 9, 14, 16, 20), Hyperarousal (4, 10, 15, 18, 19, 21). Subscales are calculated 
as the mean of the items that form them, while the overall total is a sum of these subscales. The IES 
instruments require no special training.  
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The PTSD Symptom Scale Self-Report (PSS-SR) 
The PTSD Symptom Scale Self-Report (PSS-SR) is a screening tool for PTSD which consists of 17 items, 
each item corresponding to one of the 17 DSM-III-R diagnostic Criteria B, C and D for PTSD (Foa, Riggs, 
Dancu, & Rothbaum, 1993). 
The PSS-SR was found to have excellent internally consistent for total score (Cronbach’s alpha = .91) and 
individual subscales (0.78, 0.80, and 0.82 for re-experiencing, avoidance, and arousal scales, 
respectively). The tool was also found to have good test-retest reliability over a period of 1 month (r = 
.74) (Foa et al., 1993). Furthermore, the PSS-SR was found to significantly correlate with a range of other 
equivalent instruments (Rape Aftermath Symptom Test, IES, BDI, STAI), indicating good concurrent 
validity. Finally, convergent validity was also supported with the PSS-SR correctly identifying the PTSD 
status of 86% of the subjects (sensitivity of 62%, specificity of 100%, PPV of 100% and NPV of 82%) (Foa 
et al., 1993). These findings were supported by a recent study which found sensitivity to range between 
.80 and .90 and specificity to range between .84 and .88, with optimal cut-offs dependent upon which 
diagnostic criteria was used (i.e. 15 for DSM-IV and 8-9 for ICD-10) (Wohlfarth et al., 2003). 
Recent findings have also suggested the PSS-SR may have particular utility as a treatment outcome tool 
(Foa et al., 2005; Foa, Zoellner, & Feeny, 2006; Kindt, Buck, Arntz, & Soeter, 2007; Stalker, Gebotys, & 
Harper, 2005; van Minnen & Foa, 2006). 
The PSS-SR was modified (MPSS-SR) by Falsetti and her colleagues (1993), who reported good overall 
internal consistency and good concurrent validity. The major modifications are that the items are not 
keyed to any particular traumatic event and that the MPSS-SR includes severity ratings and frequency 
ratings for each item. Thus, items are rated on 4-point frequency (ranging from 0 = “not at all” to 3 = “5 
or more times per week”) and intensity scales (ranging from A = “not at all upsetting” to D = “extremely 
upsetting”). In addition, for each item, respondents are asked to identify, if they can, which event each 
symptom is linked to. 
An updated version, the Posttraumatic Stress Diagnostic Scale (PDS) (Foa, 1995) also exists to 
correspond with the current DSM-IV. This tool has 49 items clustering around the PTSD symptom 
structures. Consistent with DSM-IV, the measure assesses frequency of symptoms over the past month. 
It also provides information on the nature of the event that produced the symptoms, and also inquires 
about other DSM-IV criteria, such as interference with daily functioning, few other PTSD scales do this 
(Foa, Cashman, Jaycox, & Perry, 1997). It has been shown to have satisfactory test-retest reliability, 
internal consistency, and convergent and concurrent validity  (Adkins, Weathers, McDevitt-Murphy, & 
Daniels, 2008; Foa, 1995). 
Foa and colleagues (1997) reported Total Symptom Severity internal consistency to be excellent 
(Cronbach’s alpha = 0.92) and good for the separate subscales ( Re-experiencing = 0.78, Avoidance = 
0.84, Arousal = 0.84). Test-retest reliability was also high (coefficients of .74 for total score and 
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coefficients ranging between .77 and .85 for the individual subscales). The sensitivity of the PDS was .89, 
whereas its specificity was .75, yielding correct diagnosis 82% of the time. Significant correlations were 
also found between the PDS and other equivalent instruments (IES-R, BDI, STAI), indicating good 
concurrent validity (Foa et al., 1997). In a sample of psychiatric outpatients, performance was maximised 
with a cut-off of 27, but this method resulted in much lower sensitivity and higher specificity than had 
previously been reported (Sheeran & Zimmerman, 2002).  
A recent review found the PDS to be among the most favoured tools for measuring trauma exposure 
and posttraumatic assessment (Elhai et al., 2005). Furthermore, in a review by Brewin (2005) both 
measures were found to be highly promising instruments. 
Client groups 
Both the PSS-SR and the PDS have been found to be consistent and accurate in a range of trauma 
populations (Coffey, Gudmundsdottir, Beck, Palyo, & Miller, 2006; Dunmore, Clark, & Ehlers, 1999; 
Ehring, Kleim, Clark, Foa, & Ehlers, 2007; Engstrom, El-Bassel, Go, & Gilbert, 2008; Kuwert, Spitzer, 
Träder, Freyberger, & Ermann, 2007; Scher, McCreary, Asmundson, & Resick, 2008; Spasojevic, Heffer, & 
Snyder, 2000; Thompson et al., 2003; Tolin & Foa, 1999; Ullman & Long, 2008; Weidmann, Fehm, & 
Fydrich, 2008). The tools have also been found to be valid and reliable in D&A populations (Bonn-Miller, 
Vujanovic, Feldner, Bernstein, & Zvolensky, 2007; Coffey, Dansky, Falsetti, Saladin, & Brady, 1998; 
Coffey, Schumacher, Brady, & Cotton, 2007; Engstrom et al., 2008; Kaysen et al., 2008; Plotzker, 
Metzger, & Holmes, 2007; Sullivan & Holt, 2008). For instance, using the MPSS-SR, Coffey and colleagues 
(Coffey et al., 1998) reported good internal consistency reliability (Cronbach’s alpha = 0.97) for the total 
score, and the severity (0.95) and the frequency subscales (0.94). It was found to show adequate 
convergent validity with the SCL-90-R PTSD scale and the IES. At a cut-off point of 28, sensitivity was 
89%, while specificity rate was 65%; overall correct classification rate was 74% (compared to PTSD 
interview), indicating good concurrent validity.  
These tools have also been used in young (Goodman, Morgan, Juriga, & Brown, 2004; Landolt, Vollrath, 
Timm, Gnehm, & Sennhauser, 2005; Self-Brown et al., 2006) as well as older populations (Chung, Berger, 
Jones, & Rudd, 2006) and validated in a different countries and cultural groups (Douglas, Jimenez, Lin, & 
Frisman, 2008; Griesel, Wessa, & Flor, 2006; Jobson & O'Kearney, 2008; Mirzamani, Mohammadi, 
Mahmoudi-Gharaei, & Mirzamani, 2007; Stieglitz, Frommberger, Foa, & Berger, 2001). 
Availability/cost 
The PSS-SR and the PDS are copyrighted instruments and enquiries into purchasing/obtaining the 
measures can be made from: 
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• Edna B. Foa, Center for the Treatment and Study of Anxiety, Medical College of Pennsylvania 
Division, Allegheny University of the Health Sciences, 3200 Henry Avenue, Philadelphia, 
Pennsylvania,19129, Email: foa@AUHS.edu   
• http://www.pearsonassessments.com/pds.aspx  
• Sherry Falsetti, Medical University of South Carolina, Crime Victims Research and Treatment 
Center, 171 Ashley Avenue, Charleston, SC 29425-0742 
Scoring, administration and expertise required 
The PSS-SR consists of 17 items corresponding to the 17 DSM-III-R criteria which are rated on a four-
point scale of symptom presence.  All versions of the scale take less than 15 minutes to administer 
(Coffey et al., 1998; Foa et al., 1993).  
The PDS is a longer 49-item self-report measure that assesses trauma history and all DSM-IV criteria for 
the diagnosis of PTSD. Respondents rate the frequency of each symptom item on a scale from 0 to 3, 
with higher scores indicating greater frequency of symptoms.  
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Trauma Screening Questionnaire (TSQ) 
The Trauma Screening Questionnaire (TSQ) (Brewin et al., 2002) is a recently developed 10-item 
screening tool consisting of the 10 re-experiencing and arousal items from the PSS-SR (Foa, 1995), 
modified to provide only two response options. Respondents indicate whether or not they have 
experienced each symptom at least twice in the past week.  
Preliminary investigations have shown promising results. In a sample of rail crash survivors, the TSQ was 
found to have excellent sensitivity (0.86) and specificity (0.93), as well as excellent PPV (0.86) and NPV 
(0.93) and an overall efficiency score of 0.90 when endorsing at least six re-experiencing or arousal 
symptoms in any combination. While similar scores were obtained in a second study using victims of 
crime (sensitivity = 0.76; specificity = 0.97,  PPP = 0.91, NPV = 0.92 and overall efficiency = 0.92) (Brewin 
et al., 2002). The authors conclude that these levels of overall efficiency are superior to equivalent – 
interviewer-administered or self-administered – instruments (Brewin et al., 2002). 
Based on these preliminary results, a subsequent review (Brewin, 2005) reported that the measure 
performed better than most longer instruments, despite having a simple yes/no response scale. 
In a recent study, the TSQ was found to be a useful tool in a sample of assault victims. This sample 
replicated the strong sensitivity (0.85), specificity 0.89, NPV (0.98) and overall efficiency (0.90) findings. 
However, the PPV was lower (0.48), but was likely to be the result of a low overall prevalence of PTSD 
(Walters, Bisson, & Shepherd, 2007). This finding lends support to the use of the TSQ as an effective 
means of predicting future PTSD. 
Client groups 
Limited research exists surrounding the use of the TSQ in different population groups. It was recently 
used in samples of over 2,000 young adults from the Australian Capital Territory after a major bushfire 
had occurred in the region (Parslow & Jorm, 2006, 2007; Parslow, Jorm, & Christensen, 2006). 
Further studies are required with a variety of population groups. 
Availability/cost 
The TSQ is reproduced in Brewin and colleagues (2002) it is available online at: 
• http://bjp.rcpsych.org/cgi/content/full/181/2/158  
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Scoring, administration and expertise required 
The TSQ is a 10-item self-report and takes less than 5 minutes to complete. It is split into two halves, the 
first of which screens for re-experiencing symptoms and the second of which screens for arousal 
symptoms and can be easily administered without training. Respondents answer on a dichotomous 
“yes/no” scale and the scale therefore, is easily scored. 
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The PTSD Checklist (PCL) 
The PTSD Checklist (PCL) (Weathers, Litz, Herman, Huska, & Keane, 1993) is a self-report scale where 
respondents rate the extent to which they experience each of the DSM-III-R PTSD symptoms. It consists 
of 17-items corresponding to the 17 DSM-III-R criteria which are rated on a five-point severity scale. 
Early studies found the PCL to have good test-retest reliability (0.96) and moderate concurrent validity 
as indicated by a kappa of 0.64 for diagnosis of PTSD from the Structured Clinical Interview for DSM 
(SCID). Three symptom clusters were said to comprise the PCL with internal consistency (alpha 
coefficient) values ranging from 0.89 to 0.92 (Weathers et al., 1993). 
In a subsequent study the internal consistency coefficient (Cronbach's alpha) for the total scale was 0.94 
and ranging between 0.82 and 0.94, for the different subscales (Blanchard, Jones-Alexander, Buckley, & 
Forneris, 1996). At a cut-off score of 50, the PCL yielded sensitivity of 0.78, and specificity of 0.86 and an 
overall diagnostic efficiency of 0.83, but this improved at the lower cut-off score of 44, (overall 
diagnostic efficiency = 0.90, sensitivity = 0.94 and specificity = 0.86). Overall, the PCL correlated well 
with the CAPS (0.93) and diagnostic efficiency was 0.90 compared with the CAPS (Blanchard et al., 1996). 
However, examination of the individual items showed wide ranging values of individual item 
correlations. 
In a recent study, Ruggiero and colleagues (2003) found Cronbach’s alpha coefficients (.94, .85, .85, and 
.87 for the PCL total, re-experiencing, avoidance, and hyperarousal scores, respectively) were indicative 
of high internal consistency. While high correlations (i.e., r >.75) were found between the PCL total 
scores and scores obtained on two well-established measures for PTSD: the IES and Mississippi Scale for 
PTSD indicating good convergent validity. Statistical analyses also yielded support for discriminant 
validity. Furthermore, test-retest reliability was strong, ranging from 0.92 (immediate) to 0.68 (2-week 
interval). The scale was most efficient at cut-off scores of 44, 45 or 50 (with an item score of 3-4 for 
symptom criteria). These findings supported work by Forbes and colleagues (2001) and Mueser and 
colleagues (2001). 
There are military, civilian and specific versions. An abbreviated version has also recently been created 
for use in primary care (Lang & Stein, 2005). 
Client groups 
The PCL has been shown to have strong psychometric properties across a range of trauma populations 
(Andrykowski, Cordova, Studts, & Miller, 1998; Dobie et al., 2002; Manne, Du Hamel, Gallelli, Sorgen, & 
Redd, 1998; Mueser et al., 2001; Walker, Newman, Dobie, Ciechanowski, & Katon, 2002).  
It has been found to be useful in D&A populations (Najavits et al., 1998). For instance, one study has 
yielded an optimum cut-off score of 52 to determine the presence of PTSD as measured by the CAPS. 
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However, the cut-off score of 50 provided the optimal balance between sensitivity (.86) and specificity 
(.79) (Bollinger, Cuevas, Vielhauer, Morgan, & Keane, 2008). 
The PCL has also been used in elderly populations, however, a lower cut-off score may be necessary in 
older populations (Cook, Elhai, & Areán, 2005; Schinka, Brown, Borenstein, & Mortimer, 2007), while a 
higher cut-off score may be required in severely mentally ill populations (Grubaugh, Elhai, Cusack, Wells, 
& Frueh, 2007). 
The PCL has been translated and is used in different cultural groups internationally (Kocabasoglu, 
Özdemir, Yargiç, & Geyran, 2005; Miles, Marshall, & Schell, 2008). 
Availability/cost 
This checklist is in the public domain. It may be used without cost, but with due acknowledgement of its 
authors. It can be found at: 
• http://idacc.healthbase.info/questionnaires.html 
Scoring, administration and expertise required 
The PCL is a self-report scale which asks the respondent how often they have been bothered by each 
symptom in the last month on a 5-point scale. The PCL can be scored in several different ways. A total 
score (range 17-85) can be obtained by summing the scores from each of the 17 items. A second way to 
score the PCL is to follow the DSM-IV criteria. It has been suggested that a combination of these two 
approaches (i.e., the requisite number of symptoms are endorsed within each cluster AND the total 
score is above the specified cut point for a specific population) may be best. Separate scores can also be 
obtained for Criteria B, C, and D. 
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The Beck Inventories  
A range of measures for the assessment of various mental health symptoms have been developed by 
Aaron Beck and colleagues. The Beck Depression Inventory (BDI or BDI-II) is a 21-item self-report 
instrument intended to assess the existence and severity of symptoms of depression (Beck & Steer, 
1987; Beck, Steer, & Brown, 1996). The Beck Hopelessness Scale (BHS) is a 20-item scale designed to 
detect negative feelings about the future and has been found to be a good predictor of suicide attempts 
(Beck & Steer, 1988). This can be helpful in ongoing treatment where particular thoughts can continue 
to be monitored. The Beck Scale for Suicidal Ideation (BSSI) is a 21-item scale assessing intention to 
commit suicide (Beck & Steer, 1991). The Beck Anxiety Inventory (BAI) (Beck & Steer, 1990) consists of 
21 items, each describing a common symptom of anxiety.  
The BDI is one of the most widely used self-report measures of depression. The items (of the BDI-II) 
correspond to the DSM-IV criteria of depression and assess severity of these symptoms (Beck et al., 
1996), which include pessimism, sense of failure, self dissatisfaction, guilt, self dislike, suicidal ideas, 
social withdrawal, indecisiveness, agitation, concentration difficulties, worthlessness, insomnia, fatigue, 
loss of energy, and loss of libido. Importantly, the BDI appears sensitive to change and can be used to 
evaluate treatment outcome (Richter, Werner, Heerlein, Kraus, & Sauer, 1998). 
The BDI has been found to have good internal consistency reliability with Cronbach’s alpha ranging from 
.76 to .95 in psychiatric samples and from .73 to .92 in non-psychiatric samples (Beck, Steer, & Garbin, 
1988). The BDI-II was found to have similarly good internal consistency (Cronbach’s alpha ranging from 
.89 to .93) (Dozois, Dobson, & Ahnberg, 1998; Steer & Clark, 1997; Whisman, Perez, & Ramel, 2000). The 
test-retest reliability of the BDI is also moderate-strong (correlations ranging from .48 to .86 with 
psychiatric patients and from .60 to .83 with non-psychiatric groups (Beck, Steer, & Garbin, 1988). Of 
particular pertinence is that these findings have been replicated in substance misusing populations 
(Buckley, 2001; Kleinman et al., 1990). 
Beck and colleagues (1988) found significant correlations between clinical ratings of depression and 
scores on the BDI, indicating good construct validity. Similarly, high correlations have been found 
between the BDI and other depression scales (e.g., the depression subscale of the SCL-90-R). It has also 
been found to accurately discriminate between depressed and non-depressed patients, although its 
ability to differentiate anxiety from depression has been criticised (Richter et al., 1998). The validity of 
the BDI-II has been found to be equally strong (Dozois et al., 1998; Riskind, Beck, Brown, & Steer, 1987; 
Steer & Clark, 1997). 
In a student sample, the BDI-II scores correlated strongly (r = .83) with number of SCID depressed mood 
symptoms reported by students. A BDI-II cut-off score of 16 yielded a sensitivity rate of 84%, test-retest 
reliability was 0.96 (Sprinkle et al., 2002). While in a psychiatric population of adolescents, internal 
reliability estimates were good (ranging from .72 to .91) for the BDI-II total and subscale scores. 
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Evidence for the concurrent, convergent, and discriminant validity of the BDI-II was also established 
(Osman, Kopper, Barrios, Gutierrez, & Bagge, 2004). 
The BDI was reported to have the best combination of sensitivity and specificity compared with 
competing scales in screening for depression in cocaine addicts (Weiss, Griffin, & Mirin, 1989). However, 
specificity was generally low. Nevertheless, it has been reported that a cut-off score of 18 has been 
found to provide good sensitivity (73%) and specificity (73%) for depression (Dawe et al., 2002). Cut-off 
scores for the BDI-II are reported in Table 8 and have been found to yield a sensitivity of 81% and 
specificity of 92% (Beck et al., 1996). However, different populations have been found to have varying 
optimal cut-off scores. For instance, in a medical sample, high sensitivity/specificity and NPV were 
obtained with a cut-off score of 9/10 (sensitivity = 100%, specificity = 83.1%, NPV = 100%). While high 
sensitivity/specificity and PPV were obtained with a cut-off score of 13/14 (sensitivity = 93.5%, 
specificity = 96%, PPV = 85.3%) (Furlanetto, Mendlowicz, & Bueno, 2005). 
Table 8. BDI-II cut-off scores 
Score Classification 
0-13 Minimal 
14-19 Mild depression  
20-28 Moderate depression  
29–63 Severe depression 
Adapted from Beck and colleagues (1996) 
The BHS was developed to assess hopelessness and, in particular, negative attitudes about the future. 
Across seven clinical groups, Beck and Steer (1988) found the instrument to have high internal 
consistency (Cronbach’s alpha = .93). While the test-retest reliability has also been found to be 
moderate to good (r = .69). 
The BHS has been found to be highly correlated with clinician ratings of hopelessness (r = .64-.74) 
among general outpatients and suicide attempters and was significantly correlated with related items 
on the BDI (Beck, Weissman, Lester, & Trexler, 1974). The scale correlates highly with seriousness of 
suicide attempt and measures of suicidal intent (Beck, Kovacs, & Weissman, 1979; Ellis & Ratliff, 1986). 
A large scale prospective follow-up study of suicidal inpatients and outpatients found a cut-off score of 9 
yielded high sensitivity (94.1%) in the prediction of completed suicide, although moderate to poor 
specificity (41.0%) (Beck, Brown, Berchick, & Stewart, 1990). Similarly, psychiatric outpatients with a 
score of 9 or more were found to be at 11 times the relative risk of committing suicide (Beck et al., 
1990). However, some have questioned its utility in predicting eventual suicide (Nimeus, Traskman 
Bendz, & Alsen, 1997). 
The BSSI aims to assess a person’s thoughts, plans and intent to commit suicide, as well as the number 
and seriousness of previous suicide attempts. The BSSI demonstrated a high level of internal consistency 
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in early study samples (Cronbach’s alpha = .87 - .90). However, in a subsample of 60 inpatients the test-
retest reliability was moderate to poor (r = .54). The BSSI has demonstrated concurrent validity with the 
BDI and BHS (Beck & Steer, 1991; Beck, Steer, & Ranieri, 1988). The BSSI was among the best predictors 
of admission to hospital in a review by Cochrane-Brink and colleagues (2000). At a cut-off score of 24 the 
BSSI had a both excellent sensitivity (100%) and specificity (90%) for predicting hospital admission 
among suicidal patients and an overall PPV of 71% (Cochrane Brink et al., 2000). 
The BAI is a measure that assesses the severity of anxiety in adults and adolescents. The psychometric 
properties have been extensively studied in a range of inpatient and outpatient populations and among 
those suffering various anxiety disorders (Beck, Epstein, Brown, & Steer, 1988; Beck & Steer, 1990; 
Creamer, Foran, & Bell, 1995; de Beurs, Wilson, Chambless, Goldstein, & Feske, 1997; Fydrich, Dowdall, 
& Chambless, 1992; Kabacoff, Segal, Hersen, & Van Hasselt, 1997; Kumar, Steer, & Beck, 1993; Steer, 
Ranieri, Beck, & Clark, 1993; Steer, Rissmiller, Ranieri, & Beck, 1993). 
Both the internal consistency (Cronbach’s alpha = 92-.93) and the test-retest reliability (.75-.83) has 
been found to be consistently high (Beck & Steer, 1990; de Beurs et al., 1997; Fydrich et al., 1992). 
The concurrent validity of the BAI has been demonstrated by correlations between BAI scores and 
anxiety diaries, clinically rated anxiety and other self-report measures of anxiety across a number of 
studies (Beck, Epstein et al., 1988; Fydrich et al., 1992; Kabacoff et al., 1997; Steer, Ranieri et al., 1993). 
However, the tool has been criticised for failing to discriminate between anxiety and depression (Beck, 
Epstein et al., 1988; Fydrich et al., 1992). Nevertheless, these correlations tend to be lower than those 
with anxiety measures and are likely to be the result of shared symptoms between the disorders (de 
Beurs et al., 1997). De-Beurs and colleagues (1997) also found the BAI to show good sensitivity to 
change, indicating its potential as a treatment outcome tool. The greatest utility of the BAI is reported to 
be its ability to assess panic symptomatology, as opposed to other forms of anxiety (Leyfer, Ruberg, & 
Woodruff-Borden, 2006). 
Limited studies into the sensitivity and specificity of the measure prevent the designation of optimal cut-
off scores (Dawe et al., 2002). These points also tend to differ on the specific anxiety concern. One study 
has suggested the cut-off score for optimal sensitivity (but moderate specificity) for “any anxiety 
disorder” is 3.5 and 5.5, for optimal specificity (but moderate sensitivity) (Leyfer et al., 2006).  
Client groups 
The use of the Beck inventories has been extensive across different population groups. Generally, 
however, a reading level of eighth or ninth grade education is required (Beckman & Lueger, 1997). The 
BDI has been used and validated in a range of cultural settings and ethnic groups (e.g., Spanish, German, 
Arabic, Bulgarian, Swedish, Japanese and Chinese) (Alansari, 2006; Bonicatto, Dew, & Soria, 1998; Byrne, 
Baron, & Balev, 1996; Byrne, Baron, Larsson, & Melin, 1996; Byrne, Stewart, & Lee, 2004; Carmody, 
2005; Chang, 2005; Gorenstein, Andrade, Filho, Tung, & Artes, 1999; Kapci, Uslu, Turkcapar, & 
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Karaoglan, 2008; Kojima et al., 2002a; Kojima et al., 2002b; Uslu, Kapci, Oncu, Ugurlu, & Turkcapar, 
2008; Wiebe & Penley, 2005; Xu, 1991).  
It has been validated in adolescent and older populations (Jo, Park, Jo, Ryu, & Han, 2007; Osman et al., 
2004; Simith, Schwartz, George, & Panke, 2004; Sprinkle et al., 2002). 
The BHS, BAI and the BDI have been used in a diverse sample of clinical groups including substance 
misusers (Buckley, 2001; Hesse, 2006; Husband et al., 1996; Johnson, Neal, Brems, & Fisher, 2006; 
Kleinman et al., 1990; Luty & O'Gara, 2006; Lykke et al., 2008; Sumnall, Wagstaff, & Cole, 2004).  
The BAI has demonstrated validity for use with adult, adolescent and older psychiatric patients and non-
clinical samples (Osman et al., 2002; Wetherell & Gatz, 2005). Translated versions of the BAI have 
demonstrated adequate psychometric properties (Cheng et al., 2002; Freeston, Ladouceur, Thibodeau, 
Gagnon, & Rheaume, 1994; Sica, Ghisi, & Lange, 2007; Ulusoy, Sahin, & Erkmen, 1998). However, BAI 
scores have been found to be significantly related to age and gender. Women with anxiety disorders 
have been found to score on average 4 points higher than males with anxiety disorders in clinical 
samples (Beck & Steer, 1990) and also score higher among non-clinical samples (Osman, Kopper, Barrios, 
Osman, & Wade, 1997). Similarly, BAI scores were also found to be inversely related to age, with 
younger patients reporting more anxiety than older patients with the same anxiety disorders (Beck & 
Steer, 1990). 
Less work has been conducted on the BHS and BSSI than the other Beck scales, however, both have 
been used in different cultural groups (Aguilar, Hidalgo, Cano, & Lopez 1995; Tanaka, Sakamoto, Ono, & 
Fujihara, 1996; Wu & Chan, 2007) and elderly and adolescent populations (Boyd, 2007; Chellappa & 
Araújo, 2007; Kong, Zhang, Jia, & et al., 2007; Rajpal, 2006). 
Availability/cost 
The BSSI and BHS may be used by a range of mental health professionals. However, the scoring and 
interpretation of the measure should be supervised by a Registered Psychologist. The BAI and BDI can 
only be purchased by a Registered Psychologist. All the Beck scales are copyright protected and may not 
be reproduced without permission. Copies may be purchased from: 
• http://www.psychcorp.com 
Scoring, administration and expertise required 
Each Beck scale takes between 5 and 10 minutes to administer. Most can be either self-completed or 
administered orally by the clinician. Full administration and scoring guidelines are provided in the 
respective manuals. Most Beck scales can be administered in paper and pencil or computer-based 
formats (Steer, Rissmiller, Ranieri, & Beck, 1995). 
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The Beck scales are quite simple to administer but scoring and interpretation (and in some cases 
administration) must be supervised by a Registered Psychologist and the instruments must be 
purchased by a Registered Psychologist.  
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The Spielberger State Trait Anxiety Inventory (STAI) 
The Spielberger State Trait Anxiety Inventory (STAI) (Spielberger, 1983) measures two separate forms of 
anxiety. State anxiety refers to the transient/situational status of stress, while trait anxiety refers to a 
more lasting predisposition to feel anxious (enduring personality characteristic) associated with anxiety. 
The former is entirely bound to a stressful situation and is measure on the STAI-S subscale, while the 
later is a more general personality attribute and is measured on the STAI-T subscale. 
The preliminary testing process reported the test-retest reliability of the STAI-T scale to be moderately 
high for both college students (.76) and high school students (.69) (Spielberger, 1983), although lower 
for the STAI-S (a median reliability coefficient of .33). However, one might assume that this transitory 
anxious state would be less consistent over time. Internal consistency was found to good (Cronbach’s 
alpha = .90). A recent review found average reliability coefficients for the STAI were acceptable for both 
internal consistency and test-retest, but variation was present among the estimates. However, STAI-S 
test-retest coefficients were again much lower than internal consistency coefficients (Barnes, Harp, & 
Jung, 2002). 
The STAI-T and STAI-S scales have demonstrated discriminant validity in distinguishing between 
psychiatric and non-psychiatric patients. While stressful situations have been found to elicit significantly 
higher scores on the STAI-S scale (e.g., immediately before an exam, during military training) compared 
with non-stressful settings (e.g., after a relaxation class) (Spielberger, 1983). Furthermore, a number of 
experimental studies indicate the STAI (and the STAI-S scale particularly) may have some utility as an 
outcome measure (Fisher & Durham, 1999; Muris, Mayer, & Merckelbach, 1998; O'Leary et al., 2000; 
van Balkom et al., 2008). 
Client groups 
The STAI has been widely used and there are no special issues or concerns regarding its appropriateness 
as a measure of anxiety in women unlike the BAI (Dawe et al., 2002). A children’s version of the scale is 
available – the State-Trait Anxiety Inventory for Children (STAIC). However, there are some concerns 
about the validity of the Trait subscale in this population (Carey, Faulstich, & Carey, 1994).   
The STAI has also been validated for use with older adults with and without anxiety disorders (Stanley, 
Beck, & Zebb, 1996). A recent study on older individuals, found the optimal cut-off score on the STAI-S 
was 55/54 corresponding with sensitivity of 0.82 and specificity of 0.88 (Kvaal, Ulstein, Nordhus, & 
Engedal, 2005). 
The tool has also been used in a variety of substance misusing populations (Cahill, Adinoff, Hosig, Muller, 
& Pulliam, 2003; de Almeida & Silva, 2005; Drummond & Phillips, 2002; Hoshi et al., 2007; Ilhan, 
Demirbas, & Dogan, 2007; Nagel, Schweinsburg, Phan, & Tapert, 2005).  
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A range of translations of the STAI have also been developed (Gauthier & Bouchard, 1993; Gorenstein, 
Pompeia, & Andrade, 1995; Mote, Natalicio, & Rivas, 1971; Van der Ploeg, 1980). However, further 
validation with various cultural groups is required (e.g., Indigenous Australians).  
Availability/cost 
The STAI is copyright protected and may not be reproduced without permission. A copy may be 
purchased from:  
• ACER Press: Australian Council for Educational Research, ACER Customer Service, 347 
Camberwell Road (Private Bag 55),Camberwell Victoria Australia 3124, Tel: (03) 9835 7447 Fax: 
(03) 9835 7499 via e-mail: sales@acer.edu.au or http://www.acerpress.com.au.  
Scoring, administration and expertise required 
The scale consists of 40-items, rated on a four-point scale and takes approximately 10 minutes to 
complete. The authors suggest a reading level of 4th or 5th grade is required. Half of each scale is scored 
normally and the other 10 items on each scale are reverse scored. This test can only be purchased by 
Registered Psychologists with post graduate training. Full administration and scoring guidelines are 
provided in the manual. 
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The Eating Attitudes Test (EAT) 
The Eating Attitudes Test (EAT) (Garner, Olmstead, Bohr, & Garfinkel, 1982) is a screening test that 
detects disturbed eating patterns. It may also prove a useful outcome tool for anorexia and bulimia 
interventions (Garner & Garfinkel, 1979; Williamson et al., 1989). However, no version of the EAT 
assesses more general dysfunctional attitudes and related psychopathology. The Eating Disorder 
Inventory (EDI) is a larger tool (not discussed here) which is useful for more thorough assessment. The 
40 items of the EAT were obtained by a series of administrations and inclusion of only those items that 
reliably discriminated anorexic patients from normal controls (Garner & Garfinkel, 1979). Shortened 
versions (EAT-26; EAT-16) of the EAT have been developed and shown to have similar properties to the 
original. The 26-item version was found to reflect the three main facets (Dieting and avoidance; bulimia 
and food; and oral control) (Garner et al., 1982). Research on the 16-item version has found four factors 
(Self-perception of body shape, dieting, awareness of food contents, and food preoccupation) (Ocker, 
Lam, Jensen, & Zhang, 2007).  
In the preliminary study the EAT-40 demonstrated good internal consistency for both a clinical sample 
(Cronbach’s alpha = .79) and for a pooled sample of both clinical patients and normal controls 
(Cronbach’s alpha = .94) (Garner & Garfinkel, 1979). The EAT has also demonstrated good test-retest 
reliability (r = .84) (Williamson, Anderson, Jackman, & Jackson, 1995). 
The construct validity has been supported in studies in which the EAT has been found to correlate highly 
with the subscales from the EDI, for instance the drive for thinness subscale (r = .81) (Gross, Rosen, 
Leitenberg, & Willmuth, 1986). The EAT also correlates moderately with self-monitoring records of 
frequency of bingeing (r = .66) and purging (r = .54) and other established measures of bulimia (r ≥ .67) 
(Garner & Garfinkel, 1979). The instrument has demonstrated the ability to discriminate between 
anorexic and non-anorexic women and between binge-eating women and non-binge-eating women 
(Prather & Williamson, 1988), but could not distinguish between anorexic and bulimic individuals 
(Williamson et al., 1995).  
Garner and colleagues (1982) reported that a cut-off score of 20 on the EAT-26 or 30 for the EAT-40 
correctly identified 84% and 85% of the subjects as either anorexic or controls women respectively. 
Others authors have suggested different cut-off scores. For instance, according to ICD-10 criteria, the 
cut-off of 25 was found to be most sensitive (87.5%) and specific (93.9%) (Canals, Carbajo, & Fernández-
Ballart, 2002). 
Overall, The EAT has been found to have good psychometric properties of reliability and validity, and 
reasonable sensitivity and specificity (Engelsen & Laberg, 2001; Garfinkel & Newman, 2001; Mintz & 
O'Halloran, 2000). PPV is generally very low because eating disorders are relatively uncommon. It is used 
to screen for eating disturbances in general as the first part of a two-part diagnostic screen, it has the 
ability to compare groups and to measure change between groups and over time (Garfinkel & Newman, 
2001).  
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Client groups 
Eating disorders are common in D&A treatment services and are commonly not detected (Holderness, 
Brooks Gunn, & Warren, 1994). But although the EAT has been used in studies of substance misusing 
women, the robustness of the EAT’s psychometric properties has not been systematically investigated in 
this population (Dawe et al., 2002). Similarly, while the EAT has been used with male participants, little 
validation within this population has occurred.  
The EAT has been translated into a range of languages, however, when applied outside a western 
context some items and concepts are lost or do not translate accurately, this is likely to be due to the 
fact that eating disorders generally are a particularly Western concept (Fedoroff & McFarlane, 1998). 
Nevertheless, the EAT has been used in a variety of cultures and ethnic groups (Alvarez-Rayón et al., 
2004; Choudry & Mumford, 1992; Ko & Cohen, 1998; Lee, 1993; Lee, Kwok, Liau, & Leung, 2002; 
Leichner, Steiger, Puentes-Neuman, Perreault, & et al., 1994; Nakai, 2003; Neumärker, Bettle, Bettle, 
Dudeck, & Neumärker, 1998; Nunes, Camey, Olinto, & Mari, 2005). 
A modified version, the CHEAT (Children’s EAT) has also been developed to assess disordered eating 
attitudes in younger girls (Maloney, McGuire, & Daniels, 1988). 
Availability/cost 
This instrument is copyright protected, but may be used free of charge, with due acknowledgement of 
the source. It is available from:  
• http://psychcentral.com/quizzes/eat.htm  
• http://medical.state.gov/index.cfm?fuseaction=public.display&id=1cb40add-dda0-4ba1-be22-
b3bdbf81ddab   
• http://www.stuaff.niu.edu/csdc/EAT26.HTM   
• Garner, D.M. (1997). Psychoeducational principles in treatment. In D.M. Garner & P.E. Garfinkel 
(Eds.) Handbook of treatment for eating disorders, New York: Guilford Press. 
Scoring, administration and expertise required 
The EAT is a simple, brief tool requiring no specific training to administer/score. It takes less than 10 
minutes to administer, however, as it is a self-report measure, a 5th grade reading level is required by 
the respondent (Williamson et al., 1995). Items are scored on a 6-point scale ranging from “always” to 
“never.” 
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Body Dysmorphic Disorder Questionnaire (BDDQ) 
The Body Dysmorphic Disorder Questionnaire (BDDQ) (Phillips, 1996) was originally developed as a 9-
item self-report to screen for disturbed body image. Items include concern (dissatisfaction) with “the 
appearance of some part(s)” of one's body, whether or not these are weight-related concerns, 
preoccupation with these concerns, ensuing distress, interference with “social life” and with school 
work, job, or role functioning, effects on avoidance and on other people in one's life, and the amount of 
time spent thinking about the perceived physical defect. A 7-item modification of the BDDQ has also 
found to screen acceptably for body dysmorphic disorder (Dufresne, Phillips, Vittorio, & Wilkel, 2001). 
The is based on the criteria outlined in DSM-IV and has been found to be highly correlated with clinician 
diagnoses of body dysmorphic disorder (Phillips, 1996). In an inpatient psychiatric setting, the BDDQ had 
a high sensitivity (100%) and acceptable specificity (89%) (Phillips, Atala, & Pope, 1995). Whilst in a 
dermatology setting, it had a sensitivity of 100% and a specificity of 93% (Dufresne et al., 2001), and in a 
sample of 105 adult and 17 adolescent psychiatric inpatients, it had a sensitivity of 100% and a 
specificity of 93% (Grant, Kim, & Crow, 2001). 
A recently developed tool derived from the BDDQ is the Body Image Disturbance Questionnaire (BIDQ) 
(Cash, Phillips, Santos, & Hrabosky, 2004). The advantage this tool has is that it measures a continuum of 
body image disturbance rather than a categorical (yes/no) measure. This tool was found to be internally 
consistent and free of impression-management response bias. The measure also converged 
appropriately with other body image indices (evaluation, affect, investment, and impact), was positively 
correlated with depression, social anxiety, and eating disturbances. Scores on this assessment also 
predicted psychosocial functioning above and beyond body dissatisfaction (Cash et al., 2004).  
Availability/cost 
The BDDQ can be found in Phillips (1996) with copyright held by the publisher: 
• Phillips, K. A. (1996). The broken mirror: Understanding and treating body dysmorphic disorder. 
New York: Oxford University Press. 
The BIDQ is printed in Cash and colleagues (2004), with copyright held by the Journal. However, scoring 
and interpretation requires the purchasing of the scale. It can be purchased for $15 at: 
• http://www.body-images.com/assessments/order.html  
Client groups 
The tool has been used in an array on inpatent and outpatient populations (Bartsch, 2007; Conroy et al., 
2008; Dufresne et al., 2001; Dyl, Kittler, Phillips, & Hunt, 2006; Grant et al., 2001; Grant, Kim, & Eckert, 
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2002; Phillips et al., 1995). A slightly modified version of the BDDQ (with language more appropriate for 
adolescents) has been developed but not thoroughly evaluated (Dyl et al., 2006).  
Although not extensively evaluated in exclusively D&A populations, higher scores on the BDDQ have 
been found to correlate with increased self-reported illicit substance use histories and comorbidity 
(Stewart, Stack, & Wilhelm, 2008). 
A German version of the scale also exists (Daig, Burkert, Albani, Martin, & Brähler, 2008), but to the 
author’s knowledge few other cross cultural studies have been conducted.  
Scoring, administration and expertise required 
Items on the BDDQ use a yes/no response format, and scoring is not continuous, while on the BIDQ it is 
continuous. The scales consist of 7-9 and 12 items respectively. No special qualifications are required to 
administer the scales, and the scales take approximately 5-10 minutes to complete. 
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Positive Mental Health Outcome Measures  
The Recovery Assessment Scale 
The Recovery Assessment Scale (RAS) (Giffort, Schmook, Woody, Vollendorf, & Gervain, 1995) is an 
outcome tool which tests for empowerment, coping ability, and quality of life. The RAS is a 41-item 
survey rated on a 5 point scale. A shorter, 24-item version the RAS also exists.  
In a study of thirty-five inpatients, the RAS was found to have good test-retest reliability (r = 0.88) along 
with good internal consistency (Cronbach’s alpha = 0.93). The scale showed recovery to be positively 
associated with self-esteem, empowerment, social support, and quality of life, indicating good 
concurrent validity. It was inversely associated with psychiatric symptoms suggesting discriminant 
validity (Corrigan, Giffort, Rashid, Leary, & Okeke, 1999). 
In a recent sample of 1,824 persons with serious mental illness, the RAS yielded five factors: personal 
confidence and hope, willingness to ask for help, goal and success orientation, reliance on others, and 
no domination by symptoms. These findings suggest the RAS has good construct validity for assessing 
the recovery processes (Corrigan, Salzer, Ralph, Sangster, & Keck, 2004). In this study hope was found to 
be an essential element of recovery. The combination of variables accounted for a substantial amount of 
variance in the recovery factors (offering some evidence of convergent validity) but also the factors 
were found to be distinct elements of recovery. 
This finding was replicated in a sample of 168 individuals with severe and persistent psychiatric disability 
in which the RAS was found to load on five factors, each of which had satisfactory internal reliability 
(Cronbach’s alpha range = .73-.91). The factors displayed convergent validity with positive and 
significant correlations with other recovery measures. Concurrent validity was demonstrated with 
significant but lower correlations with symptoms and clinician-rated measures of psychiatric functioning 
(completed self-report recovery and other mental health measures and their case workers completed 
the HoNOS) (McNaught, Caputi, Oades, & Deane, 2007).  
Client groups 
Preliminary studies suggest the RAS to be useful tool as an outcome measure for recovery. However, it 
has not been empirically tested in a range of populations. Nevertheless, the RAS has proved a valid 
measure in psychiatric populations (Corrigan et al., 2004; McNaught et al., 2007). In addition, it has been 
used successfully in a war veteran population (Flinn, Ventura, & Bonder, 2005).  
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Availability/cost 
The RAS is freely available at: 
• http://chester.nami.org/Job/RAS.pdf  
• http://www.stigmaresearch.org/publications/measures/measure.cfm?mdes=RAS  
Scoring, administration and expertise required 
The RAS is a 24- or 41-item patient self-report measure. Each item is rated on a 5 point scale and takes 
approximately 5-15 minutes to complete. No special qualifications are required for its use. 
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Scales of Psychological Well-being (SPWB) 
The Scales of Psychological Well-being (SPWB) (Ryff, 1989a, 1989b) consist of a series of statements 
reflecting the six areas of psychological well-being: autonomy, environmental mastery, personal growth, 
positive relations with others, purpose in life, and self-acceptance.  
Recent studies have questioned the construct validity of the SPWB and have revealed fewer factors than 
the six proposed by Ryff in the original studies (Kafka & Kozma, 2002; Springer & Hauser, 2006; van 
Dierendonck, 2004). Ryff's own studies (Ryff, 1989b; Ryff & Keyes, 1995) have reported high correlations 
among scores for the constructs that were proposed as independent. Abbott and colleagues (2006) 
suggest that the measures may not, in practice, adequately operationalise the originally proposed 
constructs. However, the authors did report good predictive validity (Abbott et al., 2006).  Concurrent 
validity findings are limited and correlations between the SPWB subscales and other measures are only 
moderate (Ryff & Keyes, 1995). 
Client groups 
This tool has been used in a range of populations including the elderly, and adolescents (Burton, 2006; 
Clayman, 2005; Lawler-Row & Piferi, 2006; Schanowitz & Nicassio, 2006; Vleioras & Bosma, 2005)  and 
has been translated into a number of languages (Chang, 2006; Cheng & Chan, 2005; Laukka, 2007; 
Pulkkinen, Feldt, & Kokko, 2006; Vleioras & Bosma, 2005).  
Availability/cost 
There is no charge to use the SPWB; however, institutions must pay for the cost of reproducing it from 
the electronic master file, which is sent upon request to:  
• Dr. Carol Ryff; University of Wisconsin; Institute on Aging; 2245 Medical Sciences Center; 1300 
University Avenue; Madison, WI 53706; Phone: (608) 262-1818; Fax: (608) 263-6211; email: 
cryff@wisc.edu.   
Scoring, administration and expertise required 
The original instrument included 120 items (20 per dimension) but shorter versions comprising 84 items 
(14 per dimension), 54 items (9 per dimension), 42 items (7 per dimension) and 18 items (3 per 
dimension) are now widely used. A 14-item scale also exists but concerns have been raised about its 
reliability. 
Respondents rate statements on a scale of 1 to 6, with 1 indicating strong disagreement and 6 indicating 
strong agreement. No testing supervisors are required. Responses are totalled for each of the six 
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categories (about half of the responses are reverse scored). Higher scores indicate mastery in that area, 
while low scores indicate a lack of comfort in that area.  
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Dispositional Hope Scale (DHS) 
The Dispositional Hope Scale (DHS) (Snyder et al., 1991) consists of two subsets of items measuring 
Agency and Pathways, these two factors form the definition of Hope as Snyder and colleagues (1991) 
defined it: The positive motivational state that is based on an interaction between successful agency 
(goal-directed energy) and pathways (planning to meet goals). However, recent findings suggest the tool 
may only have a single factor (Brouwer, Meijer, Weekers, & Baneke, 2008). 
Snyder and colleagues (1991) reported that the scale was internally consistent (alphas in the range of 
.75-.85 for several studies) and evidenced satisfactory construct and discriminant validity in a number of 
studies (Snyder et al., 1991). 
A modified 6-item State Hope Scale has also been developed and found to be internally consistent, 
reflecting the theorised agency and pathways components. Evidence supporting the concurrent and 
discriminant validity for this version has also been reported (Snyder et al., 1996).  
Client groups 
The DHS has been translated and validated in a variety of different countries (Kato & Snyder, 2005; Lee, 
Lee, & Choi, 2008). In a large multiethnic sample found the structure of the DHS to be relatively stable 
and robust, however, some gender differences were found (Roesch & Vaughn, 2006). 
A children’s version has also been developed and shown to have good internal consistency (Cronbach’s 
alpha = .84) along with good convergent and discriminant validity (Snyder et al., 1997). 
Availability/cost 
The DHS is printed in Snyder and colleagues (1991): 
• Snyder, C. R., Harris, C., Anderson, J. R., Holleran, S. A., Irving, L. M., Sigmon, S. T., et al. (1991). 
The will and the ways: Development and validation of an individual-differences measure of 
hope. Journal of Personality and Social Psychology, 60, 570-588. 
The State Hope Scale is printed in Snyder and colleagues (1996), which is freely available online: 
• Snyder, C. R., Sympson, S. C., Ybasco, F. C., Tyrone F. Borders, Babyak, M. A., & Higgins, R. L. 
(1996). Development and Validation of the State Hope Scale. Journal of Personality and Social 
Psychology, 70(2), 321-335. 
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Scoring, administration and expertise required 
The DHS consists of 12 items (including four distracters), with 4-items tapping the agency factor, and 4-
items tapping the pathways thinking factor. Participants respond on an 8-point continuum (1 = definitely 
false, to 8 = definitely true), so that scores can range from a low of 8 to a high of 64. 
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Stages of Recovery Instrument (STORI) 
The Stages of Recovery Instrument (STORI) (Andresen, Caputi, & Oades, 2006) was developed as a 
method of measuring recovery as the concept is described by mental health consumers. The 
development of the STORI was based on the Stage Model of Recovery (Andresen, Oades, & Caputi, 
2003), which reflects the experiences of people who have recovered from mental illnesses, such as 
schizophrenia and the scales focus on mental health, psychological well-being, hope, resilience and 
recovery. It is intended to measure constructs that are more meaningful to consumers than 
conventional outcome measures. The STORI was developed in response to consumer criticisms of 
traditional clinical measures, which tend to focus on illness and disability. In contrast, the STORI focuses 
on psychological recovery and personal growth. 
Preliminary data suggest the STORI correlates well with all of the psychological health variables, and the 
five stage subscales were found to be internally consistent (Cronbach’s alpha ranging from 0.88 to 0.94). 
Despite requiring some minor refinement and further testing, the authors concluded that these findings 
indicated the STORI was a measure of the consumer definition of recovery (Andresen et al., 2006). 
A shorter version of the tool, called the Self-Identified Stage of Recovery is also currently being refined 
and evaluated.  
Client groups 
Only limited data exists on the STORI but it has been translated into French and Spanish versions.  
Availability/cost 
Provided no profit is made, the STORI may be freely downloaded with due acknowledgement of the 
authors: 
• http://www.uow.edu.au/health/iimh/stori/  
Scoring, administration and expertise required 
The STORI is a self-report measure consisting of fifty items, each rated from 0 to 5.  The items are 
presented in 10 groups of five (subscales), with one item in each group representing a different stage of 
recovery.  The highest subscale score indicates the stage of recovery that the person is experiencing. The 
subscales are as follows:  
• Moratorium – A stage of hopelessness and self-protective withdrawal. 
• Awareness – The realisation that recovery and a fulfilling life is possible 
• Preparation – The search for personal resources and external sources of help. 
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• Rebuilding – Taking positive steps towards meaningful goals. 
• Growth – A sense of having control over life and looking forward to the future. 
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Social and Emotional Wellbeing and Empowerment Tool 
Empowerment programs seek to encourage people to take control of their own lives. There is 
considerable international and national evidence that interventions which empower socially excluded 
populations across psychological, organisational and community levels have achieved improved health 
outcomes and quality of life of disadvantaged groups (Wallerstein, 1992; Wallerstein, 2006). Indigenous 
people of Australia are one such population who have experienced severe and systematic 
disempowerment with devastating health and social impacts.  
Work is currently being done on a quantitative tool to measure empowerment outcomes for individual, 
organisational and structural levels in Australian Indigenous peoples/communities. Preliminary data has 
shown positive results (Haswell-Elkins, 2009; personal communication). 
This tool will enable cost benefit and sustainability analysis of empowerment interventions, based on 
aspects of empowerment as defined by Australian Indigenous people, and may eventually be used 
across health promotion and community development activities more broadly. The development of the 
measure had a strong Indigenous focus and involved the analysis of individual interviews on the process 
of empowerment (Haswell-Elkins, 2009; personal communication). Work by Tsey and colleagues (Tsey & 
Every, 2000; Tsey et al., 2005; Tsey et al., 2007) on the Family Well-being Tool and the Family Well Being 
Empowerment Program formed the context for the development of this empowerment tool. 
The tool has three main components: K10, and two newly developed instruments: a 13-item Emotional 
Empowerment Scale (EES) and set of 12 scenarios (12S). It was piloted in eight small group settings 
involving 90 participants working or volunteering in Indigenous social health activities. Both the EES 
(self-capacity and inner peace) and 12S (psychological and social empowerment) have been found to 
have adequate reliability and validity (CRCAH, 2008).  
Client groups 
This tool was specifically designed for the Aboriginal and Torres Strait Islander community. 
Availability/cost 
The empowerment tool is still being finalised and publication of data and the tool itself is scheduled for 
2009. 
Scoring, administration and expertise required 
The K10 component is scored as normal, the two new scales consist of 13 items and 12 scenarios, 
scoring for these items is explained in the tool itself. 
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General Drug and Alcohol Screening, Assessment and Outcome Measures 
The Alcohol Use Disorders Identification Test (AUDIT) 
The Alcohol Use Disorders Identification Test (AUDIT) is a 10-item screening instrument developed 
by a WHO collaborative designed to screen for a range of drinking problems (Saunders, Aasland, Babor, 
Fuente, & Grant, 1993). It is generally considered the ‘gold standard’ for providing an indication of 
current alcohol use disorders (e.g. harmful use, abuse, dependence), and aims to measure three aspects 
of alcohol misuse: consumption, dependence, and related-problems. Although originally found to load 
on three factors (and often used as a one-factor screening instrument with a single cut-off score) recent 
findings support a two-factor solution for the AUDIT (alcohol consumption and alcohol-related 
consequences) (Doyle, Donovan, & Kivlahan, 2007). 
The psychometric properties of the AUDIT have been explored in a number of populations, including 
inpatient care, rural and urban communities and emergency room patients, the unemployed and college 
students (Reinert & Allen, 2002). Internal reliability has been consistently strong, with Cronbach’s alpha 
scores in the range of.80-.94 (Allen, Litten, Fertig, & Babor, 1997; Bohn, Babor, & Kranzler, 1995; Shields 
& Caruso, 2003). While test-retest reliability has been has also shown good temporal stability (r = .88) 
(Daeppen, Yersin, Landry, Pecoud, & Decrey, 2000). AUDIT scores have been used to predict alcohol-
related physical disorders and social problems (Conigrave, Hall, & Saunders, 1995; Conigrave, Saunders, 
& Reznik, 1995) and also the likelihood of remaining unemployed after a two-year period (Claussen & 
Aasland, 1993). Similarly, the AUDIT score was also shown to be a better predictor of subsequent 
alcohol-related medical and social problems than standard biochemical markers (Conigrave, Saunders et 
al., 1995). These findings indicate the AUDIT has high levels of predictive validity. The construct validity 
of the AUDIT has also been studied, with AUDIT scores showing moderate to high correlations with 
other self-report alcohol screening tools (e.g. the MAST and the CAGE), but lower correlations with 
biochemical measures (Allen et al., 1997; MacKenzie, Langa, & Brown, 1996), although it has been 
suggested that this may be due to a lack of sensitivity from such measures (Aertgeerts, Buntinx, Ansoms, 
& Fevery, 2001).  
Saunders and colleagues (1993) suggested cut-off points of 8 and 10 for maximal sensitivity and 
specificity. Of those individuals who scored 8 or more on the AUDIT, 95-100% were classified in the 
hazardous alcohol consumption group; 93-100% were classified as having abnormal drinking behaviour; 
100% were alcohol dependent (Dawe et al., 2002). Other authors have suggested ≥8 as the cut -off for 
harmful consumption, ≥10 for hazardous consumption and ≥19 for abuse and dependence diagnosis  
(MacKenzie et al., 1996). In a clinical sense, Babor and colleagues  (2001) suggest individuals with scores 
between 8 and 15 should receive simple advice focused on the reduction of hazardous drinking. Those 
with scores between 16 and 19 should receive brief counselling and continued monitoring and those 
with scores of 20 or above clearly warrant further diagnostic evaluation for alcohol dependence. 
However, these cut-off scores may need to be modified depending upon the characteristics of the client 
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group (Cherpitel, 1995). The cut-off values of 7 and 16 were observed to have the best trade-offs 
between sensitivity, specificity, the ratio of positive likelihood to negative likelihood ratios, and PPV in a 
recent male Sri Lankan sample (De Silva, Jayawardana, & Pathmeswaran, 2008). While Bradley and 
colleagues (1998) suggest that lowering the recommended cut-off point from 8 to 4 may enhance the 
sensitivity of the AUDIT in adult women. This was supported by a recent review (Reinert & Allen, 2007), 
which otherwise supported the use of the AUDIT in most populations.  
A recent meta-analysis of 19 relevant studies, at a cut-off point of 8, sensitivity ranged from .31 to .89 
and specificity ranged from .83 to .96 across the eight studies conducted in primary care. A single trial in 
general hospital inpatients found a sensitivity of .93 and a specificity of .94; another trial in emergency-
department patients found a sensitivity of .72 and a specificity of .88. A study in university students 
found a sensitivity of .82 and a specificity of .78. Three studies in elderly patients found sensitivities 
between .55 and .83 at a pooled specificity of .96. The authors concluded the large heterogeneity 
between results, could only partly be explained by setting diversity (Berner, Kriston, Bentele, & Härter, 
2007). 
Client groups 
As mentioned above the AUDIT has been used successfully in a number of different populations (Berner 
et al., 2007; Cherpitel, 1998; Gómez, Conde, Santana, & Jorrín, 2005; Kokotailo et al., 2004; Reinert & 
Allen, 2002, 2007).  It was purposely devised to be literally translated to different languages (Saunders, 
Aasland, Amundsen, & Grant, 1993) and has been validated in a number of cultures (Adewuya, 2005; 
Bergman & Källmén, 2002; Carey, Carey, & Chandra, 2003; Dybek et al., 2006; Gache et al., 2005; Giang, 
Spak, Dzung, & Allebeck, 2005; Kim, Gulick, Nam, & Kim, 2008; Lima et al., 2005; Tsai, Tsai, Chen, & Liu, 
2005). 
A modified version of the AUDIT has been developed for use with the Australian population. The 
AusAUDIT (Conigrave & Elvy, 1998; Degenhardt, Conigrave, Wutzke, & Saunders, 2001) retains the 10 
items of the original AUDIT but makes some changes to detect lower, but still harmful drinking. The 
AusAUDIT can be found in Degenhardt  and colleagues (2001). The AusAUDIT was found to show good 
sensitivity but somewhat limited specificity (Degenhardt, Conigrave et al., 2001). To improve specificity, 
the authors recommend increasing the cut-off points (from 6 for women and 7 for men) to 7 for women 
and to 10 for men. This resulted in sensitivity of .85 and specificity of .70 for both men and women. 
Using a cut-off point of 7 for both men and women, the AusAUDIT was somewhat less sensitive to 
detecting those participants who met ICD-10 diagnoses of dependence and/or harmful use, with 
sensitivities ranging from 85.7% to 87.2%.  
The AUDIT has been shown to be an equally valid or superior measure for adolescents (compared to the 
TWEAK, the Problem Oriented Screening Instrument for Teenagers substance use/abuse scale (POSIT) 
and the CAGE) (Chung et al., 2000; Knight, Sherritt, Harris, Gates, & Chang, 2003). However, there has 
been some concern that the instrument lacks sensitivity in females and older populations (Dawe et al., 
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2002). For instance Powell and McInness (1994)  found the AUDIT had low sensitivity (57%) to alcohol 
abuse in a large sample of hospitalised Australian inpatients over 65 years of age. Morton and 
colleagues (1996) found the AUDIT sensitivity to be even lower in American male war veterans over 65 
years (33%). Dawe and colleagues (2002) suggests the poor performance of the AUDIT in the elderly may 
be due to the emphasis on the actual consumption of alcohol, which may be less relevant to alcohol 
misuse and related problems in this age group (Conigliaro, Kraemer, & McNeil, 2000). Nonetheless, 
recent findings have tended to find the AUDIT to be an adequate tool in ageing populations (Berner et 
al., 2007; Gómez et al., 2006). 
The AUDIT has been used among the Aboriginal and Torres Strait Islanders in research studies (Brady, 
Sibthorpe, Bailie, Ball, & Sumnerdodd, 2002; Kelly & Kowalyszyn, 2003; Schlesinger et al., 2007), 
however; there has been a dearth of specific field trials within this population so the use of the 
instrument and interpretation of scores should only proceed with caution. Despite the items for the 
AUDIT being derived from a cultural diverse cross national data set (Saunders, Aasland, Babor et al., 
1993), one study has reported the AUDIT was felt to be intrusive and some questions were poorly 
understood by an Australian Indigenous population (Brady et al., 2002).  
In a sample of Australian male psychiatric in-patients with a primary diagnosis of schizophrenia, the 
AUDIT showed good sensitivity (87%) and specificity (90%) in detecting past 12 month CIDI-diagnosed 
alcohol disorders, when the standard cut-off of 8 was used (Dawe, Seinen, & Kavanagh, 2000). Similarly, 
Kavanagh and colleagues (1999) found the tool had a sensitivity of 100% and specificity of 77% in 
detecting current alcohol disorder in a sample of young inpatients suffering psychotic episodes. 
Preliminary research in this area has shown the AUDIT to be an appropriate and valuable instrument. 
Equally strong results were found in various psychiatric outpatient populations (Hill & Chang, 2007; 
Maisto, Carey, Carey, Gordon, & Gleason, 2000). Similarly, the AUDIT has been found to have good 
sensitivity and moderate to good specificity for hazardous drinking, and alcohol use disorders in drug 
dependent samples (Skipsey, Burleson, & Kranzler, 1997). 
O'Hare and colleagues (2004) found the AUDIT to be a reliable screening tool in a severely mentally ill 
population, with good concurrent validity with other measures of alcohol abuse and psychosocial 
difficulties. A lower cut-off score (3) however, may lead to more accurate detection of alcohol use 
disorders than the traditional cut-off score. However, in a recent study of a psychosis-sufferers the 
AUDIT functioned best with a problem drinking cut-off score of 10 (sensitivity, 85%; specificity, 91%) 
(Cassidy, Schmitz, & Malla, 2008).  
Recently a number of new modified versions of the AUDIT have been developed for use in other drug 
using populations (i.e., other than alcohol). The Cannabis Use Disorders Identification Test (CUDIT) was 
found to have a PPV of 84.6% and sensitivity of 73.3% at a cut-off of 8, making it a superior instrument 
for measuring frequency of cannabis use compared to simply the number of cannabis use days 
(Adamson & Sellman, 2003). Internal consistency was good (Cronbach’s alpha = 0.84). However, there 
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has been concerns raised about the validity of particular items on the measure and further studies are 
required (Piontek, Kraus, & Klempova, 2008). 
Similarly, the Drug Use Disorders Identification Test (DUDIT) is an 11-item self-report instrument, which 
has recently been developed and tested (Berman, Bergman, Palmstierna, & Schlyter, 2005).  
Psychometric properties were examined in a sample of heavy drug users from prison, probation, and 
inpatient detoxification settings, and in a general Swedish population sample. In the drug user sample, 
the DUDIT predicted drug dependence with a sensitivity of 90% for both DSM-IV and ICD-10 and a 
respective specificity of 78 and 88%. Reliability according to Cronbach’s alpha coefficient was 0.80. 
Availability/cost 
The AUDIT is in the public domain and therefore can be used without cost but with due 
acknowledgement of the source. This tool is available from a number of websites: 
• http://whqlibdoc.who.int/hq/2001/WHO_MSD_MSB_01.6a.pdf 
• http://www.nceta.flinders.edu.au/pdf/GP-Project/GP-Resource-Kit_files/B31-Ho5.pdf 
• http://www.therightmix.gov.au/pdfs/HealthProviderAUDIT.pdf 
Scoring, administration and expertise required 
The AUDIT can be self- or clinician-administered and can be administered and scored without specific 
training. It is scored by simply adding the scores on each of the ten items (items 1 to 8 are scored on a 
0 – 4 scale and items 9 and 10 are scored 0, 2, 4). A score of 8 or above (for men and perhaps 4 and 
above for adolescents and women) is thought to be indicative of alcohol problems. It takes between 2-5 
minutes to complete and one minute to score. It has been shown to require a minimum reading level of 
seventh grade (Hays, Merz, & Nicholas, 1995), which suggests it is suitable for people with low levels of 
literacy (e.g., those for whom English was a second language).  
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CAGE / CAGEAID  
The CAGE (Ewing, 1984) is a four-item screening tool that is designed to identify  problem drinking via 
four constructs (each its own question). Cutdown, Annoyed, Guilty, Eye-Opener. The CAGEAID (Adapted 
to Include Drugs) is an equivalent tool developed to screen for drug use disorders has been.  
The items on the CAGE have good internal reliability (Mischke & Venneri, 1987), but test-retest 
reliability may be less consistent over the lifetime (Green & Whichelow, 1994) and may function better 
as a screen for recent problems (Watson et al., 1995). In an early UK sample it was reported that using a 
cut-off point of ≥2 affirmative responses, the CAGE showed good sensitivity (84%) and specificity (95%) 
for detecting current high-risk drinking (defined as 8 or more standard drinks a day), and had an overall 
PPV of 45% (King, 1986). MacKenzie and colleagues (1996) recommend using a cut-off point of 1 for 
detecting hazardous/harmful use and a cut-off point of 3 for identifying those likely to meet a DSM 
diagnosis. However, using a cut-off point of 1 for harmful use is likely to overly compromise specificity 
(for the sake of sensitivity) and lead to a high rate of false positives which may render the CAGE 
somewhat impractical (Watkins, Eisele, & Matthews, 2000). Some authors have suggested that 
introducing the CAGE questionnaire in a non-judgmental way (e.g., “do you have a drink now and 
then?”) dramatically increases its sensitivity without this compromise to specificity  (Steinweg & Worth, 
1993).  
With a cut-off of ≥1 the CAGE -AID exhibited sensitivity of .79 and specificity of .77. At a cut off of ≥2
sensitivity dropped to .70 and specificity increased to .85 (Brown & Rounds, 1995). This was higher in 
schizophrenic patients with alcohol use disorders, high sensitivity (0.91) and specificity (0.83) at the 
lower cut-off and the higher cut-off points (sensitivity = 0.82, specificity = 0.94) (Dervaux et al., 2006). In 
a sample of war veterans a cut-off score of ≥ 1 achieved a sensitivity of 86% and specificity of 93% when 
using the diagnostic interview as the criterion standard (Liskow, Campbell, Nickel, & Powell, 1995). 
While in a French hospital inpatient population, at a cut-off of 2 the CAGE had a sensitivity of 77% and a 
specificity of 94%. The CAGE test was more sensitive for patients diagnosed as alcohol-dependent than 
for alcohol abusers (61% vs. 84%) with the same specificity (94%) (Malet, Schwan, Boussiron, Aublet-
Cuvelier, & Llorca, 2005).  
A review found reliability of the CAGE to be varied with median internal consistency reliability across 22 
samples reaching .74, but ranged from .52 to .90. Sample age was the only identified sample 
characteristic that demonstrated a statistically significant relationship with CAGE score reliability 
(Shields & Caruso, 2004). 
Client groups 
The CAGE has been used in many cultures worldwide, but often careful translation is required to retain  
accuracy. One problem that both forms of the CAGE may face is that an increased awareness of the 
dangers associated with alcohol/drug consumption (for instance Australia’s growing public health 
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campaign) may produce an increase in the number of non-problem drinkers answering in the affirmative 
to items 1 and 3 (Waterson & Murray-Lyon, 1988). 
Unlike many of the other instruments, the CAGE has been used in studies with Australian Indigenous 
communities. Skowrow and Smith (1986) found that high scorers on the CAGE consumed significantly 
more alcohol both on the day before interview, and on a typical drinking day and drank more often in a 
sample of 106 homeless Aboriginal men. Further studies found CAGE scores to correlate with both 
quantity and frequency of alcohol intake among Indigenous Australians in the Kimberley region (Hunter, 
Hall, & Spargo, 1991). After community consultation, these authors deemed it necessary to alter the 
wording for the items. The amended items are shown below (Hunter et al., 1991): 
1. Do you sometimes think you shouldn’t drink, or maybe drink less? 
2. Do you feel angry or upset when other people get on your back about drinking, or tell you to cut 
down? 
3. Do you ever feel shame or guilty about drinking? 
4. Do you sometimes take a drink early in the morning for headache or because you feel no good, 
a reviver? 
The CAGE was found to perform poorly in younger age groups (Aertgeerts, Buntinx, Bande-Knops et al., 
2000; Chung et al., 2000; O'Hare & Tran, 1997). Some suggest this is because the items may be less 
relevant to adolescent populations, such as morning drinking, which is indicative of long-term alcohol 
dependence, rather than more recent problematic drinking (O'Hare & Tran, 1997). To increase the 
sensitivity of the CAGE in this population, Aertgeerts and colleagues (2000) suggested replacing the 
“Annoyed” item with “Have you ever been under the influence of alcohol in a situation where it 
increased your chances of getting hurt, for example, when riding a bicycle or driving a car”, referred to 
as the “Under the influence” item (CUGE). However, validation of this new form of the instrument is 
required. Dawe and colleagues (2002) suggest, in light of these findings, that instruments that tap 
psychological symptomatology of alcohol misuse, such as cravings, high consumption and loss of 
control/memory (i.e., the AUDIT & TWEAK) may be more appropriate to the assessment of young 
alcohol misusers than those that index physiological dependence and long-term alcohol-related 
problems (i.e., the MAST & CAGE). In a similar sense, some authors have suggested the CAGE is less 
sensitive to the discrimination of less severe cases of alcohol misuse in the general population (Bisson, 
Nadeau, & Demers, 1999; MacKenzie et al., 1996). 
However, the CAGE is perhaps the best measure of problematic drinking behaviour in older populations. 
It appears to be as sensitive as the MAST-G in the United States, with sensitivity for alcohol problems 
and dependence ranging from .77 to .94 at a cut-off point of ≥1 for persons over 60 years, but its brevity 
and ease of use make it arguably more efficient (Conigliaro et al., 2000). Buchsbaum and colleagues 
(1992) found the CAGE effectively discriminated between primary care patients over 60 with a history of 
alcohol misuse from those who did not. However, like the MAST-G, the CAGE showed extremely low 
sensitivity (.15 and .13 for excessive alcohol intake and dependence, respectively) in a British sample of 
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elderly emergency room attendees, suggesting that its utility within older Australian populations 
requires further investigation. 
It has also been argued that the CAGE may lack sensitivity in the female population, especially when the 
usual cut-off point of 2 was used (Bradley et al., 1998; Cherpitel, 1998; Cherpitel, 1999; O'Hare & Tran, 
1997).  
Wolford and colleagues (1999) report the CAGE as having a sensitivity of 61% and specificity of 69% in 
detecting alcohol-related disorders, in inpatients with serious mental disorders. Lending support to early 
findings casting doubt on its effectiveness in psychiatric populations (Breakey, Calabrese, Rosenblatt, & 
Crum, 1998; Watson et al., 1995).  
Availability/cost 
The CAGE and CAGEAID are both in the public domain and therefore can be used without cost but with 
due acknowledgement of the source. This tool is available from a number of websites: 
• http://ajp.psychiatryonline.org/cgi/reprint/131/10/1121 
• http://counsellingresource.com/quizzes/alcohol-cage/index.html 
• http://www.mentalneurologicalprimarycare.org/downloads/primary_care/11-
1_cage_questionnaire.pdf 
• http://www.recoveroz.com.au/CAGE 
• http://nyc.gov/html/doh/downloads/pdf/csi/alcoholkit-clin-sticker.pdf 
• http://www.mqic.org/pdf/CAGE_CAGE_AID_QUESTIONNAIRES.pdf 
• https://www.mhn.com/static/pdfs/CAGE-AID.pdf 
• http://www.cqaimh.org/pdf/tool_cageaid.pdf 
Scoring, administration and expertise required 
Both forms of the CAGE are easily administered and scored and even memorised. The tests themselves 
take only one minute to perform and despite being traditionally interview-style measures no difference 
was found between the oral and the written versions of the CAGE (Aertgeerts, Buntinx, Fevery, & 
Ansoms, 2000). They are simply scored by adding the “yes” responses and can be used by any health 
worker requiring a brief scan for substance problems. Further assessment to attain more specific 
information is generally required, due to the brevity of the instrument.  
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Michigan Alcoholism Screening Test (MAST) 
The Michigan Alcoholism Screening Test (MAST) is a 24-item screening tool designed to identify and 
assess alcohol disorders (Selzer, 1971). Early studies showed strong internal consistency (Cronbach’s 
alpha = .95) (Selzer, Vinokur, & van Rooijen, 1975) but more recent studies suggest a number of items 
are not highly correlated and that the instrument itself might not be measuring one factor but rather 
several factors related to problem-drinking (Crook, Oei, & Young, 1994; Parsons, WallBrown, & Myers, 
1994; Saltstone, Halliwell, & Hayslip, 1994). 
Selzer (1971) suggested a cut-off point of 5 to identify harmful or hazardous drinking. However, a cut-off 
score of 13 (at which the test has sensitivity of .91 and specificity of .76) is suggested for detecting the 
presence of alcohol abuse and dependence (Ross, Gavin, & Skinner, 1990). 
Recent studies have reported the MAST to correlate with the AUDIT moderately well and correlate more 
highly than the AUDIT or the SADQ with DSM-IV criteria (Conley, 2001; Conley, 2002), indicating 
excellent construct validity. Internal consistency was also strong (0.86). 
However, the MAST does not discriminate between past and present drinking and is therefore more 
useful in detecting lifetime alcohol issues than those which may be current (Dawe et al., 2002). A 
number of short versions of the MAST also exist and recently the standard version was shortened to 22 
items. The most frequently studied short versions are the 10-item Brief MAST (bMAST) (Pokorny, Miller, 
& Kaplan, 1972) and the 13-item Short MAST (SMAST) (Selzer et al., 1975).  
Connor and colleagues (2007) found the bMAST to have good construct reliability and both single-factor 
and two-factor scoring were equally effective as the AUDIT in assessing dependence severity. The 
authors concluded that the decision to use the original or two-factor bMAST should be based on criteria 
of purpose and efficiency. If the primary purpose is screening, the 10-item bMAST has demonstrated 
reliability and efficiency. In a recent meta-analysis of the MAST and the SMAST, Shields and colleagues 
(2007) found that both the MAST and the SMAST observe moderate to good internal consistency 
reliability estimates. However, in individual assessment and outcome measurement where personal and 
social costs are considered significant, the MAST and SMAST should be used with caution.  
Client groups 
Like the AUDIT, the MAST seems more applicable to men and less reliable and sensitive to detecting 
alcohol problems in females (Cherpitel, 1998; Shields et al., 2007). Several items are specifically aimed at 
men while others seem to focus on particularly male behavioural issues, which occur less frequently in 
women. However, it has been shown to have some utility in pregnant females (Chang, 2001). Similarly, 
the instrument includes a number of American words and phrases and may not be properly understood 
in the Australian community. However, the limited studies that exist suggest language of administration 
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and sample ethnicity were found to have very little association with the variation in MAST and SMAST 
reliability (Shields et al., 2007). 
It has been suggested that the MAST may be insensitive to older individuals. However, in an elderly 
Brazilian population a cut-off score of 4/5 was associated with a sensitivity of 91.4%, specificity of 83.9%, 
and PPV and NPV of 69.6% and 96.0%, respectively (Hirata, Almeida, Funari, & Klein, 2001), suggesting 
that the MAST is a good screening test for the detection of alcohol abuse and dependence in an elderly 
male population. Furthermore, a geriatric version of the MAST (MAST-G) is available, along with an 
adolescent version. Each have been found to be satisfactory (Blow, 1991; Snow, Thurber, & Hodgson, 
2002). The MAST-G was found to have good sensitivity (ranging from .70-.95) and specificity (.65-.84) in 
an American sample of individuals aged over 65, when a cut-off score of ≥5 was used  (Fingerhood, 
2000), but these findings were not replicated in a British sample suggesting the tool might be limited in 
some non-American cultures (Conigliaro et al., 2000). The instrument has not been validated on 
Australian Indigenous populations and requires evaluation in an Australian context. 
The MAST has been found to differentiate between non-alcoholic and alcoholic patients with 
schizophrenia with an overall detection rate of 80% (Searles, Alterman, & Purtill, 1990). It has also been 
used successfully on an outpatient basis with women who were psychiatric patients (Swett, Cohen, 
Surrey, & Compaine, 1991) and with clients undergoing methadone treatment programs (Stastny & 
Potter, 1991). However, in a recent study of in-patients with severe psychiatric disorders, Wolford and 
colleagues (1999) reported only moderate  sensitivity (63%) and specificity (68%). Nevertheless, the 
psychometric properties of the MAST in psychiatric populations have been the topic of two meta-
analyses (Teitelbaum & Mullen, 2000; Teitelbaum & Carey, 1996), both indicating the MAST was a useful 
tool and generally showed good sensitivity and moderate specificity in most studies. In the most recent 
meta-analysis, average sensitivity was 87.7%, while average specificity was 68.1% across nine MAST 
validity studies in psychiatric populations (Teitelbaum & Mullen, 2000). As in the general population, the 
MAST shows lower sensitivity to subclinical levels of alcohol misuse. The meta-analysis found the 
psychometric properties of the MAST were unaffected by respondents’ psychiatric condition (i.e., 
psychotic, mood, or anxiety diagnoses). 
Availability/cost 
The MAST may be reproduced for non-commercial use (clinical, research, training purposes) as long as 
the author is credited. It has also been reproduced online at: 
• http://www.ncadd-sfv.org/symptoms/mast_test.html 
• http://www.dorris.com/objects/MichiganAlcoholScreeningTest.pdf 
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Scoring, administration and expertise required 
The MAST is a self-report measure and can be used by any worker needing to screen for alcohol 
problems. It takes approximately 10 minutes to complete. Scoring is simple and instructions are 
provided with the test itself but differ slightly depending on what test is used. In addition to the original 
22-item test, the bMAST and SMAST are composed of 10 and 13 items, respectively. All tests are 
dichotomously endorsed as yes or no.  
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Drug Abuse Screening Test (DAST) 
Drug Abuse Screening Test (DAST) (Skinner, 1982) is a screening instrument developed in order to 
identify drug abuse problems and was based on the same style of questions as the MAST. In contrast to 
the MAST, the DAST items refer to the past 12-months rather than lifetime. There are several forms 
including 28-items, 20 items and 10 item tests and are highly correlated with each other (Cocco & Carey, 
1998).  
The DAST has been shown to have good internal consistency reliability (28-item DAST; Cronbach’s alpha 
= .92; 20-item DAST, Cronbach’s alpha = .95) (Skinner, 1982) and criterion validity. It was found to 
correlate highly with the ASI (Skinner & Goldberg, 1986). Scores have also been found to correlate highly 
with the frequency of use for a range of drugs including cannabis, barbiturates, amphetamine and 
opiates. DAST scores also discriminated accurately between alcohol and drug problems (Appleby et al., 
1997).  
Using a clinical sample of 501 drug/alcohol patients Gavin and colleagues (1989) found the DAST to have 
good concurrent and discriminant validity. Subjects were classified according to the presence or absence 
of any current DSM-III drug disorder (excluding alcohol and tobacco). The DAST attained 85% overall 
accuracy in identifying subjects who met DSM-III diagnosis. The authors suggest a cut-off score of 5/6 for 
optimum sensitivity and specificity on the 28-item DAST. Similarly, a cut-off score of 3 on the 10-item 
DAST correctly classified 93% of patients (Bohn, Babor, & Kranzler, 1991). 
In a recent meta-analysis, the DAST was found to be an easy to administer, reliable, and valid tool with 
good sensitivity, and specificity. In general, all versions of the DAST yielded satisfactory levels of 
reliability and validity for use as clinical or research tools (Yudko, Lozhkina, & Fouts, 2007). Internal 
reliability was consistently high (.74-.95) for each version of the DAST. Test-retest correlation 
coefficients of 0.85 was reported for DAST-28, 0.78 for the DAST 20, 0.71 for DAST-10, and 0.89 for an 
adolescent version (DAST-A). The review also found evidence supporting the construct, criterion and 
discriminant validity of the DAST. Sensitivity and specificity (and optimal cut-off points) varied 
depending on DAST version and population studied. The authors recommend that in order “to obtain 
maximum sensitivity, a lower cut-off score from a possible cut-off score range is recommended when 
screening for drug abusers, and a higher cut-off score is recommended when screening for non drug 
abusers. The specificity of the DAST is increased when the cut-off score is high and, as a result, 
sensitivity decreases. Clinicians should select what cut-off scores to use according to the screening 
purpose” (Yudko et al., 2007, p.197). 
Client groups 
Like the MAST, it is likely that the DAST may have limitations when assessing drug use in women due to 
questions on social and behavioural aspects of drug use which may be more relevant to men, it has 
however, been used with success in an incarcerated female population (Saltstone et al., 1994). 
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Furthermore, there is limited information regarding its applicability in a wide range of cultures (Carey et 
al., 2003), and again like the MAST there are some concerns about the terminology used. The tool also 
requires validation in Australia’s Indigenous population.  
Recent research on the DAST with psychiatric outpatient populations has confirmed the internal scale 
properties with this group and established acceptable test-retest reliability, criterion-related validity, 
sensitivity and specificity. Maisto and colleagues (2000) for instance, found that a cut-off score of 2 
provided good sensitivity and specificity for identifying a current diagnosis of an alcohol or drug use 
disorder among psychiatric outpatients. The internal consistency (Cronbach’s alpha >.85) and test-retest 
reliability (r >.70) has also been found to be acceptable within this population (Cocco & Carey, 1998; 
Teitelbaum & Carey, 2000). In 250 psychiatric patients drawn from 4 treatment programs, the DAST 
evidenced high internal consistency reliability and good item-total score correlations. A factor analysis of 
the DAST revealed 5 factors: (1) self-recognition of a drug problem, (2) serious social consequences of 
drug use, (3) help-seeking for drug abuse, (4) illegal drug-related activities, and (5) inability to control 
drug use (Staley & El-Guebaly, 1990). In a first-episode psychosis population the DAST functioned best 
with a problem drug use cut-off score of 3 (sensitivity, 85%; specificity, 73%) (Cassidy et al., 2008). 
The applicability of the DAST to the older population is unknown but an adolescent version (DAST-A) has 
recently been developed (Martino, Grilo, & Fehon, 2000). Initial validation findings indicate this version 
also has good internal consistency (Cronbach’s alpha = .91), high test-retest reliability (r = .89). A cut-off 
score of 6 yielded 79% sensitivity and 84.5% specificity for identifying DSM-IV diagnoses of drug related 
disorders. 
Availability/cost 
There is a small fee to purchase copies of the DAST, which are available at: 
• http://www.camh.net/Publications/CAMH_Publications/drug_abuse_screening_test.html  
 
However, the DAST may be reproduced for non-commercial use (clinical, research, training purposes) 
with appropriate acknowledgement of the authors. It has also been reproduced online at: 
• http://counsellingresource.com/quizzes/drug-abuse/index.html  
• http://www.drtepp.com/pdf/substance_abuse.pdf  
• http://www.veteransoutreachcenter.org/documents/DRUGABUSESCREENINGTEST2.pdf  
Scoring, administration and expertise required 
The DAST can be either interviewer or self-administered and can be administered without specific 
training. It takes less than five minutes to complete and is scored by adding the number of “yes” 
responses (except items 4 and 5 which are scored 1 for “no” responses).  
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T-ACE and the TWEAK 
Both the T-ACE (Sokol, Martier, & Ager, 1989) and the TWEAK (Russell & Bigler, 1979) were developed to 
specifically identify at-risk drinking pregnant women as alternatives to the MAST. However, both have 
shown to be useful in assessment of non-pregnant women and men (Chang, McNamara, Orav, & 
Wilkins-Haug, 2006). Both scales have a similar structure to the CAGE: Tolerance; Annoyed; Cut down; 
Eye Opener (T-ACE) and Tolerance; Worried; Eye Opener; Amnesia; (K) Cut down (TWEAK).  
In pregnant women both the T-ACE and the TWEAK show consistently higher sensitivity and specificity 
than the MAST or CAGE (Chang et al., 1998; Russell et al., 1996). For instance, using a cut-off point of ≥1, 
the T-ACE had a sensitivity of 76% in predicting risky drinking during pregnancy compared with 59% for 
the CAGE and 76% for the MAST. Specificities for the T-ACE, CAGE and MAST were 79%, 82% and 76% 
(Sokol et al., 1989). Russell (1994) reported similarly strong findings, with TWEAK sensitivity of 79% and 
specificity of 83%, while T-ACE sensitivity was 70% and specificity was 85%, significantly higher than 
both the CAGE (49%; 93%) and the MAST (49%; 95%). The T-ACE Tolerance question was later changed 
to “How many drinks can you hold?” This increased the sensitivity and specificity of the T-ACE to 91% 
and 81% (Russell et al., 1994). Using this version of the Tolerance question, TWEAK sensitivity increased 
from 79% to 91% using a cut-off point of 2 (Russell et al., 1994). Based on these findings, Russell 
concluded that the TWEAK appeared to be somewhat more sensitive and less specific than the T-ACE 
but with both clearly outperforming the MAST and the CAGE test in screening for risk drinking during 
pregnancy.  
Mixed findings exist surrounding the applicability of these measures to the general population. There is 
some evidence that the TWEAK outperforms the AUDIT in detecting female alcohol abuse and 
dependence (Bradley et al., 1998) and is more sensitive to detecting current alcohol dependence in men 
in the general public than the CAGE (Cherpitel, 1999). Some studies of emergency room and primary 
care patients indicate the TWEAK outperforms the CAGE and the MAST for screening alcohol abuse and 
dependence in women in the general population (Bradley et al., 1998; Cherpitel, 1997). However, other 
studies have found the CAGE to be more sensitive to alcohol use disorders than the TWEAK, particularly 
in certain ethnic groups (Cherpitel, 1999). Overall, it appears that the TWEAK is a sensitive instrument 
for detecting alcohol problems in both pregnant women and in the general population (Cherpitel, 1998). 
However, like other instruments, it does not provide a picture of the client’s pattern of consumption. 
Therefore, a positive identification by the TWEAK may be supplemented by the AUDIT. 
Chan and colleagues (1993) suggest a cut-off point of three to show optimal sensitivity and specificity 
for assessing heavy drinking and alcohol dependence in a combined sample of men and women. Other 
authors have found this cut-off point to be a suitable cut-off for men (sensitivity of between 76%-91% 
and specificity of between 74%-86%), but to result in unacceptably low sensitivity for women (sensitivity 
ranging from 57%-80%) in clinical and general populations (Cherpitel, 1998; Cherpitel, 1999). 
Accordingly, a cut-off point of two has been found to have optimal sensitivity (89%-91%) and specificity 
(77%- 87%) for detecting alcohol problems in women (Cherpitel, 1995; Russell et al., 1996). In older 
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women this may be lower again, with one study reporting the "best predictor model" had T-ACE scores 
of 1 or higher (Stevenson & Masters, 2005). 
When the T-ACE was compared with the DSM-IV criteria for lifetime alcohol abuse or dependence (SCID, 
as Gold Standard), risky drinking was identified with sensitivities and specificities of 0.88 and 0.59 
respectively at a cut-off point of 2 in an outpatient psychiatric clinic (Hill & Chang, 2007). 
Client groups 
As most studies are conducted in US samples, these questionnaires require Australian evaluation to 
ensure the findings are generalisable across cultures and class in this country, but the international 
findings are encouraging (Varescon, Gaugue, & Wendland, 2007). In a recent Brazilian sample, both the 
T-ACE and the TWEAK had excellent inter-rater reliability (coefficients ranging from 0.78 to 0.95). 
Internal consistency was low and construct validity was moderate (Moraes, Viellas, & Reichenheim, 
2005). 
Concerns exist surrounding the T-ACE and the TWEAK utility with older persons, as Tolerance (a 
significant component of these instruments) tends to be a poor indicator of alcohol misuse in this age 
group (DeHart & Hoffman, 1997). In the adolescent population, Chung and colleagues (2000) compared 
the utility of the AUDIT, TWEAK and CAGE in detecting DSM-IV diagnoses of alcohol abuse and 
dependence in a sample of American adolescent emergency room attendees and found the TWEAK to 
have good sensitivity (84%) and specificity (80%) for this population using a cut-off point of 1 (although 
the tool was less sensitive than the AUDIT).  
The TWEAK has been found to have relatively low sensitivities but adequate specificities among female 
war veteran outpatients (Bush et al., 2003). 
Availability/cost 
The T-ACE is a copyrighted instrument, while the TWEAK is in the public domain and may be used 
without cost but with due acknowledgment of the source. Both are reproduced in Dawe and colleagues 
(2002), which is available online at: 
• http://www.alcohol.gov.au/internet/alcohol/publishing.nsf/Content/DA90  
Scoring, administration and expertise required 
Both the T-ACE and the TWEAK are easily administered and scored and even memorised. The tests 
themselves take only one minute to perform and must be administered by the worker. The T-ACE is 
simply scored by adding the “yes” responses, a score of 2 or more is suggestive of alcohol problems. The 
TWEAK is scored slightly differently with item 1 scoring 2 points if a woman reports she can hold more 
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than five drinks, a “yes” response to item 2 scores 2 points and a “yes” response to items 3-5 score 1 
point each. Therefore the maximum score obtained is 7. A total score of ≥3 for men and ≥2 for women is 
indicative of harmful/hazardous alcohol use. Both tools can be used by any health worker requiring a 
brief screen for alcohol problems. Further assessment to attain more specific information is generally 
required, due to the brevity of the instruments. 
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Timeline Followback Method (TLFB) 
The Timeline Followback Method (TLFB) (Sobell & Sobell, 1995) is a technique developed to obtain 
precise information on the amount of alcohol (or other drugs) consumed and duration of each 
drinking/drug use session over a specified period of time, usually 3 months. This measure is particularly 
useful for assessing treatment outcomes and overall assessment and is not appropriate for screening. 
The key feature of this method is a blank calendar on which the client provides an estimate of the 
amount of alcohol drunk/drugs used on each drinking/use occasion during the time period. To assist in 
memory recall and to provide a framework for the client to work within, the first task is to note all 
events that may assist with recall (e.g., national holidays, significant personal events).  
The TLFB has been used extensively in the research literature and has been found to have high test-
retest reliability, with coefficients ranging from .79 to .96 over 30- to 90-day follow-up periods across a 
range of drinking populations (Sobell & Sobell, 2000). There is also a high degree of agreement between 
client self-report and official records such as days in jail or treatment facilities. The more recent 
computerised version has been found to have good reliability with test-retest correlations exceeding .85 
(Fals-Stewart, O’Farrell, Freitas, McFarlin, & Rutigliano, 2000).  
Overall consumption, number of heavy drinking days, and number of mean drinks per drinking day have 
all been found to positively correlate with the instrument (Sobell & Sobell, 2000), along with scores on 
the ADS and the MAST indicating that the level of alcohol problems or dependence was directly related 
to drinking behaviour as determined by the TLFB method. There was a similarly high level of agreement 
between those drinking variables derived from the TLFB method and biochemical indices of alcohol-
related liver dysfunction (Sobell & Sobell, 2000).  
Some authors have expressed concern that this type of self-monitoring measure may underestimate 
actual alcohol consumption (e.g., Carney, Tennen, Affleck, del-Boca, & Kranzler, 1998). For instance, one 
study reported the TLFB consistently and significantly underestimated alcohol consumption compared 
to the aggregated daily reports (Searles, Helzer, Rose, & Badger, 2002). This underestimate, however, 
was stable across the three reporting periods. Generally though, it is believed that the disparity between 
TLFB and actual consumption is small and appears to be influenced by individual differences in reporting 
(Dawe et al., 2002; Donohue et al., 2004; Vinson, Reidinger, & Wilcosky, 2003). Nevertheless, it is 
important that data collected by the TLFB be compared to other retrospective measures for accuracy. 
Although originally designed for alcohol consumption, the TLFB has more recently been validated for 
collecting consumption data for other drug use (Carey & Correia, 1998; Fals-Stewart et al., 2000). 
Client groups 
The TLFB has been validated across a number of countries including Australia, Canada, Mexico, Poland, 
and Sweden (Annis et al., 1996; Sobell et al., 2001), along with a variety of subpopulations, including 
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those with severe mental illnesses, those in alcohol treatment facilities, and college students (DeMarce, 
Burden, Lash, Stephens, & Grambow, 2007). Carey (1997) has assessed the reliability and validity of the 
TLFB interview among psychiatric outpatients and concluded that it can appropriately be used with this 
population. Similarly, it has been used successfully in homeless populations and pregnant mothers 
(Sacks, Drake, Williams, Banks, & Herrell, 2003; Savage, Wray, Ritchey, & Fulmer, 2002). However, there 
are no reports of the use of the TLFB with Indigenous Australians.  
The TLFB has been found to be reliable in adolescent populations (Dennis, Funk et al., 2004; Levy et al., 
2004). 
Availability/cost 
The TLFB is under copyright but the pen and paper version may be obtained free of charge from: 
• Linda C. Sobell, Center for Psychological Studies, Nova Southwestern University, 3301 College 
Avenue, Fort Lauderdale, FL 33314, (phone 954-262-5811; fax 954-262-3895) or via e-mail: 
sobelll@cps.nova.edu.  
• http://www.nova.edu/gsc/online_files.html#time_followback  
Scoring, administration and expertise required 
The TLFB can be administered by the interviewer as a pen and paper instrument or via a client 
administered computer program (Sobell & Sobell, 1996). A modified version for telephone interviews 
has also been developed (Sobell, Brown, Leo, & Sobell, 1996). The time taken to complete the TLFB 
depends upon the time period covered, an individual drinker’s pattern of consumption and the method 
of administration used. Vakili and colleagues (2008) found that shorter time windows, which are more 
time and resource efficient, can be used with little to no loss in the accuracy of the data. That is, one 
month for large samples (e.g., surveys), three months for individual cases (e.g., clinical use) and smaller 
samples. Dawe and colleagues (2002) suggest that at least 30 minutes should be allowed. Some training 
is needed for proper administration. Printed instructions are available for pencil-and-paper 
administration and are included in the computer-assisted program. A training video has also been 
developed and is available from the below address: 
• http://www.camh.net/Publications/CAMH_Publications/timeline_followbk_usersgd.html  
 
The computerised version of the TLFB provides clients with detailed instructions for self-administration 
and country-specific information regarding standard drinks, and allows them to incorporate their own 
personal events or holidays into the provided calendar. The computerised version allows measurement 
of time intervals up to 12 months and takes the same amount of time to administer as the pen and 
paper version (Dawe et al., 2002). Computerised scoring and interpretation is also available. The 
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shortened version, though, may have some limitations, which may affect its utility in clinical and 
research programs. 
When treating clients in group settings a group-administered version of the TLFB has also shown 
promising results (LaBrie, Pedersen, & Earleywine, 2005; Pedersen & LaBrie, 2006) 
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Dartmouth Assessment of Lifestyle Instrument (DALI) 
The Dartmouth Assessment of Lifestyle Instrument (DALI) (Rosenberg et al., 1998) is a screening 
instrument developed specifically for substance use disorders use with people with severe mental 
illness. It consists of 18 items derived from various existing screening tools. It was developed to be 
interviewer-administered. Eight items test for drug use disorders, nine test for alcohol use disorders. 
Two items overlap alcohol and drug use disorders. The items in the DALI address several dimensions of 
substance use disorder: Patterns of use, loss of control, the physiological syndrome of dependence, 
consequences of use, and subjective distress.  
In the psychiatric population in which it was devised, the DALI was found to have a sensitivity of 80% 
and specificity of 85% in identifying alcohol use disorders and a sensitivity of 100% and specificity of 80% 
for cannabis and cocaine use disorders (Rosenberg et al., 1998). Overall classification accuracy of the 
measure for alcohol use disorders was 83.1%, while the overall classification accuracy for cannabis or 
cocaine use disorders was 89.7%. Results suggest that it is reliable over time and across interviewers, 
and that it is more sensitive and specific than several measures including the MAST, TWEAK, CAGE or 
DAST. Further replication of these results is required before the scale is recommended for routine use.  
A recent study found the diagnostic accuracy of the DALI instrument was 74% for alcohol disorders and 
88% for drug disorders (Ford, 2003). Using a cut-off score of 2, the specificity of the DALI alcohol scale 
was 0.98 and its sensitivity was 0.35. While the specificity of the DALI drug scale was 0.97 and its 
sensitivity was 0.50 (using a -1 cut-off). It showed good concurrent validity with the LDQ (Cronbach’s 
alpha = 0.92, R2=0.44).  
The Simple Substance Use Screening Scale (SUSS), is a recently developed scale based on the DALI and 
has been found to correctly identify 86% of participants for problematic alcohol use (sensitivity 88%, 
specificity 84%) and 84% for problematic drug use (sensitivity 82%, specificity 84%) in a preliminary 
study (Ley, Jeffery, Shaw, & Weaver, 2007). 
Client groups 
As outlined above the DALI was specifically designed for use in psychiatric populations and has proved a 
useful tool in these settings (Swanson et al., 2002). Further studies are required in a range of 
populations and cultural groups to ensure these preliminary findings generalise across populations.  
Availability/cost 
The DALI is freely available at: 
• http://dms.dartmouth.edu/prc/instruments/dali/  
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Scoring, administration and expertise required 
The DALI is a short and easy to administer interview. It is slightly more difficult to score than some other 
measures, but requires no special training. It can be used by any worker requiring a brief screening tool 
for substance use related problems particularly people with severe mental illness 
. 
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The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) 
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) was a tool developed through 
the World Health Organisation (WHO) by an international group of specialist addiction researchers and 
clinicians in response to the worldwide public health burden associated with problematic substance use 
(World Health Organization ASSIST Working Group, 2002). The instrument was designed to screen for 
problem or risky use of tobacco, alcohol, cannabis, cocaine, amphetamine-type stimulants, sedatives, 
hallucinogens, inhalants, opioids and ‘other drugs’. A risk score is obtained for each substance and falls 
into either a ‘low’, ‘moderate’ or ‘high’ risk category which determines the type of intervention (‘none’, 
‘brief intervention’, ‘brief intervention plus referral’). 
The ASSIST screens for lifetime/recent substance use, specific substance involvement, frequency, 
dependence, abuse, intravenous drug use and was found to have excellent concurrent, construct, 
predictive and discriminative validity (Humeniuk & Ali, 2006). Internal consistency (Cronbach’s alpha) 
was over 0.80 for the majority of domains and ASSIST items. Preliminary reliability studies were 
conducted at ten collaborating centres chosen for their ability to provide access to culturally diverse 
samples of individuals with different substance use patterns in Australia (coordinating centre), Brazil, 
India, Ireland, Israel, United Kingdom, the Palestinian Territories, Puerto Rico, the USA and Zimbabwe 
(Ali et al., 2002). In general, the test-test reliabilities were in the range of good to excellent, with 
coefficients ranging from 0.90 (consistency of reporting ‘ever’ use of substance) to 0.58 (regretted what 
was done under influence of substance). The average test-retest reliability coefficients for substance 
classes ranged from 0.61 for sedatives to 0.78 for opioids. (Ali et al., 2002; World Health Organization 
ASSIST Working Group, 2002). 
Concurrent validity of the ASSIST was investigated by statistical comparison with other Gold Standards 
and standardised measures of parameters comparable with the ASSIST. Significant correlations were 
demonstrated between the ASSIST and similarly worded items of other questionnaires (the ASI, the SDS, 
the MINI International Neuropsychiatric Interview (MINI-Plus), the Rating of Injection Site Condition 
(RISC), the DAST, the Revised Fagerstrom Tolerance Questionnaire (RTQ), the MAP and the AUDIT) 
(Newcombe, Humeniuk, & Ali, 2005). Correlation coefficients between ASSIST scores and scores from 
these other measures were generally strong (e.g., r = 0.76-0.88 (ASI), 0.82 (AUDIT) and 0.78 (RTQ)) 
Construct validity was established by significant correlations between ASSIST scores and measures of 
risk factors for the development of drug and alcohol problems (r = 0.48-0.76) (Humeniuk & Ali, 2006; 
Humeniuk, Ali et al., 2008). 
Discriminative validity of the ASSIST was investigated by comparison of ASSIST scores as grouped by 
known standards of dependence, abuse and non-problematic use. The measure was found to 
discriminate between substance use, abuse and dependence (Humeniuk & Ali, 2006; Newcombe et al., 
2005). Suitable specificities (50-96%) and sensitivities (54-97%) for most substances were established 
and outlined in Table 9. 
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Table 9: Rounded cut-off scores for all substances for the ASSIST (version 3.0) 
Risk Alcohol Other Substances 
Low risk 0-10 0-3 
Moderate risk (Abuse) 11-26 4-26 
High risk (dependence) 27+ 27+ 
Adapted from  Humeniuk and Ali (2006)  
A final process in the development of the ASSIST program was the evaluation of an ASSIST-linked brief 
intervention. Overall, it was found that this was effective in getting participants to reduce their 
substance use and risk as measured by their ASSIST score. Similarly, clients also perceived this as the 
case at the 3-month follow-up interview (Humeniuk, Dennington, & Ali, 2008).  
Recently the National Institute on Drug Abuse has adapted this tool into a new measure to aid medicos 
in assessing whether or not their patients are using and/or "abusing" drugs (it can be found at: 
http://www.drugabuse.gov/nidamed/index.php). 
Client groups 
The development of the ASSIST was involved a range of different countries (Australia, Brazil, India, 
Thailand, UK, USA and Zimbabwe). Similarly, versions exist in a variety of languages, including English, 
French, Spanish, German, Hindi, and Portuguese.  
Availability/cost 
The ASSIST is in the public domain and may be used without cost, but with due acknowledgment of the 
source. It is available at:  
• http://www.who.int/substance_abuse/activities/assist/en/index.html  
Scoring, administration and expertise required 
This tool is clinician administered and can be conducted in 5 to 10 minutes. The ASSIST comprising of 
eight questions commences with a general screening question, frequency/recency of use in the past 3 
months. The later items assess psychological dependence and problems associated with use.  At the 
completion of the interview a number of domains can be derived for each respondent, from their 
responses to the questions. Scoring is simple and instructions are included within the instrument and 
may take 10-15 minutes. No expertise is required to administer the ASSIST, however, manuals, 
guidelines for use and information on brief interventions/self-help can be obtained from the above 
website. 
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Drug and Alcohol Severity Screening, Assessment and Outcome Measures 
Severity of Alcohol Dependence Questionnaire (SADQ) 
Severity of Alcohol Dependence Questionnaire (SADQ) (Stockwell, Hodgson, Edwards, Taylor, & Rankin, 
1979) is a 20-item questionnaire designed to measure the severity of dependence on alcohol. It is 
divided into five subscales: Physical Withdrawal Symptoms, Affective Withdrawal Symptoms, Craving 
and Withdrawal Relief Drinking, Consumption and Reinstatement. The more recent version of this scale 
(the 16 item, SADQ-C) has an additional companion scale, the Impaired Control Scale (ICQ) that focuses 
on the physical and affective aspects of alcohol dependence. 
Unlike a number of the instruments outlined above, the SADQ has been widely used in Britain and 
Australia, and has demonstrated good reliability and validity in in-patient, out-patient and community-
based treatment samples. It is useful for predicting dependence, withdrawal severity and the likelihood 
of achieving a moderate drinking outcome. It is often used as an outcome and assessment instrument 
(Foster, Peters, & Marshall, 2000; Kavanagh, Sitharthan, Spilsbury, & Vignaendra, 1999) but works less 
well as a screening tool (Dawe et al., 2002). It is particularly useful in attaining a specific measurement of 
alcohol dependence with drinkers related to the potentially fatal symptoms of alcohol withdrawal. 
The original SADQ is a widely used measure of the severity of alcohol dependence and has been found 
to have particularly good reliability and validity compared to a number of major self-report 
questionnaires (Davidson, 1986; Stockwell et al., 1979; Stockwell, Murphy, & Hodgson, 1983). The 
original study found internal consistently to be strong (Stockwell et al., 1979). Scores on the SADQ also 
correlated highly with clinicians’ case notes and diagnoses of alcohol dependence (82% concordance). 
This was supported by similar findings in a later study (Meehan, Webb, & Unwin, 1985).  A score of 30 
on the SADQ is generally taken to indicate severe dependence (Smith, 1986). Scores on the SADQ have 
also been found to correlate with withdrawal severity (Davidson, 1986; Meehan et al., 1985; Stockwell 
et al., 1983). 
Scores on equivalent items for the SADQ and SADQ-C have been found to correlate highly with each 
other and with total scores for both scales. Internal consistency was also strong for this more recent 
version (Cronbach’s alpha = .97), the SADQ-C. When the five ICQ items were added, a coefficient of 0.98 
was obtained (Stockwell et al., 1983). In a Western Australian community sample, Cronbach’s alpha 
coefficients of 0.86 (for the SADQ-C alone) and 0.87 (when it was combined with the ICQ) were obtained 
(Stockwell, Sitharthan, McGrath, & Lang, 1994). 
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Client groups 
Only limited findings exist surrounding the SADQ’s cross-cultural relevance (e.g., Ee Heok et al., 1990). It 
has not been widely translated and due to the level of English required to understand the SADQ, some 
cultural and linguistically diverse groups and those with low levels of literacy may have difficulty with 
the measure. The measure has not been evaluated in the Indigenous Australian population. Due to the 
number of consumption style questions it could be suggested that the measure may be less reliable in 
older population. Similarly, women may require a lower cut-off score, since women sustain alcohol-
related damage at lower levels of consumption than men (Dawe et al., 2002).  
To the authors knowledge, the tool has not been assessed among psychiatric populations (Singh, 
Mattoo, Sharan, & Basu, 2005). 
Availability/cost 
The SADQ-C is in the public domain and can be used without cost but with due acknowledgement of the 
source. It is available at: 
• http://www.prisonmentalhealth.org/downloads/professional_resources/09-
5_sadq_alcohol_assessment.pdf  
• http://www.alcohol-and-drug-guide.com/support-files/assesspdf.pdf  
Scoring, administration and expertise required 
The SADQ-C is a client-administered tool which takes approximately five minutes to complete. It does 
not require specialised training to administer and is easily scored. Items 1, 3 and 4 of the ICQ are scored 
on a 4-point scale ranging from 0 (never or almost never) to 3 (nearly always). Items 2 and 5 are scored 
in reverse with a score of 0 (nearly always) to a score of 3 (never or almost never). The twenty items of 
the SADQ are all scored as follows: 0 = never or almost never, 1 = sometimes, 2 = often, 3 = nearly 
always. 
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Short Alcohol Dependence Data Questionnaire (SADD) 
The Short Alcohol Dependence Data Questionnaire (SADD) (Raistrick, Dunbar, & Davidson, 1983) is a 
15-item self-report based on the same formulation of alcohol dependence syndrome as the SADQ 
(Davidson & Raistrick, 1986; Edwards & Gross, 1976). It is less focused on the experience of withdrawal 
symptoms than the SADQ and includes items reflecting behavioural and subjective changes associated 
with drinking. It has been suggested that these differences make this scale more useful for less severe 
drinking problems (Davidson & Raistrick, 1986). 
Davidson, Bunting and Raistrick (1989) demonstrated that the SADD measured alcohol dependence 
syndrome. The instrument has also been found to show good test-retest reliability (r = .87) and 
acceptable split-half reliability (a correlation between total score on odd and even numbered questions) 
(McMurran & Hollins, 1989; Raistrick et al., 1983). The SADD has been correlated with a number of 
other measures and found to have strong construct validity due to correlations between SADD scores 
and overall alcohol intake, SADQ scores, clinical assessment (Davidson & Raistrick, 1986; Doherty & 
Webb, 1989). 
Client groups 
The authors argue that the SADD is relatively independent of socio-cultural influences but there are only 
limited studies which have been conducted in order to confirm this. One early study using a Brazilian 
population does, however, lend support for this position (Jorge & Masur, 1985). Whether it is 
appropriate for use across different cultural groups in an Australian context or with Indigenous 
Australians, requires further research. There appears to be no specific studies to have tested the validity 
and reliability of the SADD with youth, elderly or women. 
The tool has also been used successfully in mentally ill populations (Carrigan, Drobes, & Randall, 2004; 
Stasiewicz et al., 2008). 
Both SADQ and SADD are routinely administered to adolescent clients of the NSW Juvenile Justice 
System and although not empirically tested, they appear useful in this context (Dawe et al., 2002) and 
the SADD particularly, is easily understood (McMurran & Hollins, 1989).  
Availability/cost 
The SADD is in the public domain and may be used without cost but with due acknowledgment of the 
source. It can be found at: 
• http://www.dva.gov.au/health/younger/mhealth/alcohol/training/appendo.htm  
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Scoring, administration and expertise required 
The SADD is a self-report measure and takes only five minutes to administer. It can be used by any 
worker regardless of expertise. A total score is obtained by adding the score from each of the items. 
Scores between 1 and 9 indicate low dependence, those between 10 and 19 indicate medium 
dependence and a score of 20 or more indicates high dependence. Each item is scored as follows: never 
= 0; sometimes = 1; often = 3; nearly always = 4. 
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Alcohol Dependence Scale (ADS) 
The Alcohol Dependence Scale (ADS) (Skinner & Horn, 1984) is a 25-item self-report questionnaire 
designed to identify and assess alcohol abuse and dependence. Like the SADQ and SADD, it is based 
upon Edwards and Gross (1976) conceptualisation of the alcohol dependence syndrome. Items forming 
the ADS were found to have good internal consistency (Cronbach’s alpha = .92). The measure was also 
found to correlate with daily consumption of alcohol and lifetime use of alcohol, social consequences 
from drinking, prior treatment for alcohol abuse, use of alcohol to change mood and feelings of guilt 
over drinking (Skinner & Horn, 1984). It has also been found to show good construct validity with the 
MAST and diagnostic validity regarding DSM diagnoses (Ross et al., 1990; Skinner & Horn, 1984). Ross 
and colleagues (1990) reported that a cut-off score of 9 was associated with sensitivity of 91% and 
specificity of 82% in identifying alcohol abuse or dependence disorders in a primarily male sample. The 
overall accuracy of the ADS at this cut-off point was 89%. A study with homeless women found a cut-off 
point of 8 to be optimal for mild/moderate dependence, while  scores greater than 15 indicated severe 
dependence (Chantarujikapong, Smith, & Fox, 1997). 
The ADS has also shown some utility as a treatment outcome measure (Loeber, Croissant, Heinz, Mann, 
& Flor, 2006; Ralevski, Ball, Nich, Limoncelli, & Petrakis, 2007; Ray, Hutchison, & Bryan, 2006). 
Shorter versions of the ADS have been developed and have been found to correlate highly with the 
original scale, and with other measures of alcohol involvement (Kahler, Strong, Hayaki, Ramsey, & 
Brown, 2003; Kahler, Strong, Stuart, Moore, & Ramsey, 2003). Despite generally good findings regarding 
the ADS’s psychometric properties, a recent study found the ADS to lack accuracy in identifying 
physiological dependence or withdrawal in treatment-seeking individuals with DSM-IV alcohol 
dependence (Saxon, Kivlahan, Doyle, & Donovan, 2007). 
Client groups 
The ADS has also been successfully adapted for use with a variety of different cultures and ethnic groups 
(Fu et al., 2008; Rajendran & Cheridan, 1990; Solís, Cordero, Cordero, & Martínez, 2007). The translated 
versions of the ADS were found to have high internal reliability.  
The ADS was found to correlate well with alcohol-related problems and post-release drinking goals with 
incarcerated male offenders (Hodgins & Lightfoot, 1989). Similarly, Peters and colleagues (2000) found 
the ADS to be one of the most effective screening instruments for detecting substance use disorders in a 
prison population. The ADS (cut-off point of ≥14) was combined with the drug use section of the ASI 
(cut-off point of ≥ 11) and found to have sensitivity of 74% and a specificity of 92% in detecting alcohol 
or drug dependence. Overall, 83% of the sample was correctly assigned. 
The tool has also been used in psychiatric population samples (Bischof, Rumpf, Meyer, Hapke, & John, 
2005; Petrakis et al., 2006; Ralevski et al., 2007). 
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Importantly, the ADS appears to be an equally valid and reliable measure of alcohol dependence in 
women (Chantarujikapong et al., 1997; Drake & Mercer-McFadden, 1995). The ADS has been used 
successfully in several studies investigating alcohol dependence in homeless and incarcerated women, 
and studies of alcohol misuse in Australian female university students (e.g., Biron, Brochu, & Desjardins, 
1995; Chantarujikapong et al., 1997; Williams, Connor, & Ricciardelli, 1998). However, there have not 
been any reports of its use with Indigenous Australians. 
Availability/cost 
The ADS is copyrighted and the kit (including questionnaires and users guide) can be purchased for $15 - 
$20 at: 
• http://www.camh.net/Publications/CAMH_Publications/alcohol_dependence_scale.html  
Scoring, administration and expertise required 
The ADS is a brief self-report measure that takes between five and ten minutes to complete. The manual 
provides scoring instructions and no special training or expertise is required to use or interpret the ADS. 
A computerised version is also available. 
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Cannabis Problems Questionnaire (CPQ) 
The Cannabis Problems Questionnaire (CPQ) (Copeland, Gilmour, Gates, & Swift, 2005; Copeland, Swift, 
& Rees, 2001) is a brief, recently developed Australian screen of cannabis-related problems. Originally 
53 items long, the CPQ was later cut to 27 and then 22 items. 
In its validation study, the 22-item CPQ was found to be a valid, reliable and sensitive measure of 
cannabis-related problems for use with clinical and research populations of current cannabis users 
(Copeland et al., 2005). Exploratory factor analyses revealed a three factor solution best described the 
data accounting for 57% of the variance in the larger item set. Test-retest correlations were between 
0.92 and 1.00 and inter-rater reliability correlations between 0.74 and 1.00. The total CPQ score 
classified DSM-IV cannabis dependence with 84% specificity and sensitivity and daily cannabis use with 
83% specificity and 55% sensitivity (Copeland et al., 2005). 
Availability/cost 
The CPQ is in the public domain, and may be used without cost, but with due acknowledgment of the 
source. It is available at: 
• http://ncpic.org.au/  
Client groups 
The CPQ is a newly developed tool and hasn’t been widely tested in different populations, however, an 
adolescent version of the CPQ has been recently developed and validated (CPQ-A) (Martin, Copeland, 
Gilmour, Gates, & Swift, 2006).  
Scoring, administration and expertise required 
The scale is dichotomously scored as “yes/no” and no special training is required to use the scale. The 
scale is self completed by the client and takes less than 10 minutes to complete. 
A Review of Screening, Assessment and Outcome Measures for Drug and Alcohol Settings 
 
Drug and Alcohol Severity Screening, Assessment and Outcome Measures 147 
 
Leeds Dependence Questionnaire (LDQ) 
The Leeds Dependence Questionnaire (LDQ) (Raistrick et al., 1994) was developed as a 10-item 
assessment and outcome measure for treatment of substance dependence. In the LDQ, severity of 
dependence incorporates broader notions of psychological dependence rather than simply measuring 
consumption and physically dependent symptoms. It has been shown to have good psychometric 
properties for alcohol and opiates but only limited findings concerning its psychometric properties for 
measuring the severity of dependence on other illicit substances exist. It has been found to be an 
effective assessment and outcome measurement tool (McCambridge & Maria, 2008; Raistrick, Tober, 
Heatherward, & Clark, 2007) 
Preliminary findings indicate the measure has good levels of internal consistency (Cronbach’s alpha = 
.94) and test-retest reliability (r = .95) as well as concurrent, discriminant and convergent validity for 
alcohol and opiate dependence. The LDQ was significantly correlated with the DALI, Severity of Opiate 
Dependence Scale (SODQ) and the SADQ scores (Ford, 2003; Raistrick et al., 1994). However, no specific 
cut-off score has been established to indicate dependence. 
In a recent sample of clinic attendees, the LDQ had high internal consistency. A number of factors were 
independent predictors of higher LDQ scores, these included age (younger), gender (male), higher score 
on the GHQ and substance category (opioid or other drugs compared with alcohol) (Heather, Raistrick, 
Tober, Godfrey, & Parrott, 2001).  
Client groups 
Lennings (1999; 2003) found the LDQ performed well in measuring drug dependence among tertiary 
students and juvenile delinquents. Among students, the LDQ was predictive of alcohol use even after 
controlling for other variables. It has been found to be a comparatively good measure of alcohol 
dependence in a youth population when administered online, with good internal consistency and test-
retest correlation statistics (Thomas & McCambridge, 2008). Similarly, in a sample of psychiatric 
inpatients, Ford (2003) found the LDQ to have very good psychometric properties and suggests it is a 
useful measure of substance dependence in this population.  
It has also been used among Aboriginal and Torres Strait Islanders in research studies (Schlesinger et al., 
2007) but its applicability to these populations has not been sufficiently tested. 
Availability/cost 
The LDQ is in the public domain, and may be used without cost, but with due acknowledgment of the 
source. It is available at: 
• http://eib.emcdda.europa.eu/attachements.cfm/att_3954_EN_leeds.pdf  
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Scoring, administration and expertise required 
The LDQ is a self-completion questionnaire and no qualifications are required for its use. Respondents 
are instructed to answer the questions about their substance use in the past week and to tick the 
relevant response. Each of the items is scored on a “never” (0), “sometimes” (1), “often” (2) and “nearly 
always” (3) scale, yielding a maximum score of 30. 
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Substance Dependence Severity Scale (SDSS) 
The Substance Dependence Severity Scale (SDSS) (Miele et al., 2000a) is a relatively newly developed 
semi-structured clinical interview designed to obtain a measure of severity of dependence on a variety 
of substances, in order to evaluate treatment outcomes. It provides DSM-IV diagnoses of dependence 
for alcohol, cocaine, heroin, stimulants, illicit opiates, sedatives, methadone, cannabis, hallucinations 
and ‘other’ substances (e.g., inhalants). Each substance is rated for symptom severity and frequency in 
the last 30 days. Preliminary validation studies supported the internal consistency and test-retest 
reliability of the SDSS for alcohol, heroin, cocaine and sedative use. The SDSS was found to have 
concurrent and predictive validity in assessing the severity of DSM-IV alcohol, cocaine and heroin 
dependence. The SDSS relies on psychometric evidence for reliability and validity both as a dependence 
severity assessment tool and as a treatment outcome indicator in substance abuse patients (González-
Saiz, 2007). 
The SDSS was validated  using  a sample of 175 recent admissions to both inpatient and outpatient drug 
and alcohol rehabilitation programs, dual diagnosis units and methadone maintenance programs (Miele 
et al., 2000a; Miele et al., 2000b). The internal consistency of the four sub-scales was assessed for 
alcohol, cocaine, heroin, cannabis and sedative use. Internal consistency estimates on the Usual Severity 
Subscale (Cronbach’s alpha = .79-.91), Worst Severity Subscale (Cronbach’s alpha = .67-.89), Total 
number of days the symptom occurred (Cronbach’s alpha = .75-.91) and Total number of days symptom 
at worst severity (Cronbach’s alpha = .66-.82) were mostly in the acceptable range for all substances, 
with estimates for cannabis tending to fall in the lower end of the acceptable range (Miele et al., 2000a). 
Test-retest reliability was found to be generally good to excellent for alcohol, heroin, cocaine and 
sedatives; but moderate for cannabis (Miele et al., 2000a). 
Concurrent validity of the SDSS was demonstrated with severity scale scores for all substances, except 
sedatives, being significantly correlated with clinical dependence severity ratings (DSM-IV). SDSS severity 
and frequency subscales were significantly correlated with frequency of alcohol, heroin, cocaine and 
cannabis use (Miele et al., 2000a; Miele et al., 2000b).  
Further studies found alcohol scales were significantly related to the ASI alcohol composite score but 
not to the ASI drug composite score, while the SDSS cocaine and heroin scales were significantly related 
to the ASI drug composite score but not the ASI alcohol composite score. All SDSS scales were 
significantly correlated with substance-specific measures of the consequences of substance use. As 
evidence of the scale’s predictive validity, it was found that SDSS scores were significantly related to 
length of time to first post-treatment alcohol, cocaine and heroin use (Miele et al., 2000b). 
Miele and colleagues (2001) again found support for the use of the SDSS for assessing the severity of the 
ICD-10 dependence and harmful use diagnoses, however, it appears to perform less well in assessing 
cannabis disorders compared with other drugs. In a sample of 180 substance users, test-retest 
reliabilities for the ICD-10 dependence scales ranged from good to excellent for alcohol, cocaine, heroin, 
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and cannabis (ranging from .69 to .90). Test-retest reliabilities for the SDSS' ICD-10 harmful use scales 
were also adequate for alcohol, cocaine, and heroin (.54-.79) and in the poor to fair range for cannabis 
(.39-.40). Internal consistency, diagnostic concordance, and concurrent validity results were comparable 
to the test-retest findings.  
Client groups 
As explained above, initial verification studies were conducted with a variety of population groups but 
its utility in an Australian context has not been systematically explored. Some concerns are held relating 
to the SDSS cannabis scale as it performed more poorly and inconsistently compared to other scales and 
was not related to other indicators of dependence. This requires further examination, along with 
instrument’s reliability and validity for assessing sedative and other drug dependence. 
Availability/cost 
A copy of the SDSS may be requested from:  
• Gloria Miele, Research Assessment Associates, Inc., 60 Haven Avenue, Suite 4D, New York 
NY10032, USA, Tel. (001) 212 781 1678, E-mail: gmm23@columbia.edu.   
• http://pubs.niaaa.nih.gov/publications/Assesing%20Alcohol/InstrumentPDFs/67_SDSS.pdf  
Scoring, administration and expertise required 
The interview takes approximately 30 to 45 minutes to administer depending on the number of 
substances. However, it was designed to be administered by clinicians with a post-graduate degree and 
clinical experience with patients with substance abuse or mental disorders. A separate score sheet is 
used for every substance used in the past 30 days. This results in each substance having four sum scores 
for usual severity, worst severity, total number of days symptom occurred and total number of days 
symptom at worst severity. Each scale is scored on a slightly different scoring range. Computerised 
scoring and interpretation is available. 
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Severity of Dependence Scale (SDS) 
The Severity of Dependence Scale (SDS) (Gossop et al., 1995) is a brief, five-item screening measure of 
psychological aspects of dependence. It was originally included as the final section in the SODQ. The SDS 
has been validated across a range of drug using groups, including heroin, cannabis, cocaine, 
amphetamine and benzodiazepine users (de las Cuevas, Sanz, de la Fuente, Padilla, & Berenguer, 2000; 
Gossop et al., 1995; Martin, Copeland, Gates, & Gilmour, 2006).  
Studies among heroin, amphetamine and cocaine users have shown the SDS to be a reliable measure of 
psychological dependence. The SDS has been found to have good internal consistency (Cronbach’s alpha 
ranging from .80 to .90) and good test-retest reliability (.89) over a one day interval in a sample of 
heroin users (Gossop, Best, Marsden, & Strang, 1997; Gossop et al., 1995). The construct validity of the 
SDS has been supported by significant correlations with behavioural indices of dependence including 
dose, frequency and duration of use (Darke, Ross, & Hall, 1996). Severity of dependence was also 
influenced by route of drug administration, with heroin smokers having significantly lower dependence 
scores than those who injected. 
Other studies concerning the SDS for cannabis dependence compared with alcohol and opiate 
dependence, have been weaker, with the SDS demonstrating only a moderate level of internal 
consistency (Cronbach’s alpha = .72) (Swift, Hall, Didcott, & Reilly, 1998). However, the SDS total score 
was more strongly related to the belief that cannabis use was a problem than the ICD or DSM-III-R 
scores. At a cut-off score of 3 as indicative of cannabis dependence as identified by the CIDI, the SDS was 
found to show sensitivity of 64% and specificity of 82% for cannabis users (Swift et al., 1998).  
More recent studies however, have found the SDS to be a brief, valid and reliable screen for cannabis 
dependence among people with psychosis. The scale has been found to demonstrate high levels of 
internal consistency and strong construct and concurrent validity in this population. Individuals with a 
score of 2 on the SDS were nearly 30 times more likely to have DSM-IV cannabis dependence (Hides, 
Dawe, Young, & Kavanagh, 2007). The SDS was the strongest predictor of DSM-IV cannabis dependence 
after controlling for other predictor variables. Similarly, Martin and colleagues (2006) found the SDS to 
have good internal consistency (Cronbach’s alpha = 0.83) and test-retest reliability (0.88) in adolescent 
cannabis users. Total SDS score correlated significantly with frequency of cannabis use and a number of 
DSM-IV dependence criteria, indicating good concurrent validity. These authors suggested, however, 
that a cut-off score of 4 was optimal for use as an indicator of cannabis dependence.  
In a recent study of Sydney cocaine users, the SDS was found to also have optimal sensitivity (67%) and 
specificity (93%) for both males and females at a cut-off of ≥3. The authors concluded that the SDS to be 
a test of high diagnostic utility for the measurement of cocaine dependence, when compared with the 
CIDI (Kaye & Darke, 2002). Others have reported this cut-off score to also be optimal for alcohol 
dependence (Lawrinson, Copeland, Gerber, & Gilmour, 2007). 
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In a sample of 100 regular benzodiazepine users attending a mental health service, de las Cuevas and 
colleagues (2000) examined the utility of the SDS as a screening instrument for benzodiazepine 
dependence. Reliability analysis using Cronbach’s alpha yielded a value of .81. Using a cut-off score of 6 
for problematic benzodiazepine use identified by the CIDI, the SDS demonstrated specificity of 94.2% 
and a sensitivity of 97.9%. 
It has also been found to be a useful instrument to measure treatment outcome and forms a part of the 
BTOM (Gossop, Stewart, & Marsden, 2007; Lawrinson et al., 2003; Sannibale et al., 2005). 
Client groups 
The SDS has been validated in a range of translations (Chen et al., 2008; Ferri, Marsden, de Araujo, 
Laranjeira, & Gossop, 2000; Gu et al., 2008; Steiner, Baumeister, & Kraus, 2008) and used in both 
adolescent and elderly populations (Cook, Biyanova, Thompson, & Coyne, 2007; Lozano et al., 2008; 
Thomas & McCambridge, 2008). The tool has been translated (and back translated) into Vietnamese in a 
Sydney study of heroin users (Swift et al., 1999). The wording of the SDS is straightforward and the 
concepts appear to be understood by a variety of drug users. It has also been used among Aboriginal 
and Torres Strait Islanders in research studies (Schlesinger et al., 2007), but its applicability to these 
populations has not been sufficiently tested. 
The utility of the SDS as a measure of cannabis dependence was recently examined among a sample of 
sample of 153 in-patients with a schizophrenia spectrum disorder in a recent Australian study (Hides, 
Dawe et al., 2007). The SDS had high internal consistency, with Cronbach's alpha of 0.81 and optimal 
sensitivity (86%) and specificity (83%) at a cut-off point of ≥2. At this cut -off, the SDS significantly 
predicted the presence of DSM-IV cannabis dependence using the CIDI (Hides, Dawe et al., 2007). 
Availability/cost 
The SDS is incorporated into the BTOM it is available at:  
• http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_11/$file/TR.156.PDF 
The version for cannabis is available at: 
• http://ncpic.org.au/assets/downloads/workforce/cannabisinfo/assessment-tools/severity-of-
dependence-scale  
It is also freely available online at: 
• http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2636780  
• http://eib.emcdda.europa.eu/html.cfm/index7343EN.html  
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Scoring, administration and expertise required 
The SDS self-report contains only five items and takes less than one minute to complete and one minute 
to score. Each item is scored on a four-point scale, and no specific training is required for use of the 
scale. 
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Craving measures 
There are limited measures designed specifically to measure craving and fewer still that measure craving 
generally across all substances. The majority have been aimed at assessing cocaine craving specifically 
and many have been insufficiently evaluated to warrant strong recommendation across all groups. 
Cocaine Craving Questionnaire (CCQ) 
The Cocaine Craving Questionnaire (CCQ) (Tiffany, Singleton, Haertzen, & Henningfield, 1993) is a 45-
item questionnaire on cocaine craving. Two versions exist: The Now version which measures current 
craving for cocaine, and the General version measuring average craving over the preceding week. The 45 
items of the CCQ are grouped according to the live content categories: desire to use, intention/planning, 
anticipation of positive outcome, anticipation of relief for withdrawal/dysphoria, lack of control over 
use.  
Internal consistency of the different scales was moderate to high (.70-.93). Examination of item content, 
correlations of factors across versions, and external correlates of the factors suggested that both 
versions were represented by the same hierarchical factor structure. Higher total scores on the CCQ-
Now were associated significantly with lower confidence in ability to quit using cocaine, greater 
frequency of use over the past 6 months, current negative mood, and lifetime use of cocaine (Tiffany et 
al., 1993). 
A shorter, 10-item version has also been developed (CCQ-Brief) and was found to be significantly 
correlated with the original, the Voris Cocaine Craving Scale, the BDI-II, the BAI and recent drug use. The 
internal consistency of the CCQ-Brief was strong (alpha = .90). The authors concluded that the CCQ-Brief 
was a valid and reliable instrument that can be easily administered as a measure of current cocaine 
craving (Sussner et al., 2006). 
Client groups 
The CCQ has been used in psychiatric populations (Brown, Nejtek, Perantie, Orsulak, & Bobadilla, 2003; 
Copersino et al., 2004; Smelson et al., 2002) and in different cultural groups (da Silveira, Fernandes, 
Silveira, & Jorge, 2006). However, to the author’s knowledge there are no validation studies in 
Australian samples. 
Availability/cost 
The CCQ-Brief is available in Sussner and colleagues (2006). 
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Scoring, administration and expertise required 
The CCQ is scored on a 7-point Likert-type scale on the extent to which the individual agreed or 
disagreed with each item. The endpoints of the scale are labeled ‘strongly disagree’ (1) and ‘strongly 
agree’ (7). The 45-item General version of the CCQ was constructed from the Now version by rewriting 
each item in the past tense. The CCQ requires little training and is administered by the client. The CCQ-
Brief takes less time to administer than the full version (less than 5 minutes compared to approximately 
10-15 minutes). 
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Weiss Cocaine Craving Questionnaire 
An identically named Cocaine Craving Questionnaire created by Weiss and colleagues (1995; 1997) 
consisted of only 3-5 questions to measure different aspects of cocaine craving: 1) current intensity, 2) 
intensity during the previous 24 hours, 3) frequency, 4) responsiveness to drug-related conditioned 
stimuli, and 5) imagined likelihood of use if in a setting with access to drugs. The scale has a high level of 
internal consistency, with Cronbach’s alpha ranging from a low of 0.82 to a high of 0.94 in hospitalised 
cocaine users and 0.85 to 0.90 in outpatients and each of the five items showed significant decreases in 
craving over time. However, the scale showed a lack of predictive validity (Weiss et al., 1995). 
The scale was shortened to just three items in a later study (Weiss et al., 2003):  
1. Please rate how strong your desire was to use cocaine during the last 24 hours. 
2. Please imagine yourself in the environment in which you previously used drugs and/or alcohol. If 
you were in this environment today, what is the likelihood that you would use cocaine? 
3. Please rate how strong your urges are for cocaine when something in the environment reminds 
you of it. 
The two items eliminated were those that correlated most highly (0.78–0.91) with the remaining items 
and that added no predictive validity to the questionnaire. The omitted items were the following: 
1. Please rate how strong your desire for cocaine is right now. 
2. Please rate how often you had the urge to use cocaine during the past 24 hours. 
Cronbach’s alpha for the three-item Cocaine Craving Scale was high (0.78) and the tool was found to 
predict the relative likelihood of cocaine use during the subsequent week (Weiss et al., 2003). 
An amphetamine version of the 3-item Cocaine Craving Scale has also been developed (Shearer, in 
press). 
Availability/cost 
The Cocaine Craving Questionnaire is outlined above, and scoring below. 
Client groups 
To this author’s knowledge there are no studies examining the questionnaire’s applicability to specific 
populations. 
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Scoring, administration and expertise required 
No training is required for the use of the scale and it takes less than 5 minutes to complete. Response 
options ranged from 0 for “no desire/likelihood of use” to 9 for “strong desire/likelihood of use.” The 
composite score was a sum of these three items, ranging from 0 to 27. 
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Marijuana Craving Questionnaire (MCQ) 
The Marijuana Craving Questionnaire (MCQ) (Heishman, Singleton, & Liguori, 2001) is a 47-item self-
report measure assessing demographics, drug use history, marijuana quit attempts and current mood. It 
was based on the CCQ and measures four constructs characterising marijuana craving: Compulsivity (an 
inability to control marijuana use); Emotionality (use of marijuana in anticipation of relief from 
withdrawal or negative mood); Expectancy (anticipation of positive outcomes from smoking marijuana) 
and Purposefulness (intention and planning to use marijuana for positive outcomes). 
The subscales were found to have adequate internal consistencies, low to moderate positive 
intercorrelations and were significantly correlated with marijuana use history and a wide range of single-
item measures of craving. The authors concluded that the MCQ is a valid and reliable instrument for 
assessing marijuana craving in individuals not seeking drug abuse treatment and that marijuana craving 
can be measured in the absence of withdrawal (Heishman et al., 2001). A follow up study using active 
imagery of auditorily presented scripts verify and extend the reliability and validity of the MCQ as a 
multidimensional measurement of marijuana craving (Singleton, Trotman, Zavahir, Taylor, & Heishman, 
2002). 
Availability/cost 
The MCQ is available upon request from: 
• Stephen J. Heishman, PhD, National Institute on Drug Abuse (NIDA) Ph: 410-550-1547 Fax: 410-
550-1849 E-mail: sheish@intra.nida.nih.gov 
Client groups 
To this author’s knowledge there are no studies examining the questionnaire’s applicability to specific 
populations. 
Scoring, administration and expertise required 
The MCQ takes approximately 7 minutes to compete, which is adequate for both research and clinical 
purposes (Heishman et al., 2001). Each item is rated on a seven-point Likert-type scale from “strongly 
disagree” to “strongly agree”. A shorter 12-item version of the instrument also exists. 
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Penn Alcohol-Craving Scale (PACS) 
The Penn Alcohol-Craving Scale (PACS) (Flannery, Volpicelli, & Pettinati, 1999) is a 5-item, single-factor 
scale that is quickly and easily administered. The first three questions are centered on the frequency, 
intensity, and duration of thoughts about drinking. The fourth question asks the individual to rate 
his/her ability to resist drinking if alcohol is available. The final question asks the subject to rate his/her 
overall average craving for alcohol during the previous week. 
The PACS demonstrated excellent internal consistency. Construct validity of the PACS was demonstrated 
via its convergence with two commonly used measures for assessing craving, the Obsessive Compulsive 
Drinking Scale and the Alcohol Urge Questionnaire. Lack of correlation between PACS scores and several 
other non-craving, self-report measures indicate that the PACS also had good discriminant validity. 
Additional analyses revealed that there were significant differences in craving scores during the initial 3 
weeks of the trial among those who did and those who did not relapse during weeks 3-12 indicating 
good predictive validity (Flannery et al., 1999). A later study found that scores on the PACS were the 
strongest predictor of drinking during treatment when compared with the Obsessive Compulsive 
Drinking Scale and the Alcohol Urge Questionnaire. 
Availability/cost 
The PACS is freely available in Flannery and colleagues (1999), with copyright held by the Journal, 
alternately, copies can be obtained from:  
• Barbara Flannery RTI International 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, 
NC 27709-1294; Phone: 919-316-3457; Fax: 919-541-6683; E-mail: bflannery@rti.org  
Client groups 
There is a dearth of empirical investigation of the use of the PACS in different populations. However, it 
has been used in both inpatient and outpatient care and in an Australian context (Flannery et al., 1999; 
Richardson et al., 2008; Yoon, Kim, Thuras, Grant, & Westermeyer, 2006). 
Scoring, administration and expertise required 
Each question is scaled from 0 to 6. It can be administered without training and takes less than 5 
minutes to administer, score and interpret. 
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Conclusion 
It is important to stress that the list above is not exhaustive but it nevertheless aims to provide a useful 
review of the available tools which have utility for screening, assessment and outcome measurement 
across mental health, D&A and general health/social functioning. Although no tool can fit all needs and 
requirements, some instruments may be more useful than others depending on a clinician’s particular 
work environment and the client they are working with.  
The author was asked to review the measures in terms of their psychometric properties, applicability 
and ease of use across a range of settings by a range of professionals as well as availability and cost. 
With these criteria in mind, the measures reviewed in this document that may be particularly useful are 
the AATOM and the BTOM as global measures, the CAN, the SF-12 and the LSP as general social 
functioning measures, the AUDIT and ASSIST for problematic drug and alcohol use, and the K10 for 
general mental health.  
The contents of this review document will inform NADA’s choice of measures to be included in the NGO 
Drug and Alcohol and Mental Health Information Management Project.  
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